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Abbreviations 
GIT   Gastrointestinal tract 
SI   Small intestine 
LP   Lamina propria 
M cells  Microfold cells 
GALT   Gut-associated lymphoid tissue 
DSS   Dextran sodium sulphate 
TFF3   Trefoil factor 3 
IECs   Intestinal epithelial cells 
APCs   Antigen presenting cells 
TJ   Tight junction 
EPEC   Enteropathogenic Escherichia coli 
PRR   Pattern recognition receptor 
HD   Human -defensin 
MMP   Matrix metalloprotease 
HBD-1   Human-β-defensin-1 
MBD-2   Murine β-defensin 2 
DC   Dendritic cell 
sIgA   Secretory immunoglobulin A 
MLN   Mesenteric lymph node 
IL   Interleukin 
TGF-β  Transforming growth factor-β 
RA   Retinoic acid 
J   ‘joining’ chain 
 pIg   Polymeric-immunoglobulin 
VH   Variable region 
BAFF   B cell-activating factor 
APRIL   B cell proliferation-inducing ligand 
LPS   Lipopolysaccharide 
PRRs   Pattern recognition receptors 
MAMPs   Microbe-associated molecular patterns 
TLRs   Toll-like receptors 
NLRs   Nod-like receptors 
LRR   Leucine-rich repeats 
TIR   Toll-interleukin 1 receptor 
CARD   Caspase recruitment domain 
NOD   Nucleotide-binding oligomerisation domain 
PG   Peptidoglycan 
MyD88   Myeloid differentiation primary response gene 88 
MAPK   Mitogen-activated protein kinase 
NF-κB   Nuclear factor κB 
IKK   IκB kinase 
IFN   Interferon  
TNF   Tumor necrosis factor 
MCP-1 or CCL-2  Monocyte chemotactic protein-1 
PPARγ  Peroxisome proliferator-activated receptor-γ 
TOLLIP   Toll-interacting protein 
TSLP   Thymic stromal lymphopoietin 
IDO   Indoleamine 2,3 dioxygenase 
IBD   Inflammatory bowel disease 
CD  Crohn’s disease 
UC  Ulcerative colitis 
Tregs  Regulatory T cells 
Th  T helper 
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1. Mutualistic host-microbe relationships 
The mammalian gastrointestinal tract (GI-tract) is specialized in the digestion and absorption 
of nutrients and is colonized by a myriad of symbiotic microorganisms collectively known as 
the microbiota. In the course of evolution the symbiotic relationship between the host and 
the microbiota has become largely mutualistic, benefiting both partners. The concentration 
of bacteria forms a gradient from the stomach, and small intestine (SI) to the colon where 
densities reach around 1012 bacteria per gram of luminal content (Whitman, Coleman et al. 
1998). Colonic bacteria can ferment complex carbohydrates, not digested in the upper GI-
tract, and provide energy to their host. In humans, this accounts for 6-9% of the total energy 
requirement whereas it can be as high as 44% for ruminants (McNeil 1984; Hume, Nisbet et 
al. 1997). Bacterial fermentation produces short chain fatty acids (SCFA), vitamins and other 
nutrients. Butyrate, one of the SCFA produced in the intestinal lumen by bacterial 
fermentation, is the main energy source for colonic epithelial cells. Other functions of the 
microbiota include the competitive exclusion of pathogens and the contribution to the 
development of the host immune system. Compared to conventional mice, germ-free mice 
have an underdeveloped mucosal immune system. Germ-free mice have smaller Peyer’s 
patches (PP) and mesenteric lymph nodes (MLN), fewer intraepithelial and lamina propria 
(LP) lymphocytes and lymphoid follicles compared to mice housed in specific pathogen free 
(SPF) conditions (Hooper and Macpherson 2010). Bacterial colonization of germ-free mice 
induces major changes in epithelial morphology and function as well as the development of 
the mucosal-associated lymphoid tissue. In addition to these developmental aspects, the 
microbiota contributes to homeostasis of tolerance and immunity through interactions of 
microbial metabolites and other components with the innate and adaptive immune systems. 
The role of specific organisms or groups of bacteria in intestinal homeostasis is just 
beginning to be unravelled and some key examples are discussed in the following sections.  
 
2. A delicate balancing act   
The coevolution of a mutualistic relationship between the host and the microbiota required 
the mucosal immune system to develop the ability to defend the body against infections of 
pathogenic microorganisms while avoiding excessive inflammatory responses to harmless 
antigens and commensal bacteria. 
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Figure 1: The mucosal epithelium, lamina propria cells and gut-associated lymphoid tissue in the small 
intestine. Intestinal homeostasis is maintained by several mechanisms involving epithelial cells, connective 
tissue and immune cells. A single layer of intestinal epithelial cells separates the luminal contents from the 
lamina propria. In the basolateral space between epithelial cells are positioned intraepithelial lymphocytes. The 
epithelium is covered by a thick layer of mucus produced by goblet cells. Enterocytes and specialized Paneth 
cells in the crypts are able to secrete antimicrobial peptides (AMP) preventing bacterial growth in proximity to 
the epithelium. Plasma cells in the lamina propria produce secretory IgA (sIgA) that mediates bacterial 
exclusion. The luminal content is continuously sampled by specialized epithelial cells and immune cells. In the 
follicle associated epithelium (FAE) of the Peyer’s patch (PP) or isolated lymphoid follicles, M cells transcytose 
bacteria and antigens. In the LP and PP, CX3CR1
+
 macrophages and DCs sample microbes and antigens through 
the epithelium to support inflammatory responses. DCs, macrophages and M cells deliver antigens and bacteria 
to antigen presenting cells (APCs). Activated APCs then move to the follicular area of the PP or they migrate to 
the mesenteric lymph nodes through the lymphatic system and present the antigen to naïve lymphocytes. 
Mature DCs drive the differentiation of naïve CD4
+ 
T lymphocytes into effector T cells, helper T cells (Th1, Th2, 
Th17) or regulatory T cells (Tregs).  
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Inflammation, the acute response to harmful stimuli including microorganisms, is a crucial 
component of this host defence. In part, the protective consequences of triggering 
inflammation result from increased vascular permeability and attraction of phagocytes to 
engulf and kill invading microorganisms. The interaction of antigen presenting phagocytes 
with the adaptive immune system then leads to protracted cellular and humoral responses 
and immunological memory against “non-self” antigens. However, if the host is not 
immunologically tolerant to commensal microbes it can cause damage to host tissues as 
seen in inflammatory bowel disease. The host must also be able to elicit a localized 
inflammatory response to an invading pathogen while, at the same time, preserving 
homeostasis in the uninfected tissues. It is this delicate act of balancing opposing functions 
that we focus on in this chapter. In the intestine, homeostasis of inflammation is maintained 
by a complex network of microbe and host cell interactions involving numerous negative 
feedback and feed-forward controls. The interacting cell types include epithelial cells, 
connective tissue cells and both innate and adaptive immune cells (macrophages, dendritic 
cells and lymphocytes) residing in the LP (Figure 1). The LP is a layer of loose connective 
tissue between the epithelium and the muscularis mucosa, containing lymphatic ducts and 
blood vessels. The main homeostatic mechanisms involve the compartmentalization of 
bacteria by physical and chemical barriers (discussed in section 3), the continuous 
surveillance of the microbial content by innate receptors (discussed in section 4), the 
induction of secretory antibody responses and a state of immunological tolerance to 
commensals and food antigens (discussed in section 5).  
Failure of intestinal immune homeostasis is clearly implicated in inflammatory bowel 
diseases (discussed in the section below), where several immunity gene defects interact with 
environmental factors including the microbiota to cause chronic intestinal inflammation. 
 
2.1. Loss of tolerance to the microbiota in inflammatory bowel disease  
Inflammatory bowel disease (IBD) is a collective term for Crohn’s disease (CD) and ulcerative 
colitis (UC) that are chronic intestinal inflammatory disorders caused by failure of intestinal 
homeostasis and inappropriate immune responses to the microbiota (Janowitz, Croen et al. 
1998). CD is characterized by transmural inflammation in the ileum and colon while in UC the 
inflammation affects only the colonic and rectal mucosa. The origin of IBD is multifactorial, 
involving genetic predisposition, environmental factors and an imbalance between beneficial 
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and potentially harmful species in the microbiota. Genome-wide association studies have 
implicated several genetic polymorphisms in IBD (Wellcome Trust Case Control 2007). The 
genes identified to date are all involved in innate immunity or intestinal barrier functions. In 
monozygotic twins with known genetic risk factors for IBD, the concurrence of disease is 
relatively low demonstrating the importance of environmental factors including the 
microbiota (Wellcome Trust Case Control 2007).  
Compared with healthy individuals, IBD patients show a reduction in the abundance and 
diversity of Firmicutes and Bacteroidetes (Frank, St Amand et al. 2007) and CD patients have 
increased numbers of adherent-invasive Escherichia coli (Barnich, Carvalho et al. 2007). 
Despite the above observations, a causal relationship between specific microorganisms and 
the disease remains unproven. On the other hand, several studies have shown a protective 
effect of specific commensal bacteria or their components against colitis in different mouse 
models, highlighting the importance of commensal bacteria in the maintenance of 
homeostasis and tolerance. For example, the human commensal Faecalibacterium 
prausnitzii, which is reduced in CD patients, protects mice from 2,4,6-trinitrobenzene 
sulfonic acid (TNBS)-induced colitis and induces high IL-10 and low IL-12 secretion in human 
peripheral blood mononuclear cells in vitro (Sokol, Pigneur et al. 2008). Another example is 
Bacteroides fragilis that protects mice from Helicobacter hepaticus-induced colitis 
(Mazmanian, Round et al. 2008). B. fragilis also induces IL-10 secretion in CD4+ T cells and 
prevents the expansion of Th17 cells in mono-associated mice, these effects are mediated by 
bacterial polysaccharide A (PSA) (Round, Lee et al. 2011). Furthermore, colonization of germ-
free mice with a cocktail of 46 strains of mouse commensal Clostridium induces an 
accumulation of regulatory T cells (Tregs) in the colon LP (Atarashi, Tanoue et al. 2011). 
These findings suggest that not only the bacteria themselves but also their products play a 
role in the maintenance of homeostasis and can have beneficial effects. 
In the following sections, we discuss in more detail how homeostasis is maintained in the SI 
and colon, which are permanently colonized by commensal bacteria and sometimes 
opportunistic or obligate pathogens.  
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3. Keeping microbes at a distance 
At the tissue level, antimicrobial factors, secretory antibodies and physical barriers limit 
exposure of the mucosal tissue to microorganisms. The mucus layer covering the epithelium 
and the epithelium itself constitute the two major physical barriers (Figure 1).  
 
3.1. Physical barriers, the mucus layer 
The first physical barrier encountered by the luminal microbes is the mucus, a thick layer of 
mucin glycoprotein secreted by specialized goblet cells in the epithelium. The mucus is 
constantly produced and removed by peristaltic flushing. In the colon, the mucus layer 
extends about 150 µm from the epithelial cell surface and can be divided in two structurally 
different layers, an outer mucus layer containing bacteria and a firmly attached inner layer 
that is almost devoid of bacteria (Johansson, Phillipson et al. 2008) (Figure 2). However, 
enteric pathogens such as Campylobacter jejuni, Samonella enterica and Vibrio cholerae are 
able to penetrate the mucus using flagella, which allow movement towards or away from a 
chemical stimulus. The spiral-shape and secreted proteases of these pathogens are also 
thought to facilitate movement through viscous mucus (Lee, O'Rourke et al. 1986; Takata, 
Fujimoto et al. 1992; Guerry 2007). Flagella are not only a feature of pathogenic bacteria and 
some prominent members of the microbiota of animals and humans such as Roseburia sp. 
and Wolinella succinogenes, a close relative of C. jejuni, are flagellated. In contrast to the 
colon, the mucus layer in the SI is thinner and possibly more penetrable to the contents of 
the lumen (Johansson, Larsson et al. 2011).  
Mice lacking MUC2, the gene encoding the major mucin in the human intestine, 
spontaneously develop colonic inflammation, highlighting the protective role of the mucus in 
limiting direct contact between bacteria and epithelial cells (Van der Sluis, De Koning et al. 
2006; Johansson, Larsson et al. 2011). Furthermore, in the development of dextran sodium 
sulphate (DSS)-induced colitis, the inner mucus layer becomes permeable to bacteria, which 
then contact epithelial cells and trigger an inflammatory response (Johansson, Gustafsson et 
al. 2010). 
The outer layer of the mucus is home to many commensal mucin-degrading bacteria that 
derive nutrients from enzymatic breakdown of the glycan structures. Nevertheless very few 
mucin dwelling bacteria have been isolated and characterized except for Akkermansia 
muciniphila (Derrien, Vaughan et al. 2004). Interestingly, SCFA have been shown to 
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modulate the expression of MUC2 in a human goblet cell-like cell line. This highlights a 
potentially important regulatory link between metabolites produced by fermentative colonic 
bacteria and the host defenses (Burger-van Paassen, Vincent et al. 2009). 
 
Figure 2: Physical and chemical defenses. Multiple chemical and physical barriers are in place to separate the 
luminal content from the intestinal epithelium. Intestinal epithelial cells are covered by a layer of mucus that 
consists of mucin glycoproteins secreted by goblet cells. The mucus layer forms an outer layer permeable to 
bacteria and an inner layer which is relatively devoid of bacteria. a) Goblet cells also produce trefoil factor 3 
(TFF3) in response to TLR2 signalling which mediates intestinal epithelial repair. b) Enterocytes, Paneth cells 
and goblet cells secrete constitutive and inducible antimicrobial peptides (AMP) that modulate immune 
functions. c) In isolated lymphoid follicles (ILFs), DC- and epithelial cell- derived factors such as the B cell-
activating factor (BAFF) and a proliferation-inducing ligand (APRIL), drive B cell differentiation into plasma cells 
that produce secretory immunoglobulin A (sIgA). d) sIgA is transported through IEC to the lumen where it can 
bind to bacteria to prevent their attachment or invasion and neutralize toxic molecules. 
 
Goblet cells also facilitate mucosal protection and epithelial repair through the production of 
trefoil factor 3 (TFF3) which induces migration and anti-apoptotic pathways in IECs (Figure 2) 
(Mashimo, Wu et al. 1996). Goblet cells appear to regulate TFF3 via a Toll-like receptor 2 
(TLR2)-dependent pathway (described in section 4) (Podolsky, Gerken et al. 2009). Thus, 
TLR2 knockout mice are deficient in TFF3 and have an increased susceptibility to DSS-
induced colitis. This provides another example of how the sensing of bacteria by the host 
intestinal epithelium regulates the expression of homeostatic factors. 
It is not known why commensal bacteria can colonize the outer mucus layer but not the 
inner layer of the colonic mucus. We also need more knowledge about the diffusion of 
bacterial TLR ligands through the mucus, mucus degrading bacteria and the mucus structure 
and function in the SI. 
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3.2. Physical barriers, the intestinal epithelium  
The most important physical barrier is the intestinal epithelium, a 30 µm single layer of IECs 
that separates the lumen from the underlying LP and the inside of the body. IECs are 
polarized having an apical and a basolateral pole each with a distinct composition of 
membrane proteins, lipids and receptors. The apical pole of mature enterocytes contains 
microvilli, finger-like membrane protrusions that increase the surface area for exchange of 
nutrients and water. The basolateral pole is attached to a matrix of loose connective tissue 
in the LP. The intestinal epithelium is renewed approximately every 5 days in humans due to 
proliferation and differentiation of multipotential Lgr5-expressing stem cells located in the 
crypts of Lieberkühn (Sato, Vries et al. 2009). Terminally differentiated cells undergo 
apoptosis and exfoliation at the tips of small intestinal villi or the equivalent epithelial 
surface in the colon. This dynamic renewal process also serves as a protective mechanism to 
remove cells that may have been damaged or invaded by pathogens. As the cells migrate 
upwards from the crypt, they differentiate into three different cell lineages; enterocytes, 
enteroendocrine cells and mucus producing goblet cells (Yen and Wright 2006). In the SI, the 
stem cells migrating to the bottom of the crypt differentiate into Paneth cells which produce 
a range of antimicrobial factors to protect the crypt cells from infection with microorganisms 
(Garabedian, Roberts et al. 1997; Salzman, Underwood et al. 2007). Remarkably, the process 
of continuous epithelial replacement occurs without compromising the integrity of cell-to-
cell junctions and intestinal permeability. The importance of maintaining junctional integrity 
is evident from studies in mice which have molecular defects in tight junction (TJ) proteins, 
such as JAM-A (Laukoetter, Nava et al. 2007), or regulatory mechanisms affecting TJ 
properties (Su, Shen et al. 2009). TJs are the most apical structures of cell-to-cell junctions 
and are composed of transmembrane proteins (such as occludins and claudins) and 
intracellular scaffold proteins (such as ZO-1, -2 and -3). TJs seal the intercellular space 
between adjacent cells thus creating a selective barrier keeping out microorganisms and 
macromolecules while allowing diffusion of fluids, electrolytes and small molecules through 
the paracellular space. TJs are crucial for the development and maintenance of epithelial 
polarity as they also prevent diffusion of plasma membrane components from the apical to 
the basolateral pole and vice versa. In mouse models and humans, increased intestinal 
epithelial permeability may precede the development of colitis (Olson, Reuter et al. 2006; 
John, Fromm et al. 2011; van Schaik, Oldenburg et al. 2012) and is characteristic of chronic 
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intestinal inflammation in humans and animals due to the effect of inflammatory cytokines 
on TJ regulation (Ye, Ma et al. 2006).  
Many enteric pathogens have evolved ways to disrupt the TJs of epithelial cells as a means 
to gain nutrients or to cross the epithelial barrier. For example, this can involve proteolytic 
degradation of specific TJs, e.g. with enterotoxin/fragilysin producing strains of Bacteroides 
fragilis. Disruption of TJs may also occur by phosphorylation or dephosphorylation of TJ 
proteins because of the injection of specific effectors into the host cell by a type III secretion 
system. For example, during infection with enteropathogenic E. coli (EPEC) a type III 
secretion system delivers several effectors into the host cytoplasm (McDaniel, Jarvis et al. 
1995), leading to rearrangements of the cytoskeleton, disruption of the cell membrane and 
apoptosis of IECs. This induces the effacement of microvilli and the formation of a cell 
protrusion known as a pedestal. In addition to these morphological and physiological 
changes, EPEC also causes the dephosphorylation of occludin (Simonovic, Rosenberg et al. 
2000) and altered distribution of ZO-1 (Philpott, McKay et al. 1996).  
In contrast to enteric pathogens, different species of commensal lactobacilli have been 
reported to enhance barrier function and/or protect against barrier disruption by pathogens 
in vitro (Wells, Kostantinov et al. 2008). Recently, Lactobacillus plantarum was shown to 
modulate TJ composition in human volunteers. In this landmark study, administration of L. 
plantarum to human volunteers increased the localization (immunofluorescent staining) of 
occludin and ZO-1 in the TJs in duodenal tissue biopsies. In vitro, TJ modification was 
mediated by TLR2 ligands and conferred protection against disruption of the TJs by phorbol 
ester (Karczewski, Troost et al. 2010). These results are in agreement with recent studies in 
mice showing protection from colitis by administration of TLR2 ligands and growing evidence 
that TLR signalling in the intestinal epithelium is crucial for homeostasis (Cario, Gerken et al. 
2007).  
Apart from serving as a semi-permeable physical barrier, the epithelium plays a key role in 
secreting antimicrobial factors to kill pathogens and microbes in proximity to the apical 
surface, which is discussed in the following section. 
 
3.3. Homeostatic effects of epithelial antimicrobial peptides and polypeptides 
Antimicrobial peptides (AMPs) and polypeptides provide the first line of chemical protection 
against pathogenic or commensal organisms that penetrate the mucosal barrier. In this 
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section, we specifically review the contribution of the enterocyte and Paneth cell produced 
antimicrobial factors to homeostasis. There have been excellent reviews covering other 
aspects such as structure and mechanism of action, including also immune cell defensins 
(Klotman and Chang 2006; Lai and Gallo 2009). Paneth cells are localized in the crypts of 
Lieberkühn throughout the SI of most mammals. A characteristic feature of Paneth cells is 
the extensive Golgi network that directs large electron dense secretory granules to the apical 
membrane for release into the crypt. The granules contain several antimicrobial factors 
including α-defensins, angiogenin-4, secretory phospholipases, lysozyme, Reg3-γ as well as 
pro-inflammatory cytokines and pattern recognition receptor (PRR) co-receptors 
(Stappenbeck 2009). In the mouse, six α-defensins have been characterized but genetic 
evidence suggests there may be as many as 17 defensin encoding mRNA expressed in the 
crypt. In humans, Paneth cells express α-defensins 5 and 6 (human α-defensin, HD). The α-
defensins are secreted as a precursor form which is activated by trypsin (or matrix 
metalloprotease (MMP) 7 in the mouse) to confer antimicrobial activity.  
Evidence for the role of Paneth cell defensins in protection of the epithelial barrier was 
demonstrated by expression of human HD-5 in transgenic mice. As a result, these mice were 
much more resistant to challenge with Salmonella typhimurium (Salzman, Ghosh et al. 2003) 
than the wild type mice strain. Mice deficient for MMP7 were used to show that the activity 
of α-defensins against the normal microbiota is important in shaping its composition 
(Salzman, Hung et al. 2010). This may be due to differences in the sensitivity of different 
microorganisms to α-defensins, their location and inter-dependencies in the intestinal 
environment. Moreover, it has important implications for IBD because changes in defensin 
production may contribute to the pathophysiology of the disease by altering the 
composition and thus the symbiotic or antagonistic activities of the microbiota. Notably, 
NOD2 polymorphisms in CD patients are associated with reduced expression of AMPs and 
loss of immune tolerance to the microbiota (Hugot, Chamaillard et al. 2001; Maeda, Hsu et 
al. 2005; Wehkamp, Salzman et al. 2005). Whereas, some components of Paneth cell 
granules are expressed in equal amounts in germ-free and colonized mice, others are 
induced by microbial exposure (e.g. Reg3-γ and angiogenin-4) (Hooper, Stappenbeck et al. 
2003; Cash, Whitham et al. 2006). Using a transgenic mouse model in which MyD88 was 
expressed in Paneth cells in a MyD88-/- background, it was shown that TLR signalling by 
commensal bacteria induces expression of several antimicrobial factors including Reg3-γ and 
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Reg3-β that inhibit growth of bacterial pathogens and commensals in the crypts of the SI 
(Vaishnava, Behrendt et al. 2008). Loss of MyD88-dependent TLR signalling did not influence 
the density of luminal bacteria emphasizing the key role for Paneth cells in protecting the 
crypt from colonization with commensal or pathogenic bacteria.  
Intestinal enterocytes have also been shown to express antimicrobial factors including β-
defensins and Reg3 proteins, which are evolutionarily conserved in mammals. In humans, 
beta-defensin-1 (HBD-1) is constitutively expressed, while HBD-2, HBD-3, and HBD-4 are 
inducible (Pazgier, Hoover et al. 2006). Although HBD-1 is highly expressed in all human 
epithelia it was suggested to have only minor antimicrobial activity compared to other 
defensins. However, recently it was shown that reducing the disulphide bonds in HBD-1, 
mimicking the reducing potential found in the anaerobic environment of the intestine, 
unmasks a potent antimicrobial activity (Schroeder, Wu et al. 2011). HBD-2 and HBD-3 are 
induced by microbial products and inflammatory cytokines (Garcia, Jaumann et al. 2001; 
Harder, Bartels et al. 2001; Liu, Destoumieux et al. 2002; Sorensen, Thapa et al. 2005). 
Inducible expression of HBD-2 and Reg3 proteins in enterocytes depends on TLR and MyD88-
dependent signalling (Vora, Youdim et al. 2004; Vaishnava, Behrendt et al. 2008).  
In addition to antimicrobial activities, HBD-2 and HBD-3 have been proposed to serve as a 
chemo-attractants for a broad spectrum of leukocytes in a CCR6- and CCR2-dependent 
manner (Biragyn, Surenhu et al. 2001; Rohrl, Yang et al. 2010). Murine β-defensin 2 (MBD-2) 
and HBD-3 have also been shown to have immunomodulatory effects on DC function by 
acting as an endogenous ligand for TLR4 and TLR1/2 heterodimers respectively (Figure 2) 
(Biragyn, Ruffini et al. 2002; Funderburg, Lederman et al. 2007). Additionally, HBD-2 has 
been shown to stimulate epithelial restitution and barrier repair in an autocrine fashion by 
binding to CCR6 expressed on the apical membrane of epithelial cells (Figure 2) (Vongsa, 
Zimmerman et al. 2009). Taken together, these findings suggest a dual or even 
multifunctional role for certain intestinal defensins in intestinal homeostasis. The 
homeostatic mechanisms of AMPs include epithelial restitution, immunomodulation and the 
innate killing of microorganisms.  
 
3.4. Secretory antibodies and the “mucosal firewall” 
Mammals produce much larger amounts of secretory immunoglobulin A (sIgA) in the 
mucosa than any other class of immunoglobulin in the body, reflecting its central role in 
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immunity and protection against microorganisms in the intestine. B cell activation and 
proliferation leading to sIgA production occurs in the organized follicular lymphoid 
structures of the gut associated lymphoid tissue (GALT). The lymphoid structures are present 
as isolated follicles in the intestinal cell wall or as large aggregates in the PP of the SI. The 
FAE overlaying PP contains specialized M cells, which transport antigens and microorganisms 
to APCs in close proximity to the basal membrane (Figure 1). Upon activation, APCs move 
from the sub-epithelial dome to the follicular area and present the antigens to naïve 
lymphocytes; alternatively, they migrate to the MLN through the efferent lymphatic ducts 
(Figure 1). The engagement of B cells with antigens in the GALT causes them to migrate to 
the interface between the B and T cell zones where they become fully activated as a result of 
interaction with CD4+ T cells and DCs. In the GALT and MLN, class switching of B cells from 
IgM to IgA is driven by a subset of DCs which release interleukin-10 (IL-10), transforming 
growth factor-β (TGF-β), IL-6 and retinoic acid (RA), a hormone-like growth factor for 
epithelial and other cell types (Iwasaki and Kelsall 2001; Sato, Hashiguchi et al. 2003; Mora, 
Iwata et al. 2006). Activated B cells then migrate to the LP from the lymph or blood, or 
directly from isolated lymphoid follicles. In the LP, IgA+ B cells differentiate into plasma cells 
which secrete IgA that is transcytosed across the epithelium to the apical surface 
(Macpherson, Gatto et al. 2000). The conventional T cell dependent pathway for high affinity 
IgA antibody production described above is associated with B-2 cells.  
In addition to the T cell-dependent pathway for IgA production, there is a faster mechanism 
for generating IgA responses to highly conserved antigenic determinants on commensal 
bacteria and pathogens (Macpherson, McCoy et al. 2008; Suzuki and Fagarasan 2008). In 
mice, this involves a specialized subset of B-1 cells that can rapidly produce secretory IgA in 
the absence of help from CD4+ T cells (Fagarasan and Honjo 2000). Much of this secretory 
antibody appears to be polyreactive, binding several antigens and is commonly known as 
‘natural’ antibody. The repertoire of ‘natural IgA’ is restricted and affinity maturation is 
limited, although the heavy-chain variable region genes used by IgA-producing plasma cells 
in the gut are somatically hyper-mutated, to diversify antibody specificity (Macpherson, 
McCoy et al. 2008). Humans lack canonical B-1 cells but it has been suggested that they may 
have functionally equivalent cells that can colonize the lymphoid tissues (Weller, Braun et al. 
2004). T cell-independent secretory antibody responses are generated in the isolated 
lymphoid follicles by the direct presentation of antigen to B cells by DCs and M cells (Figure 
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2) (Batista, Iber et al. 2001; Bergtold, Desai et al. 2005; Tsuji, Suzuki et al. 2008; Batista and 
Harwood 2009). IECs also participate in B cell responses by releasing B cell-activating factor 
(BAFF) and a B cell proliferation-inducing ligand (APRIL) which play roles in IgA class-
switching and B cell survival (reviewed in Wells et al., 2010). 
B cells and T cells activated in the GALT and MLN acquire homing receptors that target them 
back to mucosal tissues and this ensures that the immune responses occur selectively and 
locally in the mucosa. Furthermore, DCs activated by bacterial interaction in the PP are 
retained in the MLN and PP (Macpherson and Uhr 2004). This has led to the “mucosal 
firewall” concept that proposes that productive mucosal sIgA responses to intestinal bacteria 
can develop without inducing unnecessary systemic immunity (Macpherson and Uhr 2004).  
Much of the IgA produced in the gut appears not to be reactive to the commensal 
microbiota. Nevertheless, in germ-free mice IgA is present at very low levels in the gut and 
soon after colonization with bacteria the number of IgA positive B cells increases in the 
lymphoid tissue followed by the appearance of sIgA secreting plasma cells in the intestinal LP 
(Shroff, Meslin et al. 1995). At the epithelial surface, sIgA can bind to viruses and bacteria to 
prevent or inhibit their attachment to and/or invasion of epithelial cells, a process known as 
immune exclusion (Macpherson, Hunziker et al. 2001). Just as important may be the fact 
that sIgA can also interact with antigens presented by intracellular pathogens in endosomes 
during the pIgR–mediated transport through epithelial cells. These interactions have been 
shown to inhibit key steps in viral assembly and play an important role in immunity to viral 
infection (Mazanec, Coudret et al. 1995). Recent studies suggest that immune exclusion also 
helps shape the bacterial community through immunological selection (Sonnenburg, 
Angenent et al. 2004; Peterson, McNulty et al. 2007; Suzuki and Fagarasan 2008). 
Furthermore, when mice lacking a functional adaptive immune system are colonized with 
bacteria, they display a more robust innate immune response than their immunocompetent 
wild-type counterparts (Keilbaugh, Shin et al. 2005; Cash, Whitham et al. 2006). This 
indicates that in normal mice the adaptive immune response plays a critical role in 
minimizing activation of the innate immune system by the gut microbiota.  
Other homeostatic mechanisms for sIgA include the removal of antigen complexes formed in 
the LP thereby reducing  inflammatory reactions and systemic responses (Mestecky, Russell 
et al. 1999). This concept is supported by the finding that individuals carrying secretory 
antibody deficiencies are more prone to autoimmune diseases, such as celiac disease. 
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Secretory IgA also helps to prevent inflammatory reactions by neutralizing intracellular pro-
inflammatory components such as lipopolysaccharide (LPS) (Fernandez, Pedron et al. 2003). 
Moreover, in contrast to IgG and IgM, IgA does not activate the classical complement 
cascade leading to the production of C5a that is chemotactic for phagocytes.  
To avoid immune exclusion, many pathogens that colonize the mucosal surface produce IgA 
proteases that cleave IgA1 in the hinge region. IgA proteases are produced by opportunistic 
pathogens that colonize mucosal surfaces of the respiratory tract, such as Streptococcus 
pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, or the genital tract such as 
N. gonorrhoeae. As the IgA1 proteases of human pathogens only cleave the IgA1 subclass 
found in humans and closely related primates it has not been easy to prove their role in 
virulence. However, IgA1 protease has been shown to compromise IgA-mediated killing of S. 
pneumoniae both in vitro and in vivo (Kadioglu, Weiser et al. 2008).  
In summary, it is clear that IgAs are critical to mucosal protection against pathogens but it is 
only recently that we began to appreciate its homeostatic roles in shaping the intestinal 
microbiota, preventing mucosal inflammation by immune exclusion, removal of antigen-
antibody complexes in the LP and the neutralization of inflammatory mediators. 
 
4. Detecting bacterial incursions 
Apart from its critical role as a physical barrier, the intestinal epithelium provides an early 
warning system for sensing microbes. Through the expression of pattern recognition 
receptors (PRRs), the epithelium senses the microbial content of the lumen and participates 
in the innate immune response by secreting a potent array of cytokines and chemokines. 
PRRs recognize microbe-associated molecular patterns (MAMPs), consisting of conserved 
structures found both on pathogenic and non-pathogenic microorganisms. PRRs are 
expressed along the entire GI-tract by enterocytes (Cario and Podolsky 2000), Paneth cells 
(Rumio, Besusso et al. 2004) and immune cells such as DCs (Hart, Al-Hassi et al. 2005). The 
innate sensing mediated by PRRs is essential to detect pathogens and initiate immune 
responses, but needs to be tightly regulated to maintain immune homeostasis towards the 
trillions of microbes that inhabit the GI-tract. 
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4.1. Gut innate sensors and microbial interactions 
IECs have the capacity to express a range of PRRs including members of the well-
characterized families of Toll-like receptors (TLRs), and intracellular Nod-like receptors 
(NLRs). Several TLRs are expressed in IECs in human and mice, while among the NLRs only 
NOD1 and NOD2 have been well characterized in the intestine. Ten TLRs have been 
identified in humans and 12 in mice. TLRs are type I transmembrane glycoproteins, that 
share a conserved structure, with an extracellular domain that contains multiple leucine-rich 
repeats (LRR), a short trans-membrane domain and a highly conserved intracellular domain, 
the Toll-interleukin 1 receptor (TIR) domain. The extracellular LRR domains are responsible 
for the binding to MAMPs and contribute to the homo- or hetero-dimerization of the 
receptors. Dimerization of the intracellular TIR domains leads to the recruitment of adaptor 
molecules (e.g. MyD88, TIRAP and TRIF) to initiate the signalling cascade. Each PRR 
recognizes a specific molecular pattern and can be expressed on the cell surface, in 
intracellular compartments or in the cytosol (Table 1). TLR1, 2, 4, 5, 6 and 11 recognize 
mainly microbial membrane components and are expressed on the cell surface, TLR3, 7, 8 
and 9 recognize microbial nucleic acids and are expressed in intracellular compartments 
such as the endoplasmic reticulum, endosomes, lysosomes and endolysosome (Table 1). 
NOD1 and NOD2 are intracellular proteins that contain an N-terminal caspase recruitment 
domain (CARD), a nucleotide-binding oligomerization domain (NOD) and a C-terminal 
regulatory domain with multiple LRRs that bind to peptidoglycan (PG) fragments in the 
cytosol. NOD1 senses Meso-diaminopimelic acid from the PG of Gram-negative bacteria, 
while NOD2 recognizes muramyl dipeptides that are common to the PG of both Gram-
negative and Gram-positive bacteria (Chamaillard, Hashimoto et al. 2003; Girardin, Boneca 
et al. 2003)(Table 1). TLR2 can form heterodimers with TLR1 or TLR6 leading to the 
recognition of distinct ligands. The heterodimers TLR2/1 and TLR2/6, bind triacylated and 
diacylated lipoproteins from Gram-positive and Gram-negative bacteria respectively. 
Additionally, TLR2/6 can bind lipoteichoic acid, a lipidated glycan polymer present in the cell 
wall of Gram-positive bacteria. In all cases, two lipid chains present on each ligand insert into 
a hydrophobic pocket in TLR2 whereas the dimerization with TLR1 or 6 is determined by 
specific interactions with other parts of the ligands. The highly conserved lipid A of LPS, a 
component of the outer membrane of Gram-negative bacteria, is bound to MD-2 in a 
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complex with TLR4. Presentation of LPS to MD-2 is facilitated by CD14 and LPS binding 
protein.  
 
Table 1: PRRs, ligands and subcellular localization 
Receptor Subcellular localization Ligand Origin of the ligand 
TLR2 
 
 
Cell surface Lipopeptide 
PG  
LTA 
Bacteria 
G+ bacteria  
G+ bacteria 
TLR2/1 Cell surface Triacylated lipopeptide  G- bacteria, mycoplasma 
TLR2/6 Cell surface Diacylated lipopeptide G+ bacteria, mycoplasma 
TLR3 Cellular compartment dsRNA Viruses, virus infected cells 
TLR4/MD2 Cell surface LPS G- bacteria 
TLR5 Cell surface Flagellin protein Bacteria  
TLR7 Cellular compartment ssRNA ssRNA viruses 
TLR9 Cellular compartment,  
cell surface 
DNA DNA viruses, bacteria 
TLR11 Cell surface Uropathogenic bacterial 
components 
Uropathogenic bacteria 
NOD1 Cell cytoplasm Meso-DAP  PG from G-, some G+, 
mycobacterium 
NOD2 Cell cytoplasm MDP PG from G-, G+ bacteria, 
mycobacterium 
PG, peptidoglycan; LTA, lipoteichoic acid; LPS, lipopolysaccharide; DAP, diaminopimelic acid; MDP, muramyl 
dipeptide; G+, Gram positive; G-, Gram negative; ssRNA, single-stranded RNA; dsRNA, double-stranded RNA. 
 
Another important bacterial MAMP is flagellin, a protein subunit of bacterial flagella that is 
typically recognized by TLR5. TLR signalling pathways have been reviewed in detail recently 
(Kawai and Akira 2010). Essentially, after ligand binding, TLRs undergo dimerization and 
conformational changes that result in the recruitment of TIR-containing adaptor proteins. 
All TLRs, except TLR3, recruit the myeloid differentiation primary response gene 88 (MyD88), 
which in turn activates the mitogen-activated protein kinase (MAPK) pathway and the 
nuclear factor κB (NF-κB) pathway signalling cascades (Janssens and Beyaert 2002). 
TLR3 and TLR4 can signal also through a different pathway via the recruitment of the 
adaptor protein TRIF, leading to the expression of type 1 interferons. Similarly, NLRs activate 
the MAPK pathway and the canonical NF-κB pathway signalling cascades. These signalling 
cascades lead to the activation of transcription factors, such as NF-κB, that, after 
translocation to the nucleus, stimulate the transcription of genes encoding AMPs, pro-
inflammatory cytokines and chemokines, ultimately initiating the inflammatory response. In 
an inactivated state, NF-κB is located in the cytosol as a protein complex with the inhibitory 
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protein IκBα. Activation of NF-κB is triggered by different stimuli (e.g. TLRs, cytokines, NLRs, 
stress inducers) that lead to the phosphorylation of IκBα by the enzyme IκB kinase (IKK). 
Subsequently, IκBα is ubiquitinated and degraded by the cell proteasome, leading to its 
dissociation from NF-κB. Activated NF-κB then translocates into the nucleus and induces the 
transcription of specific genes. In IECs, activated NF-κB can induce the production of a broad 
range of chemokines and cytokines including interleukins (ILs), interferons (IFNs), tumor 
necrosis factors (TNFs) and growth factors. In case of microbial colonization or invasion, the 
most abundant cytokine secreted by IECs is IL-8. IL-8 forms a gradient that, together with 
others factors, acts as chemoattractant for neutrophils that are recruited at the site of 
infection. IECs can also produce the DC chemokine CCL20 and the monocyte chemotactic 
protein-1 (MCP-1 or CCL-2), inducing recruitment of monocytes and basophils.  
The importance of PRR-mediated recognition in the induction of inflammatory responses to 
pathogens is evident from infection studies in PRR–deficient mice. Mice lacking TLR4, NOD1 
or the common adaptor protein MyD88 have impaired immunity to infectious agents 
(Schilling, Martin et al. 2003; Viala, Chaput et al. 2004; Brandl, Plitas et al. 2007; Lebeis, 
Bommarius et al. 2007). It is not surprising therefore, that pathogens have evolved different 
strategies to evade the innate recognition. For example, they can target TLR signalling in 
order to suppress the host immune responses to benefit their survival and persistence. 
Brucella species are highly infectious intracellular pathogens, this bacteria express a TIR 
domain-containing protein that, mimicking the human adaptor protein TIRAP, blocks TLR2- 
and TLR4- mediated NF-κB activation (Radhakrishnan, Yu et al. 2009). The NF-κB pathway 
can also be a target for pathogens. For example, the pathogen S. typhimurium can inject 
virulence effectors into the host cells through a type III secretion system. One of these 
effector proteins, AvrA, inhibits the NF-κB pathway and induces apoptosis in IECs (Collier-
Hyams, Zeng et al. 2002). Some pathogens express MAMPs that are not recognized by the 
PRRs, for instance Campylobacter jejuni and Helicobacter pylori produce subclasses of 
flagellin that do not activate TLR5 (Andersen-Nissen, Smith et al. 2005). Interestingly LPS 
from a commensal Bacteroidetes species, has also been found to have a low endotoxicity 
(Weintraub, Zahringer et al. 1989). The lipid A part of LPS is pentacylated and consequently a 
weak activator of TLR4 compared with the hexacylated lipid A of other commensals and 
pathogens. This indicates that commensals may have also evolved to avoid detection by 
innate receptors as a means to favour their persistence in the intestinal tract.  
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4.2.  Regulation of innate sensing  
The section above clearly illustrates the requirement for TLR signalling and inflammatory 
responses to protect the host from infection with pathogens. However, to peacefully coexist 
with the commensal microbiota and avoid perpetual inflammation, PRR signalling needs to 
be carefully regulated. Mice lacking TLR9, 4, 2 and MyD88 become more susceptible to DSS-
induced colitis (Rakoff-Nahoum, Paglino et al. 2004; Lee, Rachmilewitz et al. 2006). In TLR2 
and 4 deficient mice or mice depleted of bacteria with multiple antibiotics, the severity of 
colitis and mortality levels are worse than in wild type mice, suggesting an additional role for 
NF-κB in homeostasis and the epithelial repair and renewal processes (Rakoff-Nahoum, 
Paglino et al. 2004). This concept is also supported by the finding that mice lacking TLR5 
have the tendency to develop spontaneous colitis (Vijay-Kumar, Sanders et al. 2007). Further 
evidence for the crucial role of the NF-κB regulator in intestinal homeostasis came from 
studies in mice with a conditional knockout of the intestinal epithelial IKKγ, or both IKKα and 
IKKβ. IKK knockout mice lose the capacity to activate NF-κB signalling and develop severe 
chronic intestinal inflammation (Nenci, Becker et al. 2007). The chemical and physical 
barriers described in the preceding sections, play a key role in keeping the microbes at a 
distance but in addition, several other sophisticated regulatory mechanisms have evolved to 
avoid excessive immune responses to non-pathogens. These mechanisms include (i) the 
regulation of TLR expression, (ii). TLR localization, (iii) differential apical and basolateral TLR 
signalling, (iv) negative feedback regulation of the NF-kB pathway and (v) the attenuation of 
NF-κB activation by commensal bacteria. 
In the absence of inflammation, TLRs are expressed at low levels on the epithelial surface 
and their expression is highest in the intestinal crypts to guarantee the protection of stem 
cells. For example, TLR2 and TLR4 are expressed at low levels in human colonic epithelium 
and mainly in crypt cells (Cario and Podolsky 2000; Abreu, Vora et al. 2001; Furrie, 
Macfarlane et al. 2005), TLR5 is expressed mainly in the colon (Cario and Podolsky 2000). In 
the mouse, TLR2, 4, 5 and 9 are expressed in villus and crypt epithelial cells and in the follicle 
associated epithelium (FAE). Expression of TLRs may also be polarized in intestinal epithelial 
cells and located on either the apical or the basolateral membranes. For example in villi and 
crypt, TLR2 is located on the apical side of epithelial cells. In the FAE, TLR4 and TLR5 are 
located at the apical pole, while TLR2 and TLR9 are located on both the apical and the 
basolateral side (Chabot, Wagner et al. 2006). In polarized human colonic epithelial cell lines, 
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TLR9 has been shown to be expressed on both the apical and the basolateral poles but 
activation leads to distinct responses depending on the location of the stimulus (Figure 3b) 
(Lee, Mo et al. 2006). Basolateral TLR9 stimulation activated the NF-κB pathway while apical 
stimulation prevented NF-κB activation conferring tolerance to the chronic TLR challenges 
represented by the commensal microbiota (Figure 3b) (Lee, Mo et al. 2006). TLR5 has been 
reported to be expressed on the basolateral surface in the human colonic epithelial cell line 
T84, such that it would only respond to flagella on pathogens that have crossed the 
epithelium (Gewirtz, Navas et al. 2001). However, his appears not to be the case for human 
intestinal Caco2 and HT29 cells (unpublished data, Chapter 2) and in the mouse, TLR5 is 
present on both apical and basal membranes of the villus epithelium (Chabot, Wagner et al. 
2006) bringing into question the validity of this model in humans and mice in vivo. 
 
 
Figure 3: Homeostasis of innate sensing in intestinal epithelial cells. Toll-like receptor (TLR) sensing and 
signalling is regulated at multiple levels via interacting pathways that contribute to the maintenance of 
intestinal homeostasis. a) Negative regulators of pro-inflammatory nuclear factor κB (NF-κB) signalling 
pathway: NF-кB activation pathway can be inhibited at different levels by NF-κB inhibitory regulators such as 
the peroxisome proliferator-activated receptor-γ (PPARγ), the Toll-interacting protein (TOLLIP) and the 
cytoplasmic protein A20. PPARγ competes with the p65 subunit of NF-kB and induces its nuclear export, thus 
limiting the activation of NF-kB. TOLLIP and A20 interfere with adaptor proteins essential for the signal 
transduction. b) Polarized TLR signalling: Basolateral TLR9 stimulation (in green) induces NF-кB activation and 
transcription of proinflammatory genes. Whereas apical stimulation (in red), can suppress the inflammatory 
response and induces alternative signalling pathways c) TLR signalling can be modulated by commensal 
bacteria. B. thetaiotaomicron stimulates the expression of PPARγ, promoting the export of the p65 subunit of 
NF-κB from the nucleus. L. casei and non-pathogenic strains of Salmonella inhibit the degradation of IκB.  
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Several intracellular negative regulators can inhibit TLR signalling in IECs, these include the 
peroxisome proliferator-activated receptor-γ (PPARγ), the Toll-interacting protein (TOLLIP) 
and the cytoplasmic protein A20 (Figure 3a). 
Commensal bacteria can also actively participate in the regulation of TLR signalling. The 
Gram-negative genus Bacteroidetes is one of the dominant taxa of the gut microbiota. The 
commensal Bacteroides thetaiotaomicron can induce the expression of PPARγ, promoting 
the export of the p65 subunit of NF-κB from the nucleus, thus preventing the transcription of 
proinflammatory genes (Figure 3c) (Kelly, Campbell et al. 2004). Non-virulent Salmonella 
strains can inhibit the NF-κB pathway blocking the degradation of IκBα, thus promoting the 
attenuation of inflammatory responses elicited by proinflammatory stimuli (Figure 3c) 
(Neish, Gewirtz et al. 2000). A similar mechanism is used by Lactobacillus casei, which was 
reported to down-regulate inflammation induced by an entero-invasive pathogen, 
protecting IκB from proteolytic degradation and blocking NF-κB translocation to the nucleus 
(Figure 3c) (Tien, Girardin et al. 2006).  
 
5. Immune cell responses to microbes 
Besides the recognition by PRRs, the microbial content of the lumen is constantly sampled 
by specialized cells and lymphoid structures along the gut. DCs and macrophages can directly 
sample the luminal antigens across the mucosa or encounter bacteria/antigens sampled by 
M cells in the GALT. Once activated, a subset of LP DCs migrates to the MLN where they 
induce T cell responses. APCs in the PP also interact with T cells in the inter-follicular regions 
driving their clonal expansion and differentiation. Macrophages, DCs and other immune cells 
are also responsible for the detection and phagocytic killing of invading bacteria. The 
crosstalk between IECs and immune cells is essential in driving the immune response against 
pathogens and in preserving the intestinal homeostasis (Wells, Rossi et al. 2010).  
 
5.1. Mucosal dendritic cells 
DCs are specialized APCs that regulate both innate and adaptive immunity (recently 
reviewed (Rescigno 2010)). They are found in the LP of both the small and large intestine 
and in the GALT, which includes PP and draining lymph nodes. Typically, DCs migrate from 
the peripheral tissues to the lymphoid tissue where they present antigens to T cells. Most 
tissue resident DCs are immature and poorly immunogenic due to the low expression of 
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MHC molecules and co-stimulatory molecules. Immature DCs undergo maturation when 
they sense MAMPs or “danger”-associated molecular patterns released by damaged or 
stressed cells. Mature DCs express high levels of MHC, co-stimulatory molecules and 
cytokines for antigen presentation and immune signalling. In lymphoid tissues, mature DCs 
interact with naïve CD4+ T lymphocytes inducing their activation, clonal expansion and 
differentiation. Depending on the phenotype of the DC and the cytokine environment, T cells 
will differentiate into different subsets of effector and regulatory T cells. The intestinal 
mucosa contains numerous DCs specialized in different functions depending on their 
location and subtype. In the following sections, we describe their main characteristics and 
roles in regulating immunity and tolerance.  
 
5.2. Lamina propria dendritic cells 
In the LP, CD11c+ DCs are divided in two major subsets depending on the expression of the 
CD103 receptor. These two subsets are derived from two different blood cell precursors 
(Bogunovic, Ginhoux et al. 2009; Varol, Vallon-Eberhard et al. 2009) and have different 
functions. The CD103- DCs differentiate from blood monocytes, they have features of 
macrophages and are typically in close contact with the epithelium. They can also be 
distinguished from the CD103+ DC subset for the expression of CX3CR1, the receptor for 
fractalkine, which is expressed on the basal membrane of polarized epithelial cells. CX3CR1+ 
DCs can sample luminal antigens and microorganisms directly by extending dendrites 
through epithelial cell junctions to gain access to the luminal content (Rescigno, Urbano et 
al. 2001; Niess, Brand et al. 2005). Mice deficient for CX3CR1 are more susceptible to the 
entero-invasive pathogen S. typhimurium (Niess, Brand et al. 2005). The formation of trans-
epithelial dendrites is dependent on the presence of the microbiota and on TLR signalling in 
epithelial cells (Niess, Brand et al. 2005; Chieppa, Rescigno et al. 2006). CX3CR1+ DCs also 
express CD70 and can promote Th17 differentiation from naïve CD4+ T cells in response to 
bacterial adenosine 5’-triphosphate (ATP) or TLR5 signalling triggered by flagellin (Uematsu, 
Jang et al. 2006; Atarashi, Nishimura et al. 2008). This is in agreement with the finding that 
germ-free mice lack Th17 cells and that colonization by segmented filamentous bacteria 
(SFB) or administration of bacterial ATP induces Th17 cells (Atarashi, Nishimura et al. 2008; 
Gaboriau-Routhiau, Rakotobe et al. 2009).  
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The other major subset of LP DCs is the CD103+ CX3CR1- cells that promote the conversion of 
naïve CD4+ T cells into inducible Foxp3+ Tregs and support natural CD4+ Foxp3+ Tregs 
(Powrie, Read et al. 2003; Coombes, Siddiqui et al. 2007). In the mouse SI, goblet cells 
acquire small soluble antigens from the lumen and translocate them to CD103+ DCs in the PP 
(McDole, Wheeler et al. 2012). Migratory CD103+ DCs found in the MLNs express the integrin 
CCR7 while LP CD103+ DCs are CCR7 negative. Tregs generated in the MLNs up-regulate the 
expression of the homing receptor CCR9 and the alpha4 beta7 integrin required for their 
homing cells back to mucosal tissues. The tolerogenic property of CD103+ LP DCs is 
determined by their local tissue environment and in particular by epithelial derived TGF-β, 
RA and in humans, thymic stromal lymphopoietin (TSLP) (Rimoldi, Chieppa et al. 2005; Iliev, 
Spadoni et al. 2009). Interestingly, these factors are induced in IECs after apical interaction 
with bacteria in vitro. This suggests that luminal contact with bacteria or bacterial factors can 
potentially modulate DC function in the LP. CD103+ DCs also express the enzyme 
indoleamine 2,3 dioxygenase (IDO) which is required for their tolerogenic function (Matteoli 
et al. 2010). Although these models are based on mechanistic studies in mice, the CD103+ DC 
subset is also found in the mucosa of humans. Furthermore, these DCs also produce IDO 
suggesting that this tolerogenic mechanism is conserved in humans and mice (Matteoli, 
Mazzini et al. 2010).  
 
5.3. Peyer’s Patch dendritic cells 
The DC subsets are present in the mouse PP perform different functions and are 
distinguished by the expression of CX3CR1 and the chemokine receptors CCR6 and CCR7, 
which direct their migration into the lymphoid tissues. In the dome area of the PP, CX3CR1+ 
DCs are found associated with or in close proximity to the follicular epithelium. These cells 
can transcytose antigens and were previously suggested not to induce T cell responses 
(Salazar-Gonzalez, Niess et al. 2006). However, a CD103- DC subset was recently identified 
that can prime IFN-γ and IL-17 producing T cells with gut homing properties (Cerovic, 
Houston et al. 2012).  
DCs expressing CCR6, the receptor for CCL20, are found only in the PP. They are required for 
localized CD4+ T cell activation and defence against intestinal pathogens. This was elegantly 
shown using CCR6 knockout mice, GFP-CCR6 reporter mice and S. typhimurium flagellin-
specific T cell receptor transgenic mice to identify the DC subset responsible for T cell 
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activation in the PP (Salazar-Gonzalez, Niess et al. 2006). The results were consistent with a 
model where CCR6+ DCs migrate towards the FAE during infection to engulf transcytosed 
bacteria. Mature DCs then activate specific effector T cells to mediate defence against 
entero-invasive pathogens. The CCR6+ DC subset is unique to the PP, despite the fact that 
IECs also produce CCL20.   
The PP has an important role in IgA isotype switching (discussed above) and this is mediated 
by a CD11b+ subset of DCs which release IL-10, TGF-β, IL-6 and RA (Iwasaki and Kelsall 2001; 
Sato, Hashiguchi et al. 2003; Mora, Iwata et al. 2006). PP DCs are also involved in the T cell-
dependent IgA class switching through TNF-α and inducible nitric oxide synthase (Tezuka, 
Abe et al. 2007). 
 
5.4. Effector and regulatory T cells in the gut  
The balance between pro-inflammatory effector T helper (Th) cells, such as Th1, Th2 and 
Th17 cells and anti-inflammatory Tregs is essential in maintaining immune homeostasis and 
tolerance in the GI-tract. CD4+ T cells subsets include T helper cells, Th1, Th2 and Th17, and 
regulatory T cells, Tregs (Figure 1). Each subset is characterized by a specific cytokine 
secretion profile to facilitate a different type of immune response. Th1 cells are important in 
promoting cell-mediated immunity against intracellular pathogens and secrete mainly, IFN-γ 
and TNF-α. Th2 cells produce IL-4, IL-5 and IL-13 to promote B cell development and 
antibody production (Mosmann and Coffman 1989) and are required for humoral immunity 
against helminths and extracellular pathogens. Th17 cells respond to extracellular bacteria 
and fungi and secrete mainly IL-17, IL-22 and IL-23 (Bettelli, Korn et al. 2007). The pro-
inflammatory responses mediated by effector T cells are regulated by Tregs.  
Different subsets of Tregs have been described, natural Tregs (nTregs) and inducible Tregs 
(iTregs). Natural Tregs originate in the thymus and are CD4+, CD25+ and transcription factor 
Foxp3+. iTregs are induced in peripheral lymphoid tissues such as GALT and MLN by 
interaction with APCs and dietary antigens, these cells are CD4+, CD25- and can be Foxp3+ or 
Foxp3-.  
CD4+ Foxp3- Tregs subsets are T regulatory 1 (Tr1) cells, characterized by the production of 
IL-10, and Th3 characterized by the production of TGF-β. In the colon LP, the majority of the 
IL-10 producing cells are Foxp3+ Tregs, while in the SI IL-10 is produced by CD4+ Foxp3- 
intraepithelial lymphocytes and in the LP by Tr1 cells (Maynard et al., 2007). Commensal 
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bacteria individually or in groups can influence T cell polarization. In SPF mice, more than 30 
% of CD4+ cells in the colon LP and around 27 % in the SI are Foxp3+ and conventionalization 
of germ-free mice induces an increase of Foxp3+ CD4+ T cells in the colon LP but not in the SI 
(Atarashi, Tanoue et al. 2011). Mono-colonization of mice with the mouse commensal SFB 
increases the number of CD4+ T cells, in particular Th1, Th17 and Foxp3+ Tregs in the SI and 
colon (Gaboriau-Routhiau, Rakotobe et al. 2009). Moreover, mice colonized with a cocktail 
of 46 strains from Clostridium species isolated from mouse faeces, have increased amounts 
of Foxp3+ Tregs expressing IL-10 in the colon compared with germ-free mice (Atarashi, 
Tanoue et al. 2011). In conventional mice administration of Bifidobacterium species has 
been shown to induce IL-10 producing Tregs in the colon (Jeon, Kayama et al. 2012). Taken 
together these results highlight the essential role of intestinal bacteria in shaping T cells 
responses, in particular in the induction of Tregs in the colon.  
 
5.5. Gut macrophages  
Mucosal tissues contain the largest pool of tissue macrophages of the human body. They 
derive from blood monocytes that migrate into the tissues from blood capillaries. Despite 
their potent capacity for phagocytosis and pathogen killing, mucosal macrophages are 
relatively attenuated for proliferation and chemotactic activity compared to those found in 
other tissues (Smith, Ochsenbauer-Jambor et al. 2005). Additionally, in mucosal 
macrophages innate signalling via TLRs or NLRs does not induce potent inflammatory 
responses as in the case of other tissue macrophages. Intestinal macrophages are also 
involved in the maintenance of immunological tolerance via the induction of Tregs 
(Coombes, Siddiqui et al. 2007). This is attributed to a population of CD11b+ F4/80+ CD11c- 
macrophages that constitutively produce high levels of IL-10 and express retinol 
dehydrogenases that convert retinol into RA. This population may also negatively regulate 
the ability of CX3CR1+ DCs to drive inflammatory Th17 responses (Denning, Wang et al. 
2007). 
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Thesis outline and aims  
 
The intestinal microbiota plays role in intestinal homeostasis via interactions with the 
epithelium and innate and adaptive immune mechanisms of the gut thereby profoundly 
shaping mammalian mucosal immunity and tolerance. However, in some diseases, such as 
IBD, the microbial community may assume a pathologic character accentuating the damage 
to the host. Despite the recent advances in our understanding of the microbiota structure at 
different stages of life and the perturbations associated with disease, our understanding of 
its functional impact and the contribution of individual microbial components on health is 
still in its infancy. The aim of this thesis was to contribute to our knowledge and 
understanding of several aspects of the interactions between gut commensal bacteria and 
host, focusing on one of the most abundant colonic microbes, F. prausnitzii, for the detailed 
mechanistic studies.  
In Chapter 2, we investigated whether polarized IECs regulate inflammatory responses to 
microbes by secreting IL-8 in a vectorial fashion depending on the location of the TLR 
stimulus. In the Caco-2 model of polarized epithelium, apical stimulation with TLR2 and TLR5 
ligands resulted in the apical secretion of IL-8. The CXCR1 receptor for IL-8 was expressed 
only on the apical membrane of Caco-2 cells and differentiated epithelial cells in the human 
SI and colon suggesting that IL-8 has an autocrine function. Transcriptome analyses revealed 
that Caco-2 cells respond to stimulation with IL-8, supporting the hypothesis of autocrine 
signalling via CXCR1.  
In Chapter 3, mono-associated and conventional mice were used to gain new insights into 
the interaction of bacteria with the host mucosa and mucosal-associated lymphoid tissue. 
The vast majority of the bacteria are kept at a distance by the host physical and chemical 
barriers except for SFB which has a unique and specialized physical interaction with the 
epithelium.  
Chapter 4, 5 and 6 focused on the immunoregulatory mechanisms of the human commensal 
F. prausnitzii, which has been proposed to have anti-inflammatory properties and is present 
in lower numbers in IBD patients with active disease.  
In Chapter 4, we compared the effects of F. prausnitzii and other commensal bacterial 
strains on human monocyte-derived DCs (hDCs). F. prausnitzii strain A2-165 induced a very 
different cytokine profile in hDCs compared with four other F. prausnitzii strains and eight 
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other commensal strains, this was due to the high levels of secreted IL-10 and low levels of 
IL-12. 
The effects of F. prausnitzii A2-165 and another commensal Clostridium hathewayi 82-B on 
the induction of mucosal T cell responses to the model antigen ovalbumin (OVA) in vitro and 
in vivo were studied in Chapter 5. Here we demonstrated that F. prausnitzii A2-165 had 
immunoregulatory properties in vitro which may be related to its strong capacity to induce 
IL-10 by both DCs and T cells. In vivo, these effects translated into enhanced OVA-specific T 
cell proliferation in the nose-draining cervical lymph nodes (CLNs) after combined nasal 
application of F. prausnitzii A2-165 and OVA. Strikingly, this was associated with a reduction 
in the differentiation of IFN-γ secreting T cells in the CLNs. In contrast, Clostridium hathewayi 
82-B significantly decreased the percentage of dividing OVA-specific T cells in the CLNs and 
spleen.  
In Chapter 6 we investigated the immunomodulatory effects of F. prausnitzii strains A2-615, 
and HTF-F, which forms a biofilm in liquid culture, as well as the extracellular polymeric 
matrix (EPM) purified from strain HTF-F. The protective capacity of the two strains and the 
EPM were investigated in the DSS-induced colitis model. The F. prausnitzii strains had 
protective effects, the biofilm producing strain HTF-F conferred an increased protection 
compared to strain A2-165 and this was partly due to the immunomodulatory properties of 
the EPM.  
Finally, Chapter 7 summarizes and discusses the results of the thesis in the context of wider 
literature on host-microbe interactions and mucosal immunology. Furthermore, the 
implications of our work on intestinal health and the possible directions for future research 
are discussed.  
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Abstract  
In the intestinal mucosa, several adaptations of TLR signalling have evolved to avoid chronic 
inflammatory responses to the presence of commensal microbes. Here we investigated 
whether polarized intestinal epithelial cells might regulate inflammatory responses by 
secreting IL-8 in a vectorial fashion (i.e. apical versus basolateral) depending on the location 
of the TLR stimulus. In the Caco-2 model of polarized villus-like epithelium, apical stimulation 
with TLR2 and TLR5 ligands resulted in the apical secretion of IL-8. The CXCR1 receptor for IL-
8 was expressed only on the apical membrane of Caco-2 cells and differentiated epithelial 
cells in the human small intestine and colon suggesting that IL-8 has an autocrine function. 
Transcriptome analyses revealed that Caco-2 cells respond to stimulation with IL-8 
supporting the hypothesis that IL-8 induces G protein-coupled receptor signalling. Autocrine 
signalling by IL-8 did not alter the permeability of an intact epithelial monolayer. These 
results expand our knowledge on the role of IL-8 in the intestinal mucosa.  
 
The microarray data and the raw cel files were deposited at GEO, platform number 
GSE30364. This information can be accessed via the following link:  
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ddafvqiigumcupm&acc=GSE30364 
The supplementary materials can be accessed via the following links: 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_QC_Report.pdf 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_Table_1.xls 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_Table_2.xls 
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Introduction 
 
Intestinal epithelial cells (IECs) play a key role in the inflammatory response to colonizing or 
invading microorganisms via the secretion of interleukin-8 (IL-8). The chemokine IL-8 recruits 
neutrophils from the vasculature to sites of infection or tissue injury (Arnott, Drummond et 
al. 2001). IL-8 can signal through two receptors, CXCR1 and CXCR2 both of which are 
members of the G-protein-coupled receptor (GPCR) family (Baggiolini, Dewald et al. 1997). In 
neutrophils, IL-8 binding to CXCR1 triggers G protein-coupled signalling and formation of 
second messengers that mediate cellular migration, exocytosis of effectors and a respiratory 
burst to facilitate oxygen-dependent killing of phagocytosed microorganisms (Baggiolini, 
Dewald et al. 1997). CXCR1 is expressed in the human IEC line Caco-2 (Sturm, Baumgart et al. 
2005), which is in agreement with our own microarray data using Caco-2 cell mRNA. 
Additionally, IL-8 has been shown to induce Caco-2 cell migration after wounding in a CXCR1-
dependent manner (Sturm, Baumgart et al. 2005). The intestinal epithelium is structurally 
and functionally polarized, with tight junctions (TJs) preventing the diffusion of receptors, 
transporters and enzymes between the apical and basolateral membranes (Ulluwishewa, 
Anderson et al. 2011). Several cell receptors are differentially expressed on the apical and 
basolateral membranes of polarized IECs including Toll-like receptors (TLRs), cytokine 
receptors and chemokine receptors (Chabot, Wagner et al. 2006; Lee, Mo et al. 2006). In the 
human intestinal epithelium, TLR signalling is known to induce secretion of IL-8 in a nuclear 
factor (NF)-κB-dependent manner and TLR2, TLR5 and TLR9 are expressed on the apical 
poles of IECs depending on their location and differentiation status (Cario and Podolsky 
2000; Bambou, Giraud et al. 2004; Chabot, Wagner et al. 2006; Lee, Mo et al. 2006). 
Interestingly, IL-8 has been measured in the colon milieu of healthy volunteers using a 
dialysis bag into the rectum (Keshavarzian, Fusunyan et al. 1999) suggesting that it might be 
apically secreted by colonic epithelial cells. Furthermore, IL-8 is present in significant 
amounts in breast milk (Maheshwari, Lu et al. 2002). However, it is not known if CXCR1 is 
expressed on the apical or basolateral poles in polarized Caco-2 cells or human intestinal 
tissue or whether the direction of TLR signalling influences the direction of IL-8 secretion.  
Here we investigated IL-8 secretion in response to TLR signalling using model IEC lines grown 
in the Transwell system. In this established model, Caco-2 and HT-29 monolayers 
differentiate into enterocytes (Chantret, Barbat et al. 1988) possessing intact TJs and distinct 
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apical and basolateral membranes. We investigated whether the location (i.e. apical or 
basolateral) of TLR agonists influenced the production and direction of IL-8 secretion. 
Additionally, we determined the localization of the CXCR1 receptor in Caco-2 cells and 
human intestinal tissue samples and investigated the role of IL-8 autocrine signalling using 
transcriptomics. 
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Results 
 
Secretion of IL-8 in polarised Caco-2 and HT-29 cell monolayers 
Stimulation of polarized Caco-2 cells with Pam2CSK4 and Pam3CSK4, agonists for TLR2/6, 
and TLR2/1 from the apical or basolateral sides induced secretion of IL-8 predominantly into 
the apical compartment regardless of the location of the stimulus, although basolateral 
stimulation induced smaller amounts of IL-8 compared to apical stimulation. In response to 
apical stimulation with the TLR5 agonist flagellin, IL-8 was secreted into the apical 
compartment while basolateral stimulation induced very small amounts of IL-8 only in the 
basolateral compartment (Figure 1a).  
 
Figure 1: Secretion of IL-8 in polarized Caco-2 and HT-29 intestinal epithelial cells in response to Toll-like 
receptor ligands. Caco-2 (a) and HT-29 (b) monolayers were stimulated for 24 hours from the apical (Ap 
treatment) or the basolateral compartment (Bl treatment) with: Pam3CSK4 (20 µg/ml), Pam2CSK4 (10 µg/ml) 
and flagellin (2 µg/ml). Amounts of IL-8 secreted in the apical (black bars) and basolateral (white bars) 
compartments are normalized to the volume of supernatant in each chamber. Error bars represent SEM (n=3). 
(c) IL-8 does not alter trans-epithelial electrical resistance (TER) in Caco-2 monolayers. TER of Caco-2 polarized 
monolayers untreated (black) or incubated with 100 pg/ml IL-8 on the apical (blue) or the basolateral side (red) 
for 20 hours. TER values were normalized to the initial TER value (100%). Error bars represent SEM (n=4); 
*p<0.05, **p<0.01, ***p<0.001.  
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HT-29 cell monolayers constitutively secreted relatively high amounts of IL-8 compared to 
Caco-2 cells. Stimulation of polarized HT-29 cells with the TLR5 agonist induced high 
amounts of IL-8 in both apical and basolateral compartments. In contrast to Caco-2, there 
was no significant IL-8 response to the TLR2/1 agonist (Figure 1b). We ruled out the 
possibility that IL-8 could diffuse across the cell monolayers by adding it either to the apical 
or basolateral compartment and determining the concentration in each compartment after 
24 hours. In the absence of cell monolayer, IL-8 rapidly equilibrated to an equal 
concentration in both the apical and basolateral chambers (not shown). Additionally, we 
showed that the TJs remained intact throughout the experiment (not shown) and after 
apical or basolateral addition of IL-8 to Caco-2 monolayers by measuring the trans-epithelial 
electrical resistance (TER, Figure 1c). 
 
CXCR1 is expressed on the apical membrane of polarized Caco-2 cells  
Given our observations on the apical secretion of IL-8 in IEC lines, we hypothesized that the 
localization of CXCR1 in polarized epithelium might be an important factor regulating IL-8-
mediated autocrine signalling.  
CXCR1 was localized to the apical pole of polarized Caco-2 cells by confocal microscopy 
(Figure 2a and b). The speckled or ‘patchy’ staining for CXCR1 is suggestive of its localization 
in (macro)-domains possibly microvilli. Other GPCRs and their effector proteins have shown 
patchy staining in cytoplasmic membrane domains of epithelial cells (Ostrom and Insel 2004; 
Yang, Ogawa et al. 2005). No CXCR1 staining was observed using the secondary antibody 
alone as a control, indicating that fluorescence was not due to non-specific antibody binding. 
 
In human duodenal and colonic tissues, CXCR1 is expressed on the apical surface of 
differentiated epithelial cells and is absent in the crypts 
To investigate the localization of CXCR1 in the human intestine, frozen tissue samples of 
human colon and duodenum were collected from healthy volunteers, sectioned at low 
temperature, processed and stained.  
The absorptive enterocytes forming the epithelium and the enterocytes lining the crypts 
were revealed by staining for the TJ protein occludin (red) and nuclear DNA (blue, Figure 3a-
d). In the duodenum, CXCR1 was detected on the apical membrane of villus epithelial cells 
and not in crypt epithelium (green, Figure 3a and b). Similarly, in human colonic tissue CXCR1 
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was detected on the top of the epithelium and not in crypt enterocytes (green, Figure 3c and 
d). The surface of immune cells present in the lamina propria in colonic and duodenal tissues 
also stained positive for CXCR1 (Figure 3a and c).  
These results are in agreement with the known surface expression of CXCR1 in immune cells 
such as macrophages, dendritic cells, T cells and natural killer cells and our results with Caco-
2 cells. No CXCR1 staining was observed using the secondary antibody alone as a control (not 
shown) 
 
Figure 2: Caco-2 monolayers express CXCR1 on the apical surface. The cellular localization of CXCR1 in Caco-2 
polarized monolayers visualized by immunofluorescent detection and confocal microscopy; anti-occludin (red), 
DRAQ5 (blue) and anti-CXCR1 (green). CXCR1 was expressed on the apical side of Caco-2 monolayers. (x-y (a) 
and x-z (b) sections).  
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Figure 3: In human duodenal and colonic tissues, CXCR1 is expressed on the apical surface of villus enterocytes 
and is absent in the crypts. Duodenum and colon biopsies stained with anti-occludin (red), DRAQ5 (blue) and 
anti-CXCR1 (green). In villus enterocytes, CXCR1 is located on the apical membrane (sections of duodenum (a) 
and colon (c)), and surrounding the nuclei of cells in the lamina propria (a, arrow). CXCR1 is absent in the 
enterocytes lining the crypts of duodenum (b) and colon (c). 
 
IL-8 autocrine signalling results in the differential expression of 859 genes 
The autocrine role of IL-8 on IECs was investigated by measuring genome-wide 
transcriptome responses of Caco-2 cells to IL-8 using the Affymetrix human whole genome 
expression microarrays. Polarized Caco-2 cell monolayers were stimulated on the apical 
surface with IL-8 and, after 6 hours, total RNA was isolated for hybridization to whole 
genome expression microarrays. Quality control of the hybridisations and primary data 
analysis were performed according to strict criteria (Supplementary Quality Control Report) 
to ensure that the array data were of the highest possible quality.  
Vectorial secretion of IL-8 mediates autocrine signalling in IECs via CXCR1 
 
47 
 
Stimulation of Caco-2 cells with IL-8 resulted in the differential expression of 859 genes 
(P<0.02; Supplementary table 1). As gene set comparisons and pathway reconstruction from 
differentially expressed genes are far more informative than their tabulated up- or down-
regulation (van Baarlen, van Esse et al. 2008), four complementary in silico approaches were 
employed to deduce the biological significance of the array data set. These approaches 
relate changes in gene expression to cellular pathways and processes modulated by 
transcriptional networks, and show how these are interacting towards common cellular 
processes. 
 
Gene ontology enrichment analysis and protein-protein interaction network of differentially 
expressed genes  
To identify the strongest transcriptome changes of Caco-2 cells in response to IL-8, we first 
performed Gene Ontology (GO) enrichment analysis using the software tool ErmineJ. This 
software identifies functional groups in which the differentially expressed genes are 
statistically overrepresented. Caco-2 genes involved in lipoprotein biosynthesis, protein 
transport and secretion, response to virus, regulation of transcription and the cell cycle 
showed the strongest changes upon stimulation by IL-8 (Supplementary table 2). To identify 
the gene regulatory networks driving these changes, a protein-protein interaction network 
was generated using the software platform Cytoscape (Cline, Smoot et al. 2007) and overlaid 
with expression data using the differentially expressed genes as input. In this protein-protein 
interaction network, the nodes represent proteins encoded by genes that were differentially 
expressed. Inspection of this network (Figure 4) showed that the genes with the higher 
number of interactions were as follows: cAMP responsive element binding (CREB) binding 
protein (CREBBP), E1A-binding protein p300 (EP300), histone deacetylase 1 (HDAC1), 
chromobox homologue 5 (CBX5), epithelial E-cadherin (CDH1), ezrin (EZR), beta-actin (ACTB) 
and cell division cycle 42 (CDC42).  
The genes CREBBP, EP300, CBX5, and HDAC1 encode coactivators and chromatin 
modification enzymes required for remodelling of tissue-specific gene loci and the activities 
of key transcriptional regulators during cell growth and differentiation (Wong, Pickard et al. 
2010; Thomsen, Christensen et al. 2011). CREBBP was up-regulated (red, Figure 4) in 
response to IL-8 and its overexpression in primary cultures of smooth muscle cells inhibits 
cell cycle progression (Klemm, Watson et al. 2001). The genes CDC42 and EZR were down-
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regulated in IL-8 treated cells suggesting decreased proliferation (Liu, Cao et al. 2010; Ou-
Yang, Liu et al. 2011). The genes CDH1, PTPRM (protein tyrosine phosphatase, receptor type, 
M), EZR and ACTB encode structural proteins that mediate cell-cell contact (CDH1 and 
PTPRM), define cell shape (ACTB) or act as intermediates between plasma membrane and 
actin cytoskeleton (EZR). Decreased EZR expression (discussed above) was previously linked 
to up-regulation of E-cadherin (CDH1) as observed in this study. HOXA1, a downstream 
effector of E-cadherin-directed signalling, was up-regulated by IL-8 (red, Figure 4), 
presumably due increased E-cadherin ligation. Taken together, the protein network 
responses suggest that IL-8 signalling is involved in the regulation of cell differentiation 
(structural proteins and cell-cell contact signalling) and lipid metabolism but not 
proliferation.  
 
Gene ontology categories network of differentially transcribed genes 
To characterize further the processes that are regulated via these protein-protein interaction 
networks, we performed a GO enrichment analysis of all differentially regulated genes and 
visualized the interconnections between GO categories (Figure 5). The GO enrichment 
analysis identified three interconnected networks. The two smallest networks included GO 
categories involved in positive regulation of signal transduction and intracellular protein 
kinase cascade (top centre in Figure 5) and GO categories involved in cell morphogenesis and 
development (centre right in Figure 5). The largest network consisted of a central region that 
included GO categories involved in lipid biosynthetic processes including lipid kinase activity. 
This central region was connected to sub-networks consisting of GO categories involved in 
cyclin-dependent protein kinase activity and MAP kinase activity (top left in Figure 5), 
protein secretion and epithelial morphogenesis (bottom left/centre in Figure 5) and 
activation of phospholipase C (PLC) activity (bottom centre/right in Figure 5) which results 
from GPCR signalling. The latter was expected, as it is known that CXCR1 is a GPCR. These GO 
categories correlated well with the enriched categories found using ErmineJ 
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Discussion 
 
In IECs, IL-8 expression is known to be induced by proinflammatory cytokines, TLR signalling 
and cellular stress (Baggiolini, Dewald et al. 1997; Schroder and Tschopp 2010). Basolateral 
secretion of IL-8 plays a role in the recruitment of neutrophils from the vasculature to sites of 
infection or tissue injury (Arnott, Drummond et al. 2001). IL-8 can be measured in rectal 
dialysates of healthy subjects (Keshavarzian, Fusunyan et al. 1999) suggesting that it can be 
apically secreted in the intestine. The polarized secretion of IL-8, IL-1 and IL-6 has been 
reported in epithelial cell lines of different tissue origin (Cudicini, Kercret et al. 1997; 
Holtkamp, Van Rossem et al. 1998; Sonnier, Bailey et al. 2010). However, it is not known if TLR 
signalling can induce vectorial secretion of IL-8 in IECs. To investigate whether IECs secrete IL-
8 apically in response to TLR signalling, we stimulated polarised Caco-2 and HT-29 cell 
monolayers grown in the Transwell system with TLR agonists applied from the apical or 
basolateral side and we measured the concentration of IL-8 in the two compartments. Caco-2 
cells were most responsive to TLR2/1, TLR2/6 and TLR5 agonists applied to the apical 
membrane (Figure 1a) which is compatible with the apical localization of TLR2 and TLR5 in 
humans (Cario and Podolsky 2000; Bambou, Giraud et al. 2004). An exception is the IEC line 
T84 that expresses TLR5 on the basolateral pole (Gewirtz, Navas et al. 2001). Additionally, in 
Caco-2 cells, most of the IL-8 secreted in response to TLR agonists was located in the apical 
compartment (Figure 1a).  
In contrast to Caco-2, HT-29 cells constitutively secreted a relatively high level of IL-8 in both 
compartments and did not respond to a TLR2/1 agonist. In response to TLR5 stimulation, HT-
29 cells secreted IL-8 bidirectionally but in larger amounts in the basolateral compartment 
(Figure 1b). The differences between HT-29 and Caco-2 may be due to the fact that HT-29 
does not polarize and differentiate into mature enterocyte-like cells to the same extent as 
Caco-2. In particular, the TER values measured for HT-29 monolayers were around 200-300 
Ohms/cm2 whereas Caco-2 monolayers reached TER values of approximately 600-800 
Ohms/cm2. A high TER reflects the tightness and integrity of the epithelial monolayer, the low 
values measured using HT-29 cells indicate that the monolayer is more leaky compared with 
Caco-2 cells. 
These results show that Caco-2 and HT-29 cells can secrete IL-8 apically in response to TLR2 
and TLR5 signalling. We speculate that in vivo the steady-state activation of TLRs by microbe 
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associated molecular patterns of commensal bacteria may account for the luminal IL-8 
measured in healthy subjects (Keshavarzian, Fusunyan et al. 1999). Further support for this 
hypothesis comes from our data showing apical staining of the IL-8 receptor CXCR1 in Caco-2 
cells and human intestinal tissue (Figure 2 and 3). Interestingly, we found CXCR1 expression in 
the adult intestine localized to non-proliferating and differentiated epithelial cells and not in 
crypt epithelial cells. In the intestine, apically secreted IL-8 might have an autocrine function.  
To gain more insights into the role of IL-8 autocrine signalling, we performed a microarray 
analysis of Caco-2 cells treated with IL-8 and in total 859 genes were differentially expressed. 
The transcriptome data were analysed using GO enrichment analysis to identify the functional 
categories of genes that were significantly altered by IL-8 signalling. Additionally, a protein-
protein interaction network and GO categories network of differentially expressed genes was 
used to visualize the interactions between different processes altered by IL-8 treatment. The 
microarray data support the hypothesis that IL-8 induces GPCR signalling in Caco-2 cells. The 
GO categories network indicates activation of PLC, formation of the second messenger inositol 
1,4,5-trisphosphate, activation of phosphatidylinositol 3-kinase and consequent generation of 
phosphatidylinositol 3-phosphate (bottom right of GO categories network, Figure 5). The 
microarray analyses suggested that IL-8 induces an increase in cell-cell contact, cell adhesion 
and cell survival. In particular the gene network involved in E-cadherin regulation may play a 
role in the formation of epithelial cell-cell junctions and differentiation of epithelial cells after 
migration (Taupin and Podolsky 2003). The E-cadherin–catenin complex has been shown to be 
a crucial to the regulation of cell adhesion, polarity, differentiation, migration, proliferation, 
and survival of IECs (Zbar, Simopoulos et al. 2004).  
The microarray data also suggests that IL-8 is involved in the regulation of cell differentiation 
rather than proliferation. In this respect, it is also relevant that CXCR1 was expressed only on 
the differentiated and non-proliferative epithelial cells in the small intestine and colon and not 
in crypt enterocytes (Figure 3). Thus, IL-8 secreted in the lumen, for example in response to 
commensal antigens, would not have an effect on the differentiating cells that migrate 
upwards from the bottom of the crypts. Previously, IL-8 was reported to induce proliferation, 
differentiation and CXCR1-dependent migration in Caco-2 cells (Maheshwari, Lu et al. 2002; 
Sturm, Baumgart et al. 2005). Although the effect on of IL-8 on epithelial cell proliferation is 
controversial (Sturm, Baumgart et al. 2005) and was not confirmed by our own microarray 
data, overall the published data and our own work suggests a role for IL-8 in epithelial 
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restitution. Our observation on the apical location of CXCR1 in human intestinal tissues and 
our microarray data lend support to the hypothesis that IL-8 has an autocrine function in vivo. 
We speculate that apical secretion of IL-8 would help to initiate pathway responses in 
restitution prior to any potential loss of epithelial integrity, e.g. because of bacterial invasion 
or toxin production. In this respect, it is relevant that addition of IL-8 to the apical or 
basolateral side of an intact epithelial barrier had no significant effect on TER over a period of 
at least 20 hours (Figure 1c). This suggests that IL-8 mediated autocrine signalling would not 
affect the viability, permeability or integrity of an intact epithelium. 
Interestingly, the effects of IL-8 on proliferation, differentiation and migration have also been 
shown using fetal IECs (Maheshwari, Lu et al. 2002). As significant concentrations of IL-8 are 
found in milk and amniotic fluid, it was suggested that IL-8 might have an additional role in the 
developing intestine (Maheshwari, Lu et al. 2002).  
A similar autocrine role has been proposed for CCL20, which is also induced by inflammatory 
pathways in epithelial cells. CCL20 binds to the CCR6 receptor on the apical pole of 
differentiated epithelial cells (Yang, Ogawa et al. 2005) and induces epithelial cell migration in 
vitro (Vongsa, Zimmerman et al. 2009).  
In summary, we show for the first time that the IL-8 receptor CXCR1 is expressed on the apical 
membrane of differentiated epithelial cells in the human small intestine and colon. 
Furthermore, our data demonstrate that IL-8 is secreted from the apical pole of IEC lines in 
response to TLR signalling and suggest that polarized secretion of IL-8 may occur in 
differentiated epithelial cells of the villi in response to apical stimulation with microbe-
associated molecular patterns. 
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Materials and methods 
 
For space reason the microarray data and the supplementary materials were not included in 
the chapter. The microarray data and the raw cel files were deposited at GEO, platform 
number GSE30364 and can be accessed via the following link:  
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ddafvqiigumcupm&acc=GSE30364 
The supplementary materials can be accessed via the following links: 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_QC_Report.pdf 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_Table_1.xls 
http://pbaarlen.home.xs4all.nl/oriana/Rossi_et_al_Supplementary_Table_2.xls 
 
Human materials 
Human duodenum biopsies derive from the study of Troost et al., 2008 (Troost, van Baarlen et 
al. 2008), this study was approved by the University Hospital Maastricht Ethical Committee, 
Colon biopsies were obtained from healthy subjects at the University Hospital Örebro, 
according to the study protocol from Brummer et al: ”Characterising intestinal microbiota and 
immune response in IBD, microscopic colitis and IBS”. The University Hospital Örebro Ethical 
committee (Dnr 2010/261) approved this study. Studies were conducted in full accordance 
with the principles of the ‘Declaration of Helsinki’ (52nd WMA General Assembly, Edinburgh, 
Scotland, October 2000). All subjects gave their written informed consent prior to their 
inclusion into the study. 
 
Cell culture 
The Caco-2 BBE cell line (CRL 2102; American Type Culture Center, Manassas, VA) was 
maintained at 37°C in a humidified 5% CO2/95% O2 atmosphere. The HT-29.cl19A cell-line was 
obtained from Augeron and Laboisse (INSERM, Paris, France). Cell lines were grown in DMEM 
(Invitrogen, Paisley, UK) containing Glutamax and supplemented with 10% fetal bovine serum 
(PAA laboratories, Colbe, Germany), 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma, 
St. Louis, MO). Cells (between passage 55 and 74) were seeded at a density of 2.6 x 105 
cells/cm2 and grown for 14 days until they differentiated into polarized monolayers. After 14 
days, the TER reached 600 to 800 Ohms/cm2 for Caco-2 and 200 to 300 Ohms/cm2 for HT-29 
(Volt/Ohm-meter, World Precision Instruments, Sarasota, FL).  
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Electrical resistance measurements in monolayer cell cultures  
To measure the effects of IL-8 on epithelial permeability, polarized Caco-2 monolayers grown 
in Transwell filter inserts were treated with 100 pg/ml recombinant human IL-8 (rhIL-8, R&D 
Systems) added to the apical or basolateral compartment and the TER was measured using a 
Cellzscope (Nanoanalytics) which allows the continuous and automated measurement of 24 
individual filter inserts under cell culture conditions. 
 
IL-8 secretion 
DMEM containing TLR ligands was added to cell monolayers on day 14 either in the apical or 
in the basolateral compartment. The stimuli were used at the following concentrations: 20 
µg/ml Pam3CSK4, 10 µg/ml Pam2CSK4, 2 µg/ml flagellin (InvivoGen, San Diego, CA). After 24 
hours, 75 µl samples of apical or basolateral supernatant was taken and the concentration of 
IL-8 was determined using a cytometric bead array (BD, San Diego, CA) following the 
manufacturer instruction and flow cytometry (FACS CantoII, BD). Similar findings were 
obtained in triplicate experiments. 
 
Confocal microscopy  
Caco-2 cell monolayers grown in transparent Transwell inserts for 14 days were fixed in 4% 
(weight/vol) paraformaldehyde and permeabilized with PBS containing 0.2% (vol/vol) Triton 
X100, 1% (vol/vol) normal goat serum and 0.1% (weight/vol) sodium azide. Samples were then 
incubated with primary antibodies, 1:250 of anti-occludin polyclonal antibody (Zymed, 
Invitrogen) and 1:100 dilution of monoclonal anti-human IL-8RA (i.e. CXCR1, R&D Systems) 
were added overnight at 4°C followed by a 2 hours incubation with Cy3-and Alexa 488-labeled 
secondary antibodies at room temperature. Nuclei were stained for 20 minutes using a 
dilution 1:500 of DRAQ5 (Enzo Life Sciences BVBA, Zandhoven, Belgium). Confocal images 
were obtained using a Zeiss LSM 510 system consisting of a Zeiss Axioskop with Plan Neofluar 
×63 NA 1.3 oil objectives. Human duodenum and colon tissue sections (20 µm thick) were 
collected at -18°C on superfrost object glasses (Menzel-Glazer, Braunschweig, Germany) then 
processed and stained as described for Caco-2 cells. 
 
RNA isolation and quality control  
Caco-2 monolayers grown for 14 days were treated with none or 100 pg/ml rhIL-8. After 6 
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hours treatment, total RNA was extracted from Caco-2 cells using Trizol reagent (Invitrogen), 
purified using the RNeasy mini kit (Qiagen, Venlo, The Netherlands) and treated with DNase 
set (Qiagen) following the manufacturer’s instructions. RNA integrity was assessed using an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Amsterdam, The Netherlands) with 6000 
Nano Chips according to the manufacturer’s instructions. Only RNA samples showing intact 
bands corresponding to the 18S and 28S ribosomal RNA subunits, no chromosomal peaks or 
RNA degradation products, and an RNA integrity number (RIN) above 8.0 was used for 
microarray hybridization. 
 
Affymetrix GeneChip oligoarray hybridization and scanning  
Total RNA, extracted from Caco-2 cells was amplified and labelled using the GeneChip 3’ IVT 
Express kit (cat. no. 901229) according to the manufacturer’s specifications. Three 
independent experimental replicates per condition were used for total RNA extraction. The 
correspondingly labelled RNA was hybridised to a GeneChip Hu133 Plus2 array. Detailed 
methods for the labelling and subsequent hybridisations to the arrays are described in the 
eukaryotic section of the GeneChip Expression Analysis Technical Manual, Revision 3, from 
Affymetrix (Affimetrix, Santa Clara, CA), and are available upon request. 
 
Statistical and functional analyses of microarray data  
Transcriptome datasets underwent rigorous checks for quality control before the pathway and 
network analyses. These software packages are part of Bioconductor project 
(www.bioconductor.org) and integrated in the automated MADMAX pipeline 
(https://madmax.bioinformatics.nl) as described in previous publications (van Baarlen, Troost 
et al. 2009). Using the same statistical approaches we showed a good correlation between 
microarray and quantitative PCR (qPCR) data (van Baarlen, van Esse et al. 2008). Thus, we did 
not perform qPCR analyses on these samples.  
Four complementary methods were used for the functional analysis of microarray expression 
data: ErmineJ (GO annotation enrichment or overrepresentation; (Lee, Braynen et al. 2005)), 
Gene Set Enrichment Analysis (Subramanian, Tamayo et al. 2005), Ingenuity Pathway Analysis 
(IPA; www.ingenuity.com) and gene regulatory network reconstruction and analysis via 
Cytoscape (Cline, Smoot et al. 2007). Using these software tools, we performed: (i) 
identification of statistically supported overrepresentation of functional GO annotation 
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(Subramanian, Tamayo et al. 2005), (ii) mapping of expression data onto pathways to 
determine their up- or down-regulation in a statistical meaningful way (IPA); (iii) projection of 
transcript fold-change values of co-expressed genes onto interaction maps of the 
corresponding proteins, and (iv) reconstruction of biologically meaningful cellular pathways 
and their mode of modulation (IPA and Cytoscape). Our approach of combining data outputs 
from one bioinformatics package with another to strengthen the analysis has been described 
previously (van Baarlen, Troost et al. 2009). 
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Abstract  
 
The aim of this study was to obtain a better understanding of the mucosal interactions with 
orally administered bacteria in the small intestine and colon of gnotobiotic and conventional 
mice. This study focused on the small intestinal lymphoid tissue including Peyer’s patches 
(PPs) and mesenteric lymph nodes (MLNs). Lactobacillus plantarum was chosen as model 
commensal and was administered to germ-free (GF) mice. Lymphoid and mucosal tissues 
were collected after 20 h or after 21 days of colonization. Sections of the ileal and colonic 
tissue were fixed or cryopreserved for histochemistry and immunofluorescent microscopy. 
Additionally, immune cells were isolated from the resected PPs and MLNs for enumeration of 
lactobacilli. For comparison, tissue and organ samples were also collected from conventional 
mice of the same genetic background as the GF mice.  
We showed that the secreted mucus presents a formidable physical barrier to the direct 
interaction of bacteria with the epithelial surface with the exception of segmented 
filamentous bacteria which were seen below the mucus layer in the ileum. CFU of lactobacilli 
in cells isolated from the PPs and MLNs was highly variable between mice (up to 1 per 236 
immune cells) which may have been influenced by the location of the PPs or MLNs. Higher 
numbers of bacteria per cell were recovered from mouse PPs than MLNs. The colony counts 
of lactobacilli are an underestimate of the number of bacteria sampled by antigen presenting 
cells as L. plantarum is killed rapidly in the phagosome. In conclusion, uptake of commensal 
bacteria in the organized lymphoid structures such as PPs or isolated lymphoid follicles seems 
to be the predominant mechanism for immune sampling in the gut.  
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Introduction 
 
Commensal and probiotic bacteria can have beneficial effects on host immunity. The  
beneficial effects may be strain specific and influenced by the capacity of the bacteria to signal 
through pattern recognition receptors (PRRs) and elicit innate responses in intestinal epithelial 
cells (IECs) and antigen presenting cells (APCs) such as dendritic cells (DCs) (Wells, Rossi et al. 
2010; Rossi, van Baarlen et al. 2011).  Endocrine cells, goblet cells, and enterocytes of the 
intestinal epithelium express a range of PRRs to sense the presence of microbes. PRR 
signalling in Paneth cells and enterocytes increases the production of defensins and other 
anti-microbial factors. Thereby, limiting the number of mucosa-associated bacteria and 
preventing bacterial penetration of host tissues. Additionally, PRR signalling in IECs plays a key 
role in modulating the activities of immune cells in the lamina propria via the induction of 
tolerogenic signals such as TSLP, BAFF and APRIL (reviewed by (Wells, Rossi et al. 2010)). In 
the lamina propria, DCs exposed to TGF-β and retinoic acid (RA) produced by IECs take on a 
tolerogenic phenotype characterised by the expression CD103+ and CCR7 the integrin required 
for migration to the lymph nodes and induction of regulatory T cells (Tregs). PRR signalling and 
maturation of conditioned CD103+ DCs induce the expression of high levels of IL-10 and low 
levels of the pro-inflammatory cytokines IL-12 and TNF-α, favouring the induction of Foxp3 
expressing regulatory T cells (Tregs).  Specific strains of bacteria have been shown to induce 
tolerogenic DCs and to expand the population of Foxp3+ Tregs in mice (Kwon, Lee et al. 2010)  
and IL-10 producing Tr1 regulatory T cells that that are Foxp3- (Jeon, Kayama et al. 2012). 
However, it remains unclear to what extent the immunomodulatory effects of commensal 
bacteria are mediated through soluble microbe-associated molecular patterns (MAMPs) 
inducing PRR signalling in IECs and immune cells, or through the direct interaction of bacteria 
with the epithelium and immune cells in the intestine.  
Bacteria on the epithelial surface may be sampled directly by epithelial-associated APCs 
expressing dendritic and macrophage markers that can extend protrusions through the 
epithelial tight junctions to the luminal compartment (Rescigno, Urbano et al. 2001) in a 
TLR/MyD88-dependent fashion. The frequency of these events is dependent on the location 
and is increased by infection or MyD88/TLR epithelial signalling (Chieppa, Rescigno et al. 2006; 
Arques, Hautefort et al. 2009).  
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The exposure of the mucosal tissue to microorganisms is limited by the presence of a layer of 
mucus secreted by goblet cells in the epithelium. The mucus layer in the intestinal tract is 
composed of Muc2, a large protein of around 5,200 amino acids that is heavily glycosylated 
and assembled into huge net-like structures (Hansson and Johansson 2010). In the mouse, it 
was recently shown that the colonic mucus consists of two layers extending 150 µm above the 
epithelial surface with a similar protein composition (Johansson, Phillipson et al. 2008). The 
inner mucus layer is densely packed and devoid of bacteria and the outer mucus layer is less 
dense and colonized by bacteria (Johansson, Phillipson et al. 2008). In the small intestine, the 
inner mucus layer is thinner (Atuma, Strugala et al. 2001). However, the follicular epithelium 
covering the mucosal associated lymphoid tissue of the Peyer’s patches (PPs) in the small 
intestine is reported to be more accessible to antigens and bacteria present in the luminal 
compartment due to the absence of a mucus layer over the follicular epithelium. The follicular 
epithelium overlaying the lymphoid tissue contains specialized transport cells (M cells) which 
are the major route for the transfer of antigen, including intact bacteria and viruses, from the 
gut lumen to underlying DCs (Neutra, Mantis et al. 1999; Iwasaki and Kelsall 2001). M-cell 
mediated uptake of bacteria may also occur in the isolated lymphoid follicles associated with 
the colonic epithelium. Recent studies suggest that M cells also exist in villi where they may 
contribute to the transfer of organisms from bowel lumen to lamina propria DCs (Vallon-
Eberhard, Landsman et al. 2006). These antigen-presenting DCs can interact with associated T 
and B lymphocytes to selectively induce IgA, which helps protect against mucosal penetration 
by commensals. The commensal-loaded DCs in the PPs can prime T cell responses in the inter-
follicular region or in the draining lymph node after migration through the lymphatics 
(Macpherson and Uhr 2004).  
Immune sampling of fluorescently labelled Enterobacter cloacae by DCs in PPs was previously 
demonstrated following intragastric (i.g.) challenge of mice with 1 x 109 colony forming units 
(CFU) of bacteria expressing green fluorescent protein (Macpherson and Uhr 2004) E. cloacae 
was recovered from DCs in the washed mesenteric lymph nodes (MLNs) for up to 60 hours 
after administration, but viable bacteria were not recovered from splenocytes or other 
systemic tissues. Intestinal DCs carrying E. cloacae were restricted to the mucosal tissues and 
MLNs. Retinoic acid, synthesized by the intestinal epithelium and gut-associated DCs, induces 
expression of the specific mucosal homing receptors integrin α4β7 and chemokine receptor 
CCR9 in T cells ensuring their homing to the mucosa. This ensures that immune responses to 
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commensal bacteria are induced locally, without potentially damaging systemic immune 
responses (Iwata, Hirakiyama et al. 2004). The compartmentalisation of mucosal immune 
responses is one of the mechanisms by which pathological responses to the intestinal 
microbiota are avoided.  
The aim of this study was to obtain a better understanding of the mucosal interactions with 
orally administered bacteria in the small intestine and colon of gnotobiotic and conventional 
mice with a focus on the small intestinal lymphoid tissue including PPs and MLNs. 
Lactobacillus plantarum was chosen as model commensal since lactobacilli are relatively 
abundant in the small intestine of mice. L. plantarum were administered to germ-free (GF) 
mice. The lymphoid and mucosal tissues were collected after 20 h or after 21 days of 
colonization when the mucosal immune system had reached maturity. Sections of the ileal 
and colonic tissue were fixed or cryopreserved for histology and immunofluorescent 
microscopy. Immune cells were isolated from the resected PPs and MLNs and washed prior to 
enumeration of viable lactobacilli. For comparison, tissue and organ samples were also 
collected from conventional mice of the same genetic background as the GF mice.  
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Results 
 
In gnotobotic and conventional mice, bacteria are compartmentalized in the lumen and loose 
mucus  
These experiments were performed using L. plantarum harbouring the pTv-mCherry plasmid. 
This fluorescent protein was selected because it could be visualized both by flow cytometry 
and by confocal microscopy (Exitation max: 587 nm, Emission max: 610 nm). L. plantarum pTv-
mCherry stably expressed the mCherry protein in vitro in culture. However, we could not 
observe fluorescent bacteria in the tissue sections. For this reason, we decided to detect the 
bacteria using fluorescence in situ hybridization (FISH). For the sake of brevity, we will refer to 
L. plantarum pTv-mCherry as L. plantarum in the remaining parts of this manuscript. 
To investigate the interactions of L. plantarum with the intestinal epithelium, GF and 
conventional mice were colonized for 20 h or at day 1 and 21 after which they were sacrificed 
for tissue collection and isolation of immune cells from MLNs and PPs in the small intestine 
(Figure 1).  
 
Figure 1: Outline of the in vivo experiments performed on germ free (GF) and conventional (conv) Balb/c mice; 
Lp, L. plantarum.  
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To visualize the full complement of acid and neutral proteoglycans present in the tissue, 
sections from colon and ileum were stained using the combined PAS and Alcian blue methods. 
Colonic tissue from all mice revealed a relatively firm layer of secreted mucus covering the 
epithelium and mucus filled goblet cells in the crypts (Figure 2a). In GF mice, the firm mucus 
layer in the colon was thinner suggesting less mucus production (Figure 2b) but after 21 days 
of colonization the thickness was similar to that of conventional mice (Figure 2c). The mucus 
layer was also thinner in GF mice colonised with L. plantarum for 20 h than in mice which had 
been colonized with L. plantarum for 21 days (not shown). There was notably less epithelial-
associated mucus in the ileum than in the colon (Figure 2d, e and f). In the ileum the mucus 
resides between the villi and surrounding the ileal content. The darker purple staining on the 
surface of the epithelium most likely represents the acidic membrane bound mucins (Figure 
2f).  
Crossmon staining was used to visualize L. plantarum in monocolonized mice and microbiota 
in conventional mice. In the colon of conventional mice, the microbiota reside on top of the 
firm mucus layer covering the epithelium and within the lose mucus and faecal material as 
previously described by Johansson (Figure 3a and b) (Johansson, Phillipson et al. 2008). A few 
particles can be seen in the lose mucus in GF mice but they do not resemble the bacteria 
observed in conventional mice (Figure 3c). Evidently, there are much less bacteria in the ileum 
than in the colon and the majority appear to be attached to the loose mucus the exception 
being segmented filamentous bacteria (SFB) which are known to colonize the ileum of wild-
type mice where they form stable interactions with the villous epithelium (Figure 4a and b) 
(Ivanov, Atarashi et al. 2009). As expected, no bacteria were seen in the ileum or colon of GF 
mice even at higher magnification (Figure 4c). In gnotobiotic mice colonized with L. plantarum 
there were fewer bacteria present at 20 h than after 21 days and these were present 
throughout the intestine (Figure 5a and b). 
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Figure 2: Sections of colon (a, b and c) and ileum (d, e and f) from conventional mice (a, d), germ free mice (GF, b, 
e) and GF administered L. plantarum (c, f) on day 1 and 21. Sections were stained using the combined Alcian 
blue/PAS methods. White arrows in a, b and c indicate the dark blue stained firm mucus layer. Blue stained 
goblet cells are seen in the colon crypts (a, b, c) and villus epithelium (d, e, f).  F, faecal material in the colon.  
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Figure 3: Sections of colon from conventional mice (a and b) and germ-free mice (c) were stained using 
Crossmon’s method to visualize cells and mucus (a and c) and Gram staining to visualize bacteria, mucus and cells 
(b). Arrows indicate bacteria sitting on top of the firm mucus layer. 
      
 Figure 4: Sections of ileum from conventional mice stained using Crossmon’s method (a) and fluorescence in situ 
hybridisation with Eubacterial probe EU388 (b) and GF mice stained using Crossmon’s method (c). Arrows 
indicate segmented filamentous bacteria.  
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Figure 5: Sections of colon from mice mono-colonized with L. plantarum after 20 h (a) or 21 days (b) from 
colonization. Sections were stained using Crossmon’s method to visualize the cells, mucus and bacteria. Arrows 
indicate the bacteria. 
 
Viable L. plantarum can be recovered from immune cells within the PP and MLNs  
Resected PPs and MLNs from both groups of mice were used to generate immune cell 
suspensions that were counted and then gently lysed and plated on agar plates to enumerate 
bacterial colony forming units (CFU). As expected, no bacteria were recovered from the PPs of 
GF mice but bacteria were recovered from PPs of all the mice colonized by L. plantarum (Table 
1). The CFU of bacteria recovered per host immune cell was highly variable between mice and 
in the range of 10 to 100 CFU per million immune cells at 20 h and 21 days, although the 
CFU/cell tended to be higher in the group of mice colonized with L. plantarum for 21 days 
(Table 1). These counts most likely underestimate the number of CFU of L. plantarum in PPs 
and MLNs cells because bacteria would be killed by phagocytes such as macrophages and DCs. 
Previously, we determined that  L. plantarum is rapidly killed in human monocyte derived DCs 
(estimated 1-2 h) (Meijerink et al., unpublished).  
In mice colonized by L. plantarum, the bacterium was recovered from MLN cells presumably 
due to phagocytosis by DCs in the PP or lamina propria that can migrate to the draining lymph 
nodes and induce T cell responses.  There was a large variation in CFU counts and for some 
mice no bacteria were detected, although only some of the MLNs were used for this 
experiment. L. plantarum was recovered from the splenic cells of only one mouse although 
this was probably not due to bacteraemia as the mouse appeared to be normal. Isolation of 
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bacteria from the spleen may have be due to L. plantarum carrying antigen presenting cells 
entering the blood circulation from the gut-associated lymphoid tissue. 
 
Table 1: CFU of L. plantarum recovered from isolated lymphoid cells 
Inoculation 
CFU/10
6
cell  
PP 20 h  
CFU/10
6
cell  
MLN 20 h 
CFU/10
6
cell  
PP day 21 
CFU/10
6
cell  
MLN day 21 
CFU/10
6
cell  
Spleen day 21 
L. plantarum 97.1 62.2 1330 21.7 zero 
L. plantarum No PP zero 144 186 20.8 
L. plantarum 27.2 37.6 4230 1.26 zero 
L. plantarum 814 zero 163 Zero zero 
L. plantarum 1080 25 12.2 Zero zero 
L. plantarum 10.5 0.909 1050 6.69 zero 
L. plantarum 97.1 62.2 1330 21.7 zero 
PBS zero zero zero Zero zero 
PBS zero zero zero Zero zero 
PBS zero zero zero Zero zero 
CFU, colony forming units; PP, Peyer’s patches; MLN, mesenteric lymph nodes.  
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Discussion 
 
Recent studies in mice have shown that in the colon, the secreted mucus forms a firmly 
adherent layer on top of the surface of the epithelium that is devoid of bacteria and an outer 
‘loose’ mucus layer that is contact with bacteria and faecal material (Hansson and Johansson 
2010). The firm mucus layer stains appears stratified and more intensely stained than the 
loose mucus using Alcian blue/PAS staining suggesting this layer contains a higher 
concentration of mucin glycoprotein (Figure 2). Although the thickness varied between tissue 
sections, the firm mucus was notably thinner in GF mice but after colonization with L. 
plantarum for 21 days, it was similar to the conventional group (Figure 2). This is consistent 
with published observations of reduced mucus production in GF animals and with the concept 
that metabolites and other components of the microflora are key regulators of colonic mucus 
secretion (Hill, Cowley et al. 1990; Schwerbrock, Makkink et al. 2004). The appearance of both 
firm and loose mucus in GF mice suggests that the conversion of firm mucus layers into loose 
mucus does not depend on the presence of bacteria.  By combining Crossmon’s staining 
method with the Carnoy fixation we were able to visualize the compartmentalization of the 
microbiota to the loose outer mucus layer in the colon (Figure 3) as previously described using 
immunofluorescent microscopy (Johansson, Phillipson et al. 2008). Although microscopy 
techniques cannot exclude the presence of small numbers of bacteria in the firm mucus, it is 
evident that these events are rare. Previously Johansson et al., showed using semi-
quantitative qPCR of the bacterial 16S gene that there was bacterial DNA present in the firm 
mucus but in much less amounts than in the loose mucus (Johansson, Phillipson et al. 2008).  
The mucus layer in the ileum appears to be thinner, as previously demonstrated using 
different techniques (Atuma, Strugala et al. 2001) and has the appearance of densely stained 
strands residing between the villi and in-between the tops of the villi and the ileal content 
(Figure 3). In conventional mice no bacteria are seen to be in contact with the epithelium with 
the exception of the long filamentous structures characteristics of SFB (Figure 4). SFB are 
known to appear in the small intestine of Taconic mice after weaning. The most intriguing 
feature of SFB is their apparent intimate association with epithelial cells in the terminal ileum 
and their capacity to stimulate Th17 effector cell differentiation which contributes to 
protection against infection (Ivanov, Atarashi et al. 2009). The secreted mucus barrier in the 
colon and ileum prevents epithelial contact with L. plantarum in mono-colonized mice 
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although bacteria appear to be abundant in the loose mucus and lumen after 21 days (Figure 
4). The spatial segregation of bacteria does not rule out the possibility that microbial 
metabolites and other components can diffuse through the firm mucus layer to trigger 
epithelial signalling and crosstalk to the immune cells in the lamina propria. 
Live L. plantarum could be recovered from immune cells isolated from the PPs and MLNs of 
mono-colonized mice. The counts were highly variable between mice which may have been 
influenced by the location of the PPs or MLNs but overall, higher numbers of bacteria per cell 
(up to 1 in 236 total cells) were recovered from mouse PPs after 21 days colonization than 
after 20 h colonisation (Table 1). This is likely to be an underestimate of the number of 
bacteria sampled by APCs, as L. plantarum is killed in in the phagosome of DCs after 1 - 2 
hours. However, our attempts to enumerate cells containing L. plantarum expressing 
fluorescent mCherry were unsuccessful despite the fact that it was stably produced by L. 
plantarum in vitro and could be detected by flow cytometry (not shown). The reasons for this 
are not clear but most likely due to the instability of mCherry expression in vivo.  DCs are 
estimated to be around 2% of the total PP cell population depending on the gender of the 
mice (Duriancik and Hoag 2009). MLNs were also found to contain viable L. plantarum but the 
numbers were lower than in PPs.  As L. plantarum were not seen in contact with the 
epithelium in the ileum, it seems most likely that bacteria-laden DCs in the PPs or ILFs 
migrated through the lymphatics to the draining lymph nodes. Future experiments in  
CCR7-/- mice will be used to test this hypothesis as this receptor is required for migration of 
DC103+ DC from the LP to the lymph nodes.  The lower CFU recovered from the MLNs may be 
due to the variability of counts in the resected MLNs and/or the extended time of L. 
plantarum within APCs recovered from the MLNs.  
The preliminary study described in this chapter focused on PPs and antigen sampling. 
However, the colon also contains an additional type of lymphoid tissue, the solitary intestinal 
lymphoid tissues (SILT) which can develop in mature isolated lymphoid follicles (ILFs) 
(Hamada, Hiroi et al. 2002; Lorenz, Chaplin et al. 2003; Pabst, Herbrand et al. 2006). Like the 
PPs, ILFs can also function as inductive sites for mucosal immune responses (Lorenz, Chaplin 
et al. 2003).  
In summary, these results clearly demonstrate that the mucus presents a formidable barrier 
to the immune sampling of bacteria in the intestine. Nevertheless, intact and viable intestinal 
bacteria are found intracellularly in the PP and MLN cells (most likely within DCs). As contact 
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of intact bacteria with the small intestinal epithelium was not observed, uptake in the PPs or 
ILFs seems to be the predominant mechanism for immune sampling of commensal bacteria. 
Our future aims are to confirm the reported lack of mucus over the follicular epithelium of the 
PPs and to stain for both L. plantarum and DCs in these tissue sections of the ileum, colon and 
PPs. Additionally, we aim to generate L. plantarum strains that stably express fluorescent 
proteins in vivo so that bacteria can be more easily localized with specific types of immune 
cells for e.g. in transgenic mice expressing green fluorescent protein in specific subsets of 
mucosal DCs. 
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Materials and Methods  
 
Mice 
This study was conducted under the oversight of the Crown Research Institute Animal Ethics 
Committee (Palmerston North, New Zealand) according to the New Zealand Animal Welfare 
Act 1999, Animal Ethics application number 12501.   
Conventional Balb/c mice (CLEA Japan, INC. Tokyo, Japan) were housed under specific 
pathogen-free conditions. All mice were fed AIN-93M diet (Research Diets, New Jersey, US) 
and were housed with 12 hour light/dark cycles and at an environmental temperature of 21-
22°C. Germ-free (GF) Balb/c mice from the same supplier were housed in individual cages 
within gnotobiotic isolators and given the same diet sterilised by gamma irradiation (25 kGy), 
and autoclaved sterile water.  All bedding material was sterilized by gamma irradiation (25 
kGy). Access to food and water was provided ad libitum, and food intake was measured 
weekly.  
 
Bacteria  
L. plantarum harbouring pTmv-mCherry was cultured at 37oC in deMan, Rogosa Sharpe (MRS) 
medium containing 5 g/ml erythromycin overnight and stored in aliquots in MRS plus 10% 
glycerol at -80oC. On the day of administration, one aliquot was thawed and grown in MRS 
plus 5 mg/ml erythromycin to an OD at 600nm of 1-1.5, then harvested by centrifugation, 
washed in PBS and resuspended in sterile PBS prior to inoculation. 
 
In vivo experiment and collection of tissue samples 
Both GF and conventional mice were divided in 2 groups which received different treatments 
and 2 control groups (Figure 1). GF mice from group 1 (n=6) and conventional mice from 
group 2 (n=6) received 108 CFU/100µl of L. plantarum pTv-mCherry by oral gavage on day 1 
and were euthanized 20 h later (n=6); GF mice from group 3 (n=4) and conventional mice from 
group 4 (n=4) received 100 µl of PBS by oral gavage on day 1 and were euthanized 20 h later; 
GF mice from group 5 (n=6) and conventional mice from group 6 (n=6) received 108 CFU/100µl 
of L. plantarum pTv-mCherry by oral gavage on day 1 and day 21 and were euthanized 20 h 
after day 21 and GF mice from group 7 (n=4) and conventional mice from group 8 (n=4) 
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received 100 µl of PBS by oral gavage on day 1 and day 21 and were euthanized 20 h after day 
21.  
For splenocytes isolation, spleens were gently pushed through 100 m gauge cell strainers.  
The cell suspension was made up to 10 ml with PBS (4oC), and then centrifuged at 300 g (4oC) 
for 5 minutes following which the supernatant was discarded.  Red blood cells were lysed by 
adding 2 ml of ACK lysis buffer (150 mM NH4Cl, 1mM KHCO3, 0.1 mM Na2EDTA pH 7.3).  Cells 
were then incubated for 5 minutes at room temperature. Lysis was stopped by adding 10 ml 
of PBS (4oC) to each tube, which were then mixed by inversion, followed by centrifugation at 
300 g (4oC) for 5 minutes.  The supernatant was discarded and the cell pellet resuspended in 1 
ml of PBS (4oC).  
Mesenteric lymph nodes (MLNs) were removed in situ from mesenteric tissue, the fat 
removed from the lymph nodes before the MLN were dispersed by pushing through 100 m 
gauge cell strainers.  The cell suspension was washed by adding 10 ml of PBS (4oC), followed 
by centrifugation at 300 X g (4oC) for 5 minutes.  The supernatant was discarded and the cells 
resuspended in 1 ml of PBS (4oC). 
Peyer’s patches (PPs) were dissected from the ileum. PPs were pierced with a syringe needle, 
following which they were incubated in 3 ml of Rosewell Park Memorial Institute (RPMI) 
medium with collagenase type IV (Sigma C5138, 100 U/ml) in a shaking incubator at 15 min at 
37oC.  The collagenase was then neutralised by adding 9 ml of RPMI plus 10 ml of FCS.  The cell 
suspension was filtered by passing through a 100 m gauge cell strainer. The cells were then 
centrifuged at 300 g (4oC) for 5 minutes.  The cells were washed once more by adding 10 ml 
PBS (4oC), followed by centrifugation at 300 X g (4oC) for 5 minutes. The supernatant was 
discarded and the cell pellet was resuspended in 1 ml of PBS (4oC). 
To enumerate live bacteria, serial dilutions of PBS suspension with single cells isolated from 
spleens, MLNs and PPs of mice were plated on MRS agar. 
 
Histology and FISH 
Segments of colon and ileum from mice from group 1 to 8 and conventional mice were fixed 
in Carnoy’s fixative to preserve the mucus layer as described by Johansson et al., (Johansson 
and Hansson 2012). Carnoy fixed tissue was embedded in paraffin and sectioned at 5 µm. 
Sections were stained using the combined Alcian blue/periodic acid Schiff (PAS) methods, 
Gram stain, or Crossmon’s method. 
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Segments of colon, ileum and PPs were also cryopreserved for fluorescent in situ hybridization 
(FISH). FISH was performed using the method described by Johansson et al., (Johansson and 
Hansson 2012). Bacteria were stained with the universal probe EUB 338 probe (Isogen-
bioscience 26-2016-1/1) and the mucus with the rabbit anti mouse anti-Muc2C3 (1 : 500, 
Kindly gifted by Prof. Gunnar Hansson, Department of Medical Biochemistry, Institute of 
Biomedicince, University of Gothenburg, Gothenburg, Sweden) and the secondary antibody 
Goat-anti-rabbit Cy3 (Jackson ImmunoResearch, lot number : 111-165-144).  
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Abstract 
 
A reduction of Faecalibacterium prausnitzii has been associated with risk of Crohn’s disease 
recurrence. Additionally, F. prausnitzii strain A2-165 has been reported to exert anti-
inflammatory effects both in vitro and in vivo. The supernatant of F. prausnitzii cultures 
attenuated NF-kB signalling in epithelial cells and both the bacterium and its supernatant 
reduce the severity of TNBS induced colitis in vivo. As dendritic cells (DCs) are the most 
important antigen presenting cells with the unique ability to activate naïve T cells at mucosal 
sites, here we investigated the immune stimulating properties of 5 F. prausnitzii strains and 8 
other abundant intestinal commensals bacteria on DCs function in vitro. All bacteria induced 
efficient maturation and activation of DCs. F. prausnitzii A2-165 induced the largest amounts 
of IL-10, TNF-α and IL-1β and was among the weakest inducers of IL-12p70. Principal 
component analysis revealed that the immune response to F. prausnitzii strain A2-165 is 
distinct from the other strains, due to the high levels of IL-10. The TLR signalling capacity of 
the strains was also measured using NF-κB reporter cell lines expressing human TLRs. In 
general, high TLR signalling activity was associated with the ability of commensal bacteria to 
induce cytokines in the DC assays.  
This research has implications for the exploitation of F. prausnitzii as a therapeutic because all 
protection studies to date have been performed using strain A2-165 which elicits a distinct 
immune response in human immune cells.  
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Introduction  
 
The human gastrointestinal tract is colonized by more than 3000 different species of 
commensal bacteria, referred to as the microbiota, which reaches densities of 1012 bacteria 
per gram of luminal content in the colon (Whitman, Coleman et al. 1998). The dominant phyla 
of commensal bacteria are Firmicutes, Bacteroidetes and Actinobacteria (Tap, Mondot et al. 
2009). In the healthy intestine, commensal bacteria are predominantly compartmentalized to 
the lumen, but can interact with immune cells associated with the epithelium or in lymphoid 
tissues of the small intestine. The microbiota or components of the microbiota can influence 
immunity and tolerance in the gastrointestinal tract through their recognition by pattern 
recognition receptors (PRRs) expressed on intestinal epithelial cells and immune cells (Wells, 
Rossi et al. 2010; Rossi, van Baarlen et al. 2011). Changes in the microbiota are associated 
with several intestinal-related disorders including irritable bowel syndrome, autoimmune 
disease and diabetes and have a profound impact on the pathophysiology of inflammatory 
bowel disease (IBD) which includes Crohn’s disease (CD) and ulcerative colitis (UC). CD and UC 
are driven by an aberrant inflammatory T cell response to intestinal microbiota in a genetically 
susceptible host. Both diseases are associated with loss of intestinal epithelial integrity 
resulting in increased bacterial translocation into the mucosa and leading to increased 
interactions of bacteria with immune cells. In this context, it is important to understand the 
direct effects of commensal bacteria on immune cells.  
A decrease in the abundance and biodiversity of bacteria belonging to the Firmicutes phylum 
has been observed in IBD patients (Seksik, Rigottier-Gois et al. 2003; Macfarlane, Blackett et 
al. 2009). In particular, a reduction of a major member of the Firmicutes phylum, 
Faecalibacterium prausnitzii has been associated with risk of disease recurrence in CD patients 
(Sokol, Pigneur et al. 2008). In addition, certain commensal strains have been demonstrated 
to have strong effects on the mucosal immune system in vitro and in vivo (Gaboriau-Routhiau, 
Rakotobe et al. 2009; Atarashi, Tanoue et al. 2011). For example, the prominent commensal 
Bacteroides fragilis has been shown to protect against experimental colitis in mice 
(Mazmanian, Liu et al. 2005; Mazmanian, Round et al. 2008). Moreover, F. prausnitzii and its 
culture supernatant have been shown to reduce the severity of 2,4,6-trinitrobenzenesulfonic 
acid (TNBS) induced colitis in mice (Sokol, Pigneur et al. 2008).  
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The effects of commensal bacteria on the host mucosal immune system are partly mediated 
by their interaction with antigen presenting cells (APCs), such as macrophages and dendritic 
cells (DCs) (Rossi, van Baarlen et al. 2011). In the intestinal lamina propria and Peyer’s 
patches, immature DCs are activated by contact with bacteria or bacterial microbe-associated 
molecular patterns (MAMPs) via innate PRRs, such as Toll like receptors (TLRs). After 
activation, DCs undergo maturation and migrate from the mucosal tissue to the lymphoid 
tissue where they interact with naive T cells inducing their activation, clonal expansion and 
differentiation. Different subsets of DCs in the mucosal and lymphoid tissues are involved in 
the induction of regulatory T cells (Tregs, (Powrie, Read et al. 2003)) and effector T cells via 
distinct profiles of cytokine secretion and surface co-stimulatory molecules expression.  
IL-10 is pivotal for the maintenance of homeostasis in the intestine (Geuking, Cahenzli et al. 
2011; Veenbergen and Samsom 2012). It is secreted by DCs as well as Foxp3+ and Foxp3- T 
cells in the lamina propria. Secretion of IL-10 by DCs is important for the maintenance of 
functional Foxp3+ Tregs during intestinal inflammation (Murai, Turovskaya et al. 2009). IL-10 
also inhibits the production of pro-inflammatory cytokines such as IFN-γ, TNF-α, IL-6 and IL-12. 
Moreover, IL-10 was shown to play a role in controlling pro-inflammatory responses to 
translocated microbes by abrogating IL-23 production (Manuzak, Dillon et al. 2012).  
In vitro assays are considered as useful approaches to select strains for in vivo studies based 
on their immunomodulatory properties (Foligne, Nutten et al. 2007; Kwon, Lee et al. 2010; 
Snel, Vissers et al. 2011; Meijerink, Wells et al. 2012). For example, in vitro in culture with 
human peripheral blood mononuclear cells (PBMCs), F. prausnitzii induces high levels of IL-10 
and low levels of IL-12p70 and IFN-γ which correlates with its protective effect in TNBS 
induced colitis in vivo (Sokol, Pigneur et al. 2008). 
Given the important role of DCs in regulating tolerance and immunity in the intestinal mucosa, 
our aim was to investigate the immunomodulatory properties of F. prausnitzii and other 
commensal bacteria on human DCs in vitro and to assess the contribution of different TLR 
signalling in immune activation. Furthermore, little is known about the immunomodulatory 
properties of commensal bacteria as most studies have been performed on traditional 
probiotic species such as Lactobacillus and Bifidobacterium (Bron, van Baarlen et al. 2012).  
The 13 bacterial strains selected for this study belong to the Firmicutes and Actinobacteria 
phyla, they include 5 isolates of F. prausnitzii and Lactobacillus plantarum WCFS1. The 
immune responses of DCs to the commensal bacteria were assessed measuring cytokine 
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secretion and surface marker expression after incubation of DCs with the bacteria. Immature 
DCs were differentiated in vitro from CD14+ monocytes isolated from human blood (Sallusto 
and Lanzavecchia 1994; Zhou and Tedder 1996). Additionally, the TLR signalling capacity of the 
strains was measured using NF-κB reporter cell lines expressing TLRs.  
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Results 
 
Immune responses of human PBMCs to F. prausnitzii  
As F. prausnitzii was previously shown to induce relatively high IL-10 to IL-12p70 and IFN-γ 
cytokine ratio in culture with PBMCs, we compared cytokine production of PBMCs incubated 
with F. prausnitzii A2-165, L. plantarum WCFS1 or L. salivarius HMI001 at a bacterium to cell 
ratio of 10 to 1. L. salivarius HMI001 was selected as it is was previously shown to be a 
relatively high inducer of IL-10 compared to other Lactobacilli (Meijerink, Wells et al. 2012) 
and L. plantarum WCFS1, a high inducer of IL-12p70 (Meijerink, van Hemert et al. 2010).  
 
Figure 1: Cytokine secretion by PBMCs. IL-10, IL-12p70, TNF-α, IL-1β and IFN-γ were measured in the supernatant 
of PBMCs from one donor after 24 hours of incubation with bacteria (bacterium: PBMC, 10:1). 
 
PBMCs stimulated with F. prausnitzii A2-165 released the largest amount of IL-10, the smallest 
amount of IL-12p70 and small amount of IFN-γ in comparison with the other strains (Figure 1). 
Interestingly, F. prausnitzii A2-165 also induced the largest secretion of the pro-inflammatory 
cytokines IL-1β and TNF-α by PBMCs when compared to the lactobacilli strains (Figure 1).  
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Surface activation markers are up-regulated in DCs in response to commensal bacteria 
Human monocyte-derived immature DCs (DCs) were incubated with selected commensal 
anaerobic bacteria (listed in Table 1) at a bacterium to cell ratio of 10 to 1. Incubation with the 
different bacteria did not significantly alter DC viability compared to the control (typically 60-
80% viability, not shown). Surface expression of the maturation marker CD83 and the co-
stimulatory molecule CD86 were determined to assess the activation and maturation status of 
DCs in vitro after stimulation with the bacteria. All the bacteria tested induced increased 
surface expression of CD83 and CD86 when compared with the control immature non-
stimulated DCs. The degrees of surface marker expression induced by the bacteria were 
similar, indicating that they all induced DC maturation and activation (Figure 2a and b). 
 
Commensal bacteria induce differential cytokine responses in DCs 
The immune activation of DCs was assessed by measuring the levels of IL-10, IL-12p70, IL-6, IL-
1β and TNF-α in the culture supernatant after incubation of the bacteria with DCs from three 
to four different donors (Figure 3). The largest amounts of IL-10 were induced by the F. 
prausnitzii strains, Eubacterium hallii L2-7 and Megamonas rupellenesis Mag1B. In addition, 
these strains induced the largest amounts of TNF-α, as observed for F. prausnitzii A2-165 with 
PBMCs, and of IL-6. The F. prausnitzii strains, E. hallii L2-7 and E. rectale A1-86 also induced 
relatively large amounts of IL-1β. L. plantarum WCFS1, M. rupellensis Mag1B and E. hallii L2-7 
were among the strongest inducers of IL-12p70, whereas the F. prausnitzii strains were among 
the poorer inducers (Figure 3). Surprisingly, the strains Ruminococcus bromii L2-63, 
Clostridium hathewayi 82-B and C. xylanovorans Lac1D induced small or undetectable 
amounts of some cytokines (Figure 3) despite having effectively induced DC maturation 
(Figure 2a and b).  
Bacteria and DCs were incubated in the presence of antibiotics to prevent bacterial 
overgrowth. However, soluble factors released by the bacteria during growth may have 
immunomodulatory properties as shown previously for the culture supernatant of F. 
prausnitzii A2-165 which had a protective effect against TNBS-induced colitis (Sokol, Pigneur 
et al. 2008). To investigate this, DCs were stimulated with F. prausnitzii A2-165 cell free 
culture supernatants, bacterial medium or butyrate at concentrations similar to that 
measured in the bacterial culture supernatant. In an initial experiment, the bacterial 
supernatants were found to be toxic for the DCs at a concentration of 10% v/v (data not 
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shown). This toxicity can be attributed to the high concentration of butyrate produced during 
bacterial fermentation (Wang, Morinobu et al. 2008). F. prausnitzii A2-165 culture 
supernatant (1.25 and 2.5 % v/v) and butyrate (25 to 500 µM) did not affect cell viability or 
cytokine secretion by DCs compared to un-stimulated cells (data not shown). This 
demonstrates that soluble MAMPs, butyrate or other factors secreted by F. prausnitzii did not 
induce cytokine responses in DCs. 
 
Table 1: Phylum, family and phylogenetic cluster of the bacteria used 
Bacterial strain Phylum Family 
Phylogenetic 
cluster 
Reference 
F. prausnitzii A2-165 Firmicutes Ruminococcaceae Clostridium 
cluster IV 
(Duncan 2002) 
F. prausnitzii M21/2 Firmicutes Ruminococcaceae Clostridium 
cluster IV 
(Louis, Duncan et al. 
2004) 
F. prausnitzii S3L/3 Firmicutes Ruminococcaceae Clostridium 
cluster IV 
(Louis, Duncan et al. 
2004) 
F. prausnitzii L2-6 Firmicutes Ruminococcaceae  Clostridium 
cluster IV 
(Duncan 2002) 
F. prausnitzii HTF-F Firmicutes Ruminococcaceae Clostridium 
cluster IV 
(Lopez-Siles, Khan et al. 
2012) 
R. bromii L2-63 Firmicutes Ruminococcaceae  Clostridium 
cluster IV 
(Barcenilla, Pryde et al. 
2000) 
E. rectale A1-86 Firmicutes Eubacteriaceae Clostridium 
cluster XIVa 
(Barcenilla, Pryde et al. 
2000) 
E. hallii L2-7 Firmicutes Eubacteriaceae Clostridium 
cluster XIVa 
(Duncan, Louis et al. 
2004) 
B. adolescentis L2-32 Actinobacteria Bifidobacteriaceae  (Barcenilla, Pryde et al. 
2000) 
Megamonas sp. Mag1B 
95,0% homology* with M. 
rupellensis 
Firmicutes Veillonellaceae  This work 
Clostridium sp. 82B 95,4% 
homology* with C. 
hathewayi 
Firmicutes Clostridiaceae Clostridium 
cluster XIVa 
This work 
Clostridium sp. Lac1D 
90,5% homology* with C. 
xylanovorans 
Firmicutes Clostridiaceae Clostridium 
cluster XIVa 
This work 
L. plantarum WCFS1 Firmicutes Lactobacillaceae   
*based on the sequence homology of 850 nucleotides of the 16S rRNA 
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Figure 2: CD83 and CD86 surface expression in DCs after 48 hours of incubation with the bacteria (bacterium: DC 
ratio 10:1). a) Representative histograms showing the expression of the surface markers CD83 and CD86 on DCs. 
Grey lines represent the isotype controls and black lines the staining. b) Percentage of CD83
+
 (in white) and 
CD86
+
 (in grey) DCs from 3 donors. Error bars represent SEM. F. prau, F. prausnitzii; R. brom, R. bromii L2-63; E. 
rect, E. rectal A1-86; E. hall, E. hallii; M. rupe, M. rupellensis; C. hath, C. hathewayi 82-B; C. xyla, C. xylanovorans 
Lac1D; L. plan, L. plantarum WCFS1.   
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Figure 3: Cytokine secretion by DCs. IL-10, IL-12p70, TNF-α, IL-1β and IL-6 were measured in the supernatant of 
DCs from 3 to 4 donors after 48 h of incubation with the bacteria (bacterium to DC ratio 10:1). Each donor is 
represented with a different symbol and the red lines indicate the average of the donors.  
 
Differential activation of TLRs by commensal bacteria 
To investigate the potential relationship between cytokine profiles in DCs and TLR signalling, 
bacteria were incubated with HEK293 reporter cell lines expressing different human TLRs and 
a reporter plasmid harbouring the luciferase gene under the control of the NF-κB promoter.  
Incubation of each TLR expressing cell line with the respective agonist induced high luciferase 
activity (Pam2CSK4 is the agonist of TLR2 and TLR2/6, flagellin and LPS are the agonists of 
TLR5 and TLR4 respectively) compared to cells stimulated with medium alone. HEK293 cells 
transfected with the reporter plasmid alone did not produce luciferase in response to TLR 
agonists or bacteria demonstrating that the NF-κB activation was TLR dependent (data not 
shown).  
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The F. prausnitzii strains, R. bromii L2-63, E. rectale A1-86, E. hallii L2-7 and B. adolescentis L2-
32 induced high NF-κB activation in the TLR2/6 and TLR2 reporter cell lines (Figure 4). Agonists 
of TLR2 include acylated lipoprotein anchors and lipoteichoic acid present in Gram-positive 
and Gram-negative bacterial cell envelopes. As previously reported (Erridge, Duncan et al. 
2010), the flagellated strain E. rectale A1-86 (Duncan and Flint 2008) induced NF-κB activation 
via TLR5 signalling. Surprisingly, E. hallii L2-7 and M. rupellensis Mag1B activated TLR4 
signalling although they are considered Gram-positive. M. rupellensis Mag1B however, has 
been described previously as Gram-negative to Gram-variable (Chevrot, Carlotti et al. 2008). 
C. hathewayi 82-B and C. xylanovorans Lac1D did not induce NF-κB activation in any of the TLR 
assays, suggesting that these strains might express MAMPs that are shielded or not 
recognized by the TLRs tested. Alternatively, these strains may possess immunomodulatory 
components that inhibit the activation of the NF-κB pathway. 
 
Figure 4: TLR signalling properties of the commensal bacteria. NF-κB activation was measured using a 
luminescence reporter in HEK293 cell lines expressing TLR2, TLR2/6, TLR5 and TLR4 after incubation with the 
bacteria (bacterium: cell ratio 10:1). NF-κB activation is expressed as percentage of the positive control. Error 
bars represent SEM, n=6, * indicates p<0.05, ** p<0.01, *** p<0.001 compared to the control. 
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Principal component analysis 
Principal component analysis (PCA) was performed to describe the variance of the cytokine 
levels (IL-10, IL-12p70, IL-6, IL-1β and TNF-α) induced by the bacteria. 
The PC 1 and PC 2 of the PCA describe 99.9 % of the variance between the cytokine levels 
induced by the bacteria. The coefficients of PC 1 revealed that the contribution of the 
different cytokines to the variance was almost equal, the coefficient associated with IL-12p70 
was 0.2 while for the other cytokines the coefficient was in average 0.48. The PC 1, PC 2 score 
plot (Figure 5) revealed that the majority of the bacteria are grouped in the centre of the plot, 
while F. prausnitzii A2-165, E. hallii L2-7, M. rupellensis Mag1B and L. plantarum WCFS1 are 
clearly separated from the other bacteria and from each other reflecting their capacity to 
induce distinct cytokine profiles in DCs. Furthermore, PCA revealed that the immune response 
induced by F. prausnitzii A2-165 is very different from the other F. prausnitzii strains tested. 
 
Figure 5: Principal component analysis (PCA) of the cytokine profiles induced by the commensal bacteria in DCs. 
Each dot represents the average of cytokine levels of a commensal strain in DCs. The variables (level of 
cytokines) are represented by vectors. The direction and length of a vector indicates how the variable 
contributes to the two principal components in the plot.  (F. prau, F. prausnitzii; R. brom, R. bromii L2-63; E. rect, 
E. rectale A1-86; E. hall, E. hallii L2-7; M. rupe, M. rupellensis Mag1B; C. hath, C. hathewayi 82-B; C. xyla, C. 
xylanovorans Lac1D; L. plan, L. plantarum WCFS1). 
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Discussion 
 
Reduced counts of F. prausnitzii have been correlated with recurrence of colitis in CD patients. 
F. prausnitzii strain A2-165 and its culture supernatant were shown to attenuate colitis in 
TNBS mouse model. Additionally, incubation of human PBMCs with F. prausnitzii A2-165 
induced a relatively high IL-10 to IL-12p70 cytokine ratio, suggesting that the bacterium might 
have an effect on APCs such as DCs (Sokol, Pigneur et al. 2008).  
Here we investigated the immune stimulating properties of F. prausnitzii and other 
commensals bacteria on DCs which play important roles in regulating mucosal tolerance and 
immunity. DCs are key APCs in the intestine, linking innate and adaptive immune responses 
via the induction of T cells in the mucosal lymphoid tissue. Furthermore, IL-10 produced by 
APCs in the lamina propria has been reported to enhance the suppressive activity of Foxp3+ 
Tregs in the mucosa (Murai, Turovskaya et al. 2009).  
The effects of F. prausnitzii on DCs have not yet been described and it is not known whether 
all F. prausnitzii strains behave similarly or if they induce different immune responses in DCs 
compared to other colonic commensals. To address these questions, we investigated the 
immunomodulatory properties of five F. prausnitzii strains and 8 other abundant intestinal 
commensal bacteria on human monocyte-derived DCs in vitro. The majority of the bacteria 
tested belong to the Firmicutes phylum, which is characterized by decreased abundance and 
biodiversity in IBD patients compared to healthy controls (Seksik, Rigottier-Gois et al. 2003; 
Macfarlane, Blackett et al. 2009). Moreover, F. prausnitzii, R. bromii, E. hallii and E. rectale 
belong to the Clostridium clusters IV and XIVa (Clostridium leptum and coccoides groups, 
respectively) that have been shown to induce the expansion and activation of Tregs after 
colonization of germ-free mice (Atarashi, Tanoue et al. 2011).  
All the bacteria tested were able to induce efficient maturation and activation of DCs (Figure 
2a and b). The highest levels of IL-10 were induced by F. prausnitzii A2-165, E. hallii L2-7 and 
M. rupellensis Mag1B (Figure 3). F. prausnitzii A2-165 was among the weakest inducers of IL-
12p70 while M. rupellensis Mag1B and E. hallii L2-7 were among the strongest inducers 
(Figure 3). Additionally, these strains induced the largest amounts of TNF-α and IL-6. The F. 
prausnitzii strains, E. hallii L2-7 and E. rectale A1-86 induced also relatively large amounts of 
IL-1β.  
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PCA revealed that F. prausnitzii A2-165, M. rupellensis Mag1B and E. hallii L2-7cause distinct 
effects on the immune cells when compared to the other strains. These differential effects 
were due to the high levels of IL-10 induced by F. prausnitzii A2-165, the high levels of IL-
12p70 and TNF-α induced by M. rupellensis Mag1B and the high levels of IL-10 and IL-12p70 
induced by E. hallii L2-7. Furthermore, F. prausnitzii A2-165 is separated from the other F. 
prausnitzii strains. Strain dependent differences in cytokine profiles have been described 
previously for L. plantarum and linked to genetic factors such as bacteriocin production and 
altered TLR recognition due to enzymes modifying structures of MAMPs (Meijerink, van 
Hemert et al. 2010). These results also have implications for the exploitation of F. prausnitzii 
as a therapeutic in IBD as the protective effects described to date have only been described 
for strain A2-165 which induces larger amounts of IL-10 than the other F. prausnitzii strains. 
Several studies have correlated in vitro cytokine profiles induced by lactobacilli with their anti-
inflammatory properties in vivo. The in vivo protective effects of lactobacilli correlated with 
high IL-10 and low IL-12p70 induction in vitro in PBMCs suggesting that these two cytokines, 
especially IL-10, were the main factors involved in protection (Foligne, Nutten et al. 2007). In 
our experiments using DCs, F. prausnitzii A2-165 induced high IL-10, low IL-12p70 but also 
high amounts of the pro-inflammatory TNF-α and IL-6 compared to the other bacteria.  
In our experiments, bacteria and DCs were co-incubated in the presence of antibiotic to 
prevent bacterial overgrowth and medium acidification which would affect DC viability and 
cytokine secretion. However, F. prausnitzii A2-165 culture supernatant and the short chain 
fatty acid butyrate were tested separately for their capacity to activate and induce cytokines 
in DCs. Neither F. prausnitzii A2-165 culture supernatant nor butyrate induced cytokine 
secretion or the expression of surface activation and maturation markers in DCs (not shown).  
In general, high TLR signalling activity was associated with the ability of commensal bacteria to 
induce cytokines in the DC assays. The ability of E. rectale A1-86 to induce NF-κB activation 
through TLR5 is in agreement with a previous study (Erridge, Duncan et al. 2010). TLR4 
signalling was induced by E. hallii L2-7 and M. rupellensis Mag1B. Phylogenetically, M. 
rupellensis Mag1B and E. hallii L2-7 belong to the Firmicutes lineage. TLR4 signalling induced 
by the Firmicutes bacteria is ambiguous, as by definition these bacteria are considered Gram-
positive. However, due to their unique cell wall composition, upon Gram staining these 
bacteria appeared to be Gram-negative to Gram-variable (Duncan and Flint 2008, Chevrot 
2008). C. hathewayi 82-B and C. xylanovorans Lac1D induced low or no NF-κB activation in the 
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TLR assays and low or undetectable cytokines in DC assay (Figure 3 and 4) despite the fact that 
they induced activation and maturation of DCs (Figure 2).This suggests that these strains 
might express MAMPs that are shielded or not recognized by the TLRs tested or that they 
possess immunomodulatory components that inhibit activation of the NF-κB pathway. This 
appears to be a unique property and may be an evolutionary adaptation to avoid immune 
recognition by the host as proposed for Bacteroides fragilis (Weintraub, Zahringer et al. 1989). 
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Materials and methods 
 
Bacterial strains and culturing conditions 
All the commensal bacteria used (Table 1) were isolated from human faeces and identified by 
16S rRNA sequencing, L. plantarum WCFS1 was isolated from human saliva.  
F. prausnitzii strains A2–165, L2-6, M21/2, S3L/3, HTF-F, R. bromii L2-63, E. rectale A1-86, E. 
hallii L2-7 and B. adolescentis L2-32 have been described elsewhere (Barcenilla, Pryde et al. 
2000; Duncan 2002; Duncan, Louis et al. 2004; Louis, Duncan et al. 2004; Lopez-Siles, Khan et 
al. 2012). Strains C. hathewayi 82-B, M. rupellensis Mag1B and C. xylanovorans Lac1D were 
isolated from freshly voided human faeces as described previously (Lopez-Siles, Khan et al. 
2012). Briefly, strains were isolated by plating 1 µl of the faecal material directly on yeast 
extract, casitone, fatty acid and glucose medium (YCFAG, described in (Lopez-Siles, Khan et al. 
2012)). After 12 h to 16 h of incubation at 37°C in an anaerobic tent (80% N2, 12% CO2, and 
8% H2), 500 translucent colonies per sample were selected and cultured on fresh plates. After 
growth, the colonies were presumptively identified based on morphology, further purified 
and Gram stained. Up to 5 colonies per sample were identified by 16S rRNA gene sequencing.  
All the commensal bacteria were maintained at 37°C on YCFAG in an anaerobic tent. In all 
experiments bacteria were grown in YCFAG broth to an optical density at 600nm (A600) of 
0.8, which corresponds to the late exponential or early stationary growth phase. L. plantarum 
WCFS1 was cultured overnight to stationary phase in deMan, Rogosa Sharpe broth (MRS, 
Merck, Darmstadt, Germany) at 37°C. Bacteria were harvested by centrifugation, washed in 
phosphate buffer saline (PBS), resuspended in PBS containing 20% glycerol and stored at -80°C 
prior to use in the immunoassays. Bacteria were quantified by fluorescent in situ hybridization 
(FISH) or phase contrast microscopy. All buffers and media used for the anaerobic bacteria 
were deoxygenated by flushing with oxygen free nitrogen for 30 minutes.  
 
Human PBMCs and DCs assays 
This study was approved by Wageningen University Ethical Committee and was performed 
according to the principles of the Declaration of Helsinki. Buffy coats from healthy blood 
donors were obtained from the Sanquin Blood bank in Nijmegen (The Netherlands). A written 
informed consent was obtained from each volunteer before sample collection. 
Differential cytokine induction and TLR signalling by F. prausnitzii and other commensals 
 
95 
 
PBMCs were isolated from buffy coats of healthy donors using Ficoll Paque Plus density 
gradient (GE Healthcare, Diegem Belgium) according to the manufacturer’s protocol. After 
centrifugation, the mononuclear cells were collected, washed in IMDM + glutamax 
(Invitrogen, Breda, The Netherlands) and resuspended in IMDM + glutamax supplemented 
with 10% foetal calf serum (FCS), 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma, St. 
Louis, MO). PBMCs were seeded at 1 x 106 cells/ well in 48-well plates and, after 2 hours, cells 
were treated with the bacteria (bacterium to cell ratio, 10:1) or were left untreated. After 24 
hours, the supernatant was collected for cytokine measurement.  
The immune response of DCs to the bacteria was investigated by measuring the expression of 
surface markers in human monocyte-derived DCs and the cytokines secreted in the 
supernatant. Monocytes were isolated from PBMCs by positive selection of CD14+ cells using 
CD14-specific antibody coated magnetic microbeads (Miltentyi Biotec, Leiden, The 
Netherlands). CD14+ cells were cultured for 6 days in complete medium in the presence of IL-4 
and granulocyte-macrophage colony-stimulating factor (GMCFS, R&D Systems, Minneapolis, 
MN) to differentiate into immature monocyte-derived DCs. At day 6, cells were seeded at 106 
cells/ well in 24-well plates and were treated with the bacteria (bacterium to cell ratio, 10:1). 
After 48 hours, the supernatant was collected for cytokine measurements.  
During the culture period and the stimulation, DCs were cultured in RPMI (Invitrogen) 
supplemented with 10 % FCS, 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma, St. 
Louis, MO) and no bacterial growth was observed. On day 6 and 8, the activation and 
maturation status of the CD14+ cells were assessed by measuring CD83 and CD86 surface 
expression and the cell viability was measured using annexin V and propidium iodide (PI). Cells 
were stained with fluorescence conjugated monoclonal antibodies specific for CD83, CD86, 
their isotype-matched controls and with annexin V and PI (BD Biosciences, Breda, The 
Netherlands) and analysed on a flow cytometer (FACS Canto II, BD). CD86 and CD83 were 
expressed at low levels on immature or untreated DCs and were strongly expressed after 
stimulation. On days 6 and 8 the viability of the cells was between 60–80% (not shown). 
 
TLR signalling assays 
TLR assays were performed using human embryonic kidney cells (HEK293) stably expressing 
human TLR2 and TLR2/6, TLR4 or TLR5 (Invivogen, Toulouse, France) and transfected with a 
reporter plasmid (pNiFTY, Invivogen) containing the luciferase gene under the control of the 
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NF-κB promoter. HEK293 cells expressing the different TLRs and pNiFTY were seeded at 6 x 
104 cells/ well in 96-wells plates and incubated with bacteria (bacterium to cell ratio, 10:1), 
TLR agonists, Pam2CSK4 (Invivogen) for TLR2 and TLR2/6, flagellin (Invivogen) for TLR5 and 
LPS for TLR4, or medium alone as a control. After 6 hours of incubation, the medium was 
replaced with Bright glow (Promega), and the luminescence was measured using a 
Spectramax M5 (Molecular Devices). As a negative control HEK293 cells not expressing TLRs 
but harbouring pNiFTY were tested in the same conditions and did not show any luciferase 
activity. Mean values are shown for 6 replicates, error bars represent SEM. 
 
Cytokine analysis 
Cytokine concentrations in the DC culture supernatants were determined using Cytokine bead 
array (BD) and a flow cytometer (FACS Canto II, BD). In human PBMC and DC studies, the 
limits of detection were the following: for IL-1β 7.2 pg/ml, for IL-10 3.3 pg/ml, for TNF 3.7 
pg/ml, for IL-12p70 1.9 pg/ml and for IFN-γ 1.8 pg/ml.  
 
Statistics and principal component analysis 
Differences in NF-κB activation in the TLR assays were analysed by one way Anova with 
Dunnett’s multiple comparison test using the GraphPad PRISM (GraphPad Software). Principal 
component analysis (PCA) was used to analyze the variance of the level of cytokines along the 
different types of bacteria studied. PCA was computed on the standardized data by using the 
function princomp of the software Matlab.  
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Abstract 
 
Faecalibacterium prausnitzii is one of the most abundant commensal bacteria in healthy 
humans. F. prausnitzii has anti-inflammatory properties both in vitro and in vivo but the 
underlying mechanisms are still unknown. The aim of this work was to investigate the 
modulatory effects of F. prausnitzii strain A2-165 on the induction of mucosal T cell responses 
to the model antigen ovalbumin (OVA) in vitro and in vivo. The influence of F. prausnitzii A2-
165 on OVA-specific T cell activation and polarization was studied in vitro using naive CD4+ T 
cells and mouse bone marrow-derived dendritic cells (BMDCs) and in vivo using a model for 
nasal tolerance induction to OVA. F. prausnitzii A2-165 was compared to another commensal 
Clostridium hathewayi 82-B, which induced very low cytokine secretion in BMDCs despite 
inducing their activation. Our results demonstrate that F. prausnitzii A2-165 has immune-
regulatory properties which may be related to its strong capacity to induce IL-10 by BMDCs 
and T cells. In vivo, these effects translated into enhanced OVA-specific T cell proliferation in 
the nose-draining cervical lymph nodes (CLNs) after combined nasal application of F. 
prausnitzii strain A2-165 and OVA. Strikingly, this was associated with a reduction in the 
differentiation of IFN-γ secreting T cells in the CLNs. In contrast, Clostridium hathewayi 82-B 
significantly decreased the percentage of dividing OVA-specific T cells in the CLNs and spleen. 
This may be related to the fact that molecules CD40 and CD86 were expressed at lower levels 
on BMDCs incubated with C. hathewayi 82-B than on BMDCs incubated with F. prausnitzii A2-
165. 
Overall these data demonstrate that F. prausnitzii can modulate the OVA-specific mucosal T 
cell response indirectly by affecting antigen presentation but also directly by acting on T cells 
leading to reduced differentiation of IFN-γ secreting T cells in vivo. 
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Introduction  
 
In the intestine, the epithelial surface is protected by a secreted mucus layer that spatially 
compartmentalizes bacteria to the intestinal lumen, however, molecules and metabolites 
produced by bacteria can diffuse through the mucus and affect epithelial gene expression. 
Harmless antigens that pass the epithelial barrier can elicit adaptive immune responses in 
mucosa-associated lymphoid tissue such as Peyer’s patches (PPs) or in gut-draining 
mesenteric lymph nodes (MLNs). At these sites, antigen presenting cells (APCs), such as 
dendritic cells (DCs), can sample microbes and food proteins and prime mucosal naive T cells 
driving their activation, clonal expansion and differentiation. In steady-state conditions, 
regulatory T cell (Treg) conversion in response to presentation of harmless protein antigens 
occurs with a higher frequency in PPs and MLNs when compared to non-mucosa-draining 
lymphoid tissue. It has long been known that this preferential tolerance induction at mucosal 
sites is dependent on microbial sensing (Kiyono, McGhee et al. 1982; Tanaka and Ishikawa 
2004). Recent advances in the field have now made it possible to dissect how individual 
components of the microbiota endow the mucosal immune system with tolerogenic potential. 
Over the past 5 years, it has become apparent that not all components of the microbiota are 
equal in terms of their impact on host physiology. It has been shown that particular 
commensal bacteria can steer mucosal T cell polarization. For example, colonization of germ-
free mice with the mouse commensal segmented filamentous bacteria induces an increase in 
the number of CD4+ T cells, in particular T helper 1 cells (Th1), Th17 and Foxp3+ Tregs in the 
small intestine and colon (Gaboriau-Routhiau, Rakotobe et al. 2009). Conversely, colonization 
of germ-free mice with a cocktail of 46 commensal Clostridia, induces increased numbers of 
Foxp3+ Tregs expressing IL-10 in the colon while mildly inducing Th17 cells and not affecting 
Th1 cells (Atarashi, Tanoue et al. 2011). Accumulation of colonic IL-10 secreting Foxp3+ Tregs 
is also induced by colonization of germ-free mice with Bacteroides fragilis (Round and 
Mazmanian 2010). The mechanisms by which these commensal bacteria affect mucosal T cells 
appear diverse. Colonization with Clostridia acts on Foxp3+ Tregs through the induction of 
TGF-β and indoleamine 2,3-dioxygenase (IDO) in epithelial cells (Atarashi, Tanoue et al. 2011) 
while B. fragilis acts on T cells via TLR2 ligation (Round and Mazmanian 2010). This implies 
that commensal bacteria may act upon mucosal T cells at different stages during activation, 
differentiation, accumulation in the lamina propria and maintenance in the lamina propria.  
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Faecalibacterium prausnitzii is one of the most abundant species of human intestinal bacteria 
(Barcenilla, Pryde et al. 2000; Duncan 2002). This Firmicute has recently raised interest 
because strain A2-165 attenuates 2,4,6-trinitrobenzenesulfonic acid (TNBS) induced colitis in 
mice, and induces high IL-10 to IL-12p70 ratio in human peripheral blood mononuclear cells 
(hPBMCs). Crohn’s disease (CD) and ulcerative colitis (UC) are forms of inflammatory bowel 
disease characterized by a chronic and relapsing inflammation of the gastrointestinal tract. 
Patients with active CD and UC have lower faecal counts of Firmicutes, in particular lower 
counts of F. prausnitzii, compared with healthy subjects (Sokol, Seksik et al. 2009). Moreover, 
F. prausnitzii along with Roseburia spp. are the prominent butyrate producers in the intestine 
(Pryde, Duncan et al. 2002). Butyrate is a primary energy source for the epithelial cells lining 
the colon (Yin, Laevsky et al. 2001) and appears to have both anti-inflammatory and cancer 
chemopreventive activities (Yin, Laevsky et al. 2001; Pryde, Duncan et al. 2002; Place, Noonan 
et al. 2005). We previously showed, using human monocyte-derived DCs (hDCs), that F. 
prausnitzii strain A2-165 has very distinct immunomodulatory properties compared to other 5 
F. prausnitzii strains and 8 other abundant commensal strains. This was due to the high levels 
of IL-10 and low levels of IL-12p70 produced by hDCs incubated with F. prausnitzii A2-165 
(Chapter 4).  
The aim of this work was to investigate the modulatory effects of F. prausnitzii A2-165 on the 
induction of mucosal T cell responses to the model antigen ovalbumin (OVA) in vitro and in 
vivo. First, the influence of F. prausnitzii A2-165 on OVA-specific T cell activation and 
polarization was studied in vitro using naive CD4+ T cells and mouse bone marrow derived DCs 
(BMDCs). Thereafter, we used a well characterized model for nasal tolerance induction to OVA 
to determine the effect of F. prausnitzii A2-165 on mucosal T cell differentiation in vivo. Nasal 
tolerance is known to have many similarities to oral tolerance induction (Unger, Hauet-Broere 
et al. 2003; Samsom 2004) and application of bacteria via the nasal route effectively targets 
responses in the nose-draining cervical lymph nodes (CLNs). 
The effects of F. prausnitzii A2-165 were compared to Clostridium hathewayi 82-B which was 
selected from a panel of human intestinal commensals on the basis of cytokine production in 
culture with BMDCs. Strain Clostridium hathewayi 82-B was chosen for inclusion in a mouse 
study because it activated BMDCs but induced very low levels of all cytokines in comparison to 
F. prausnitzii A2-165.  
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Results 
 
Co-stimulatory molecules expression on mouse BMDCs incubated with commensal bacteria 
The immune response of BMDCs incubated with F. prausnitzii A2-165 and 5 other human 
commensal bacterial strains was measured in order to select a strain to compare with F. 
prausnitzii A2-165 in subsequent experiments. The candidate strains were previously tested in 
culture with hDCs (Chapter 4) and chosen on the following basis: F. prausnitzii A2-165 was the 
highest inducer of IL-10 release by hDCs, C. hathewayi 82-B and C. xylanovorans Lac1D 
induced low or undetectable cytokine responses, Lactobacillus plantarum WCFS1 was one of 
the highest inducers of IL-12p70 release and Eubacterium rectale A1-86 and Bifidobacterium 
adolescentis L2-32 induced intermediate levels of secreted cytokines compared to the other 
strains. 
Incubation with bacteria did not significantly affect the percentage of CD40 or CD86 positive 
cells within the BMDCs cultures (Figure 1a). Overall, all the bacterial strains induced increased 
surface expression of the co-stimulatory molecules CD86 and CD40 by BMDCs compared to 
the control untreated BMDCs (Figure 1b and c). However, the degree of induction of co-
stimulatory molecules expression varied upon bacterial strain as the CD86 and CD40 mean 
fluorescence intensity (MFI) values induced by C. hathewayi 82-B were lower compared to the 
other strains (Figure 1b and c). In addition, CD86 expression on BMDCs was lower in cultures 
with C. xylanovorans Lac1D when compared to the other strains (Figure 1b). Thus, all strains 
induced increased expression of BMDC surface molecules known to co-stimulate T cells during 
antigen presentation.  
 
Mouse BMDCs cytokine responses to commensal bacteria 
Culture of BMDCs with F. prausnitzii A2-165 induced the largest amount of IL-10 release 
(mean ± SEM, 8098 ± 176 pg/ml), followed by E. rectale A1-86 (4390 ± 154 pg/ml) and B. 
adolescentis L2-32 (3849 ± 181.6 pg/ml). IL-12p70 release by BMDCs was mostly induced by F. 
prausnitzii A2-165 and L. plantarum WCFS1 (136 ± 24 and 161 ± 10 pg/ml respectively, Figure 
2). However, for all the strains tested the levels of IL-12p70 were around 10 fold lower than 
those obtained in similar assays with hDCs (Chapter 4). The amounts of IFN-γ in the culture 
supernatants of stimulated BMDCs were low (10-15 pg/ml) but high levels of TNF release were 
induced by virtually all bacterial strains with L. plantarum WCFS1 and F. prausnitzii A2-165 
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being the strongest inducers while C. hathewayi 82-B and C. xylanovorans Lac1D were low to 
weak inducers. As C. hathewayi 82-B was the lowest inducer of all cytokines, it was selected 
for comparison to F. prausnitzii A2-165 in subsequent experiments in vitro and in vivo.  
  
Figure 1: CD86 and CD40 surface expression in BMDCs. Percentage of CD86
+
 (a) or CD40
+
 (b) BMDCs and mean 
fluorescence intensity (MFI) of CD86 (c) and CD40 (d) after 24 h of incubation with bacteria (bacterium: BMDC, 
10:1). Error bars represent SEM, n=3, *** indicates p<0.001, n.s. indicates non significant compared to the 
control. 
 
Bacteria differentially affect T cell polarization in BMDC-T cell co-cultures  
In order to investigate the influence of F. prausnitzii A2-165 and C. hathewayi 82-B on T cell 
activation and polarization in the presence of APCs, BMDCs were cultured in the presence or 
absence of the bacteria or LPS, after 24 h, OVA was added and after other 6 h, naive CFSE 
labelled OVA-specific CD4+ T cells (OVA-specific T cells) were added for additional 72 h.  
All conditions of BMDC stimulation increased the number of OVA-specific T cells undergoing 
proliferation compared to the unstimulated BMDC control. No significant differences in the 
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percentage of dividing T cells were observed between BMDC stimulation with LPS, F. 
prausnitzii A2-165 or C. hathewayi 82-B (Figure 3a and b).  
 
Figure 2: Cytokine secretion by BMDCs. IL-10, IL-12p70, TNF and IFN-γ were measured in the supernatant of 
BMDCs (5 x 10
5 
BMDCs/well in 24w plate) after 24 h of incubation with bacteria (bacterium: BMDC, 10:1). Error 
bars represent SEM, n=3, *** indicates p<0.001, ** p<0.01, *p<0.05 compared to the control. 
 
Intracellular staining of OVA-specific T cells revealed that F. prausnitzii A2-165 decreased the 
percentage of total IFN-γ+ T cells compared to the control and had no effect on IL-17+ and 
Foxp3+ T cells (Figure 4a). In contrast, C. hathewayi 82-B induced an increase in the 
percentage of IFN-γ+, IL-17+ and Foxp3+ T cells compared to the control (Figure 4a). Despite 
the bacteria-induced changes in the percentage of IFN-γ+ and IL-17+ T cells, the levels of 
secreted cytokines were not different to the control (Figure 4b). Notably, BMDCs pre-
incubated with F. prausnitzii A2-165 induced increased IL-10 secretion during OVA-specific T 
cell proliferation (Figure 4b) compared to the control. As no T cells stained positive for 
intracellular IL-10, we could not determine which cells produced the IL-10 measured in the 
Chapter 5 
 
106 
 
culture supernatants. None of the bacteria altered the levels of secreted IL-2, IL-6 or TNF 
compared to the control (not shown).  
Figure 3: Dividing OVA-specific T cells (KJ1-26
+
/CD4
+
) after incubation with BMDCs pre-stimulated with bacteria. 
BMDCs were cultured in the presence or absence of the bacteria or LPS and after 24 h, CFSE labelled OVA-
specific T cells were added for additional 72 h. a) Percentage of dividing OVA-specific T cells. b) Representative 
histograms showing divided CFSE labelled OVA T-cells. Error bars represent SEM, n=3, *** indicates p<0.001 
compared to the control.  
 
Bacteria influence differentiation of activated T cells in the absence of antigen presenting cells  
As B. fragilis is proposed to directly modulate mucosal T cells through TLR2 (Round and 
Mazmanian 2010), we wished to investigate the potential direct effects of F. prausnitzii A2-
165 and C. hathewayi 82-B on T cells in an APC free system. OVA-specific T cells were 
activated in vitro with anti-CD3ε/CD28 mAb in the presence of bacteria and OVA. At 72 h of 
culture, effects on T cell proliferation, intracellular protein expression and cytokine secretion 
were measured. As expected, anti-CD3ε/CD28 mAb treatment induced OVA-specific T cell 
activation which was not influenced by the presence of bacteria (not shown). However, the 
direct contact with bacteria during T cell receptor triggering modulated the intracellular 
cytokine secretion and cytokine release compared to the control indicating a direct effect of 
bacteria on T cell polarization. F. prausnitzii A2-165 induced an increase in the percentage of 
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IL-10 secreting and IFN-γ secreting T cells (Figure 5a) and enhanced IFN-γ, IL-10, IL-6, IL-17 and 
TNF secretion compared to the control (Figure 5b). Similar but smaller changes were observed 
in T cells that were activated in the presence of C. hathewayi 82-B. It should be noted that 
although both bacterial strains increased the secretion of IL-17 no changes were observed in 
the percentage of IL-17+ cells (Figure 5a and b). Treatment with either one of the bacteria 
during cellular activation did not affect the percentage of Foxp3+ T cells (not shown).  
These results show that the bacterial strains can have a direct effect on T cell differentiation in 
the absence of APCs. In particular, F. prausnitzii A2-165 induces a 5 fold increase in the 
percentage of IL-10 secreting T cells and a 4 fold increase in IL-10 secretion. The percentage of 
IFN-γ+ T cells increased 2 fold after incubation with F. prausnitzii A2-165 and 1.8 fold after 
incubation with C. hathewayi 82-B. 
 
Figure 4: Percentage of IFN-γ
+
, IL-17
+
, Foxp3
+
 cells (a) and cytokine secretion (b) after incubation of OVA-specific 
T cells (KJ1-26
+
/CD4
+
) with BMDCs pre-stimulated with bacteria (bacterium: BMDC, 10: 1). BMDCs (5 x 10
4
 
BMDCs/well in 96w plate) were loaded with OVA (0.5mg/ml) and cultured in the presence or absence of the 
bacteria or LPS and after 24 h CFSE labelled OVA-specific CD4
+
 T cells (5 x 10
5
 T cells/well) were added, after 72 h 
cytokine secretion in the supernatant and intracellular markers were measured. Error bars represent SEM, n=3, 
*** indicates p<0.001, *p<0.05 compared to the control. Intracellular IL-10 staining was negative for all samples. 
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Figure 5: Percentage of IFN-γ
+
, IL-17
+
, IL-10
+
 (a) and cytokine secretion (b) after incubation of OVA-specific T cells 
(KJ1-26
+
/CD4
+
) with bacteria (bacterium: T cell, 1:1). CFSE labelled OVA-specific T cells (5 x 10
5
 T cells/well) were 
activated in vitro with anti-CD3ε/CD28 mAb and incubated with bacteria, after 72 h cytokine secretion in the 
supernatant and intracellular markers were measured. Error bars represent SEM, n=3, *** indicates p<0.001, ** 
p<0.01, *p<0.05 compared to the control. 
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In vivo CD4+ T cell response  
To investigate the impact of the strains on the development of mucosal T cell responses in 
vivo, a model for nasal tolerance induction was used (Unger, Hauet-Broere et al. 2003). In 
short, BALB/c acceptor mice were adoptively transferred with CFSE labelled naive DO11.10 
OVA T cell receptor (TCR) transgenic T cells and after 24 h, received an intranasal (i.n.) 
application of either the bacteria together with OVA or OVA alone. After 72 h, single cell 
suspensions isolated from cervical lymph nodes (CLNs) and spleens were analysed to assess 
the proliferation and phenotype of OVA-specific T cells.  
In F. prausnitzii A2-165 treated mice the percentage of dividing OVA-specific T cells in the 
CLNs was increased compared to the control mice administered OVA alone. This was found to 
be significant in a second independent experiment (Supplementary Figure 1). In the spleen of 
control mice, that received OVA i.n., a population of OVA-specific T cells is found that are in 
third, fourth or fifth division. In agreement with previous observations no CFSE fluorescence 
was detected corresponding with T cells in first or second division. Therefore, this population 
reflects cells that have differentiated in the CLNs and entered the circulation upon exiting the 
CLNs. Administration of F. prausnitzii A2-165 together with OVA significantly increased the 
number of divided OVA-specific T cells isolated from spleens compared to control mice (Figure 
6a and Supplementary Figure 1). Together, these data demonstrate that i.n. administration of 
F. prausnitzii A2-165 enhances the number of OVA-specific T cells that divide in the CLNs. In 
contrast, C. hathewayi 82-B administration significantly decreased the proliferation of OVA-
specific T cells isolated from CLNs compared to the control and F. prausnitzii A2-165. This 
effect was also observed in a second independent experiment although it was not significant 
(Figure 6a and Supplementary Figure 1). In agreement, no increased numbers of divided OVA-
specific T cells were detected in the spleen (Figure 6a). 
Intranasal administration of either F. prausnitzii A2-165 or C. hathewayi 82-B together with 
OVA significantly decreased the number of IFN-γ secreting OVA-specific T cells isolated from 
the CLNs. In particular, F. prausnitzii A2-165 induced an approximately three fold reduction in 
the percentage of IFN-γ secreting cells (Figure 6b). However, these bacteria did not effect the 
intracellular expression of Foxp3, IL-17, or IL-10 in OVA-specific T cells isolated from the CLNs 
(not shown). 
In a second independent experiment, performed using the same setup, single cells were 
recovered from CLNs and spleens of mice at 72h post OVA treatment and characterized after 
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ex vivo re-stimulation with OVA. Similarly to the first in vivo experiment (Figure 6), co-
administration of F. prausnitzii A2-165 with OVA induced an increased number of dividing 
OVA-specific T cells in CLN and spleen compared to the control and C. hathewayi 82-B group. 
Again, proliferation of OVA-specific T cells from CLNs was decreased in the mice administered 
C. hathewayi 82-B compared to control although these changes were not statistically 
significant (Figure 7). 
 
Figure 6: Percentage of dividing and IFN-γ
+
 OVA-specific T cells in vivo. CFSE labelled naive OVA-specific T cells 
(KJ1-26
+
/CD4
+
) were adoptively transferred in BALB/c mice, after 24 h, mice were administered intranasally with 
bacteria plus OVA and after additional 72 h, OVA-specific T cells were isolated from cervical lymph nodes (CLNs) 
and spleens and analysed. a) Percentage of dividing OVA-specific T cells (KJ1-26
+
/CD4
+
) isolated from CLNs or 
spleens. b) Percentage of IFN-γ
+
 OVA-specific T cells (KJ1-26
+
/CD4
+
) isolated from CLNs. * indicates p<0.05, ** 
indicates p<0.01 compared to the control administered OVA alone.  
 
 
Figure 7: Percentage of dividing OVA-specific T cells after ex-vivo re-stimulation. CFSE labelled naive OVA-specific 
T cells (KJ1-26
+
/CD4
+
) were adoptively transferred in BALB/c mice, after 24 h, mice were administered 
intranasally with bacteria plus OVA and after additional 72 h, OVA-specific T cells were isolated from nose-
draining cervical lymph nodes (CLNs) and spleens and re-stimulated with OVA for additional 24 h and then 
analysed. ** indicates p<0.01 compared to the control administered OVA alone.  
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Overall re-stimulation led to low and variable levels of cytokine release. This is likely to be due 
to the low frequency of OVA-specific T cells within the total CLN cell population. Notably, CLN 
cells of C. hathewayi 82-B treated mice released lower amounts of cytokines; this effect was 
statistically significant only for IL-10 and MCP-1 (Figure 8). 
 
Figure 8: Cytokine secretion by OVA-specific T cells after ex vivo re-stimulation. CFSE labelled naive OVA-specific 
T cells were adoptively transferred in BALB/c mice, after 24 h, mice were administered intranasally with bacteria 
plus OVA and after additional 72 h, OVA-specific T cells were isolated from CLNs and re-stimulated with OVA for 
additional 24 h and then analysed. * indicates p<0.05 compared to the control administered OVA alone.  
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Discussion 
 
F. prausnitzii strain A2-165 is one of the most abundant colonic bacteria in humans and has 
anti-inflammatory properties in vitro and in vivo. In particular, in vitro it induces high IL-10 to 
IL-12 ratio in hDCs (Chapter 4) and hPBMCs and in vivo it is capable of attenuating TNBS-
induced colitis in mice (Sokol, Pigneur et al. 2008). The mechanisms of these protective and 
anti-inflammatory effects have not yet been unravelled. In this study we show that F. 
prausnitzii strain A2-165 directly modulates murine DCs by enhancing CD86 and CD40 
expression and stimulating IL-10, IL-12p70 and TNF release (Figure 1 and 2). As a result, these 
DCs stimulate increased antigen-specific T cell division in co-culture which is associated with 
increased IL-10 release (Figure 3 and 4). In addition, F. prausnitzii strain A2-165 can directly 
impact on T cells by stimulating differentiation of IL-10 or IFN-γ producing T cells without 
affecting the number of proliferating cells (Figure 5). In vivo, these effects translate into 
enhanced OVA-specific T cell proliferation in the nose-draining CLNs after combined nasal 
application of F. prausnitzii strain A2-165 and OVA. Strikingly, this is associated with a 
reduction in the differentiation of IFN-γ secreting T cells in the CLNs (Figure 6). These data 
demonstrate that F. prausnitzii A2-165 has immunoregulatory properties and indicate that the 
bacterium has a strong capacity to induce IL-10 by both DCs and T cells. 
The effects of F. prausnitzii A2-165 were compared with C. hathewayi 82-B, a bacterium that 
had little or no capacity to induce TLR signalling and induced small amounts of cytokines when 
incubated with hDCs (Chapter 4) or with mouse BMDCs in vitro. Upon interaction with BMDCs, 
F. prausnitzii A2-165 induced very large amounts of IL-10 (8098 ± 176 pg/ml) compared to 
BMDCs incubated with C. hathewayi 82-B (63 ± 8 pg/ml) or other commensal bacteria (Figure 
2). Similar results were described using hDCs and hPBMCs (Chapter 4) where, among 5 F. 
prausnitzii strains and a total of 13 commensal bacterial strains, F. prausnitzii A2-165 was the 
highest inducer of IL-10. The molecules of F. prausnitzii responsible for the high IL-10 
induction are not known but might involve the anti-inflammatory factor present in the 
bacterial culture supernatants (Sokol, Pigneur et al. 2008).  
The concomitant enhanced proliferation and high levels of IL-10 secretion as seen in the co-
culture of stimulated BMDCs with OVA-specific T cells seems counterintuitive as IL-10 is a 
suppressive cytokine. In this respect, it should be emphasized that at onset of proliferation T 
cells may not be sensitive to IL-10 suppression because they down regulate expression of the 
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IL-10Rα chain (Liu, Michalopoulos et al. 1994). In vivo, F. prausnitzii A2-165 also increased the 
number of dividing OVA-specific T cells in the CLNs and spleen compared to the control group 
of mice administered only OVA (Figure 6). This may be due to the uptake of F. prausnitzii A2-
165 or microbial associated molecular patterns (MAMPs) resulting in increased DCs activation 
and CD40 expression as also seen in the in vitro experiments (Figure 1). These activated DCs 
may drive enhanced antigen presentation of OVA in the CLNs. Although F. prausnitzii A2-165 
administration increased the percentage of dividing T cells in vivo, it decreased the 
percentage of IFN-γ+ T cells without affecting the percentages of Foxp3+ or IL-17+ T cells 
(Figure 6). This finding suggests that F. prausnitzii A2-165 modulated the phenotype of 
mucosal DCs that migrate from the lamina propria to suppress IFN-γ differentiation in the 
draining CLNs. Unfortunately; we were not able to detect intracellular IL-10 staining in CLNs 
cells. IL-10 may suppress differentiation of IFN-γ secreting cells in the CLNs once the cells have 
proliferated and re-express their IL-10R. Future experiments using in vivo blocking with anti-
IL-10R antibodies would provide an answer to this hypothesis.  
In contrast to the expectation based on the prior in vitro data, C. hathewayi 82-B had 
substantial immunomodulatory capacity. BMDCs incubated with this bacterium appeared to 
be highly effective in stimulating T cells in vitro. Indeed, the percentage of T cells staining 
positive for intracellular markers of different T cell subsets (i.e. IFN-γ, IL-17 and Foxp3) were 
significantly higher for T cells incubated with BMDCs pre-stimulated with C. hathewayi 82-B 
than BMDCs pre-stimulated with F. prausnitzii A2-165, LPS or left unstimulated (Figure 4). In 
fact, this is surprising as the surface molecules CD40 and CD86 were expressed at lower levels 
on BMDCs incubated with C. hathewayi 82-B than on BMDCs incubated with F. prausnitzii A2-
165 (Figure 1).  
In contrast, in vivo, C. hathewayi 82-B significantly decreased the percentage of dividing T cells 
in the CLNs and spleen (Figure 6). The reasons for this are not clear but the bacterium may not 
release MAMPs and only activate DCs when phagocytozed. Alternatively, C. hathewayi 82-B 
may inhibit the migration of DCs from the mucosa to the draining lymph nodes, blocking the 
activation and expansion of T cells within the CLNs.  
Interestingly, different effects of the bacteria are observed when they are incubated with T 
cells activated with anti-CD3ε/CD28 mAb compared to T cells incubated with pre-stimulated 
BMDCs. In both experimental setups the bacteria have the capacity to interact with the T cells 
although they may be phagocytosed after 24h incubation with DCs. In contrast to the BMDC T 
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cell co-culture assays, using activated T cells, F. prausnitzii A2-165 induced significantly higher 
percentage of IFN-γ producing T cells and IL-10+ T cells and this was observed also after 
incubation with C. hathewayi 82-B (Figure 5). As in the anti-CD3ε/CD28 mAb assay a higher 
percentage of T cells are activated than in BMDC T cell co-culture assays, it is possible that the 
co-stimulatory effect provided by the bacterium is better detected.  
The culture supernatants of activated T cells incubated with bacteria and LPS contained 
significantly larger amounts of IFN-γ, IL-17, IL-10 and IL-6 than the supernatants of activated T 
cells alone (Figure 5). This may be due to the interaction of bacterial MAMPs and LPS with TLR 
receptors expressed on activated T cells. In vivo the direct interaction of commensals and 
mucosal T cells is likely to be a rare event except in the Peyer’s patches. However, in 
inflammatory bowel disease, damage to the gut barrier is known to increase bacterial 
translocation into the lamina propria where direct interactions of bacteria with T cells may 
occur (Waeytens, Ferdinande et al. 2008). 
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Materials and methods 
 
Mice 
Animal experiments were approved by the Animal Experimental Committee of the Erasmus 
Medical Center. BALB/c mice were obtained from Charles River Laboratories (Maastricht, The 
Netherlands) and kept in the Erasmus University Medical Centre. DO11.10 transgenic mice on 
BALB/c background, which have a T cell receptor (TCR) specific for the OVA 323-339 peptide, 
were bred at the Erasmus University Medical Centre. Mice were kept under specific pathogen-
free housing conditions.  
 
Bacterial strains and culturing conditions 
F. prausnitzii strains A2–165, E. rectale A1-86, B. adolescentis L2-32, C. hathewayi 82-B,have 
been described elsewhere (Barcenilla, Pryde et al. 2000; Duncan 2002; Duncan, Louis et al. 
2004; Louis, Duncan et al. 2004; Chapter 4) and were maintained at 37°C on yeast extract, 
casitone, fatty acid and glucose medium (YCFAG, described in (Lopez-Siles, Khan et al. 2012)) 
under anaerobic conditions. Bacteria were grown in YCFAG broth to an optical density at 
600nm (A600) of 0.8, which corresponds to the late exponential or early stationary growth 
phase. L. plantarum WCFS1 was cultured overnight to stationary phase in deMan, Rogosa 
Sharpe broth (MRS, Merck, Darmstadt, Germany) at 37°C. Bacteria were harvested by 
centrifugation, washed in phosphate buffer saline (PBS), resuspended in PBS containing 20% 
glycerol and stored at -80°C prior to use in the assays. Bacteria were quantified by Fluorescent 
in situ hybridization (FISH) or phase contrast microscopy. All buffers and media used for the 
anaerobic bacteria were deoxygenated by flushing with oxygen free nitrogen for 30 minutes.  
 
Mouse BMDCs assays 
Bone marrow-cells were isolated by flushing femurs and tibiae of BALB/c mice, and the cell 
suspension was filtered through 100 µm gauze to obtain single cells. Cells were seeded at 
2x106 cells/ petri dish in IMDM (Invitrogen) supplemented with 10% heat inactivated FCS, 100 
U sodium penicillin-G (Bio-Whittaker), 2mM GLutamax (Invitrogen), 50mM 2-
mercaptoethanol and 20 ng/ml murine rGM-CSF (X63-GM-CSF-producing cell line supernatant 
(Stockinger, Zal et al. 1996)) and cultured for 7 days to induce differentiation into dendritic 
cells. On day 7, cells were seeded at 5x105 cells/well in 24-well plates and were stimulated 
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with bacteria (bacteria to cell ratio 10:1), 1 µg/ml LPS or left unstimulated. After 24 h the 
supernatant was collected for cytokine measure and cells were stained for surface protein 
detection.  
 
Purification of DO11.10 T-cells  
For the in vitro experiments, DO11.10 transgenic T cells were isolated from DO11.10 mice and 
CFSE labelled, as described previously (Hauet-Broere, Unger et al. 2003; Unger, Hauet-Broere 
et al. 2003). Briefly, at 8–12 wk of age, DO11.10 transgenic mice were sacrificed, and spleens 
and lymph nodes (LNs) were collected. Spleens and LNs were filtered through 100 µm gauze 
to obtain single cells and erythrocytes in the splenocyte suspension were lysed by incubation 
with lysis buffer (150 mM NH4Cl, 1 mM NaHCO3, pH 7.4) for 7 min on ice. Cell suspensions 
were depleted of B cells, CD8+ T cells, and APCs by incubation with a mixture of mAb 
containing anti-B220 (clone 6B2), CD8, CD11b (MAC-1), MAC-2, F4/80, and anti-MHC-II 
(m5/114), and subsequent incubation with sheep anti-rat IgG Dynabeads, according to 
manufacturer’s instructions (Dynal Biotech). The CD4+ T cell-enriched fraction was labelled 
with CFSE (Molecular Probes) and the proportion of DO11.10 transgenic CD4+ T cells in 
suspension was determined by flow cytometric analysis of an aliquot of cells using the 
clonotypic Ab KJ1-26 (anti-OVA transgenic TCR, Caltag) and anti-CD4 (GK1.5, BD). 
For the in vivo adoptive transfer, DO11.10 T cells were isolated from spleens of DO11.10 rag-/- 
mice, as described above, but the single cell suspension was not enriched. 
 
In vitro assays with DO11.10 T cells  
For the in vitro BMDCs-T cells assay, enriched DO11.10 T cells together with OVA were co-
cultured with BMDCs stimulated for 24 h with bacteria. BMDCs were cultured as described 
above and on day 7, they were seeded at 5x104 cells/well in 96-well plates and stimulated 
with bacteria (bacteria to cell ratio 10:1), 100 ng/ml LPS or left unstimulated. After 24 h, OVA 
(Calbiochem) was added to a final concentration of 0.5 mg/ml and, after additional 6 h, 5x105 
CFSE labelled KJ1-26+ CD4+ T cells/well were added. After 72 h, cells were treated with 50 
ng/ml Phorbol 12-Myristate 13-Acetate (PMA) and 500 ng/ml Ionomycin to elicit T cell 
responses; and the intracellular transport of protein was blocked adding monensin (GolgiStop, 
BD) for the last 4 h of stimulation. Next, the supernatant was collected for cytokine measure 
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and cells were analyzed by flow cytometry for cell division and stained for surface and 
intracellular protein detection.  
For the in vitro T cell assays, enriched DO11.10 T cells were stimulated with hamster anti-
mouse CD3ε-chain mAb and hamster anti-mouse CD28 mAb (145-2C11 and 37.51, 
respectively, BD), bacteria, LPS or left unstimulated. Twenty four-wells plates were pre-coated 
with 1 µg/ml anti-CD3ε in PBS and incubated at 37˚C. After 3 h non-bound antibody was 
removed and 5x105 CFSE labelled KJ1-26+ CD4+ T cells/well were seeded together with 1 µg/ml 
anti-CD28 and bacteria (bacterium to cell ratio 1:1), 100 ng/ml LPS or left unstimulated (no 
bacteria). After 72 h, cells were treated with 50 ng/ml PMA and 500 ng/ml Ionomycin to elicit 
T-cell responses and the intracellular transport of protein was blocked adding monensin 
(GolgiStop, BD) for the last 4 h of stimulation. Next, the supernatant was collected for 
cytokine measure and cells were analyzed by flow cytometry for cell division and stained for 
surface and intracellular protein detection. 
  
Adoptive transfer of DO11.10 T cells and intranasal challenge  
For the in vivo study, acceptor BALB/c mice received 6x106 CFSE labelled KJ1-26+ CD4+ T cells 
in 200 µl saline (NaCl 0.9 %, Brown) by injection in the tail vein. DO11.10 rag-/- T cells were 
isolated as described above. Twenty four h after the adoptive transfer, mice were 
administered intranasally with 2x108 bacteria in 15 µl of saline containing 400 µg of OVA or 15 
µl of saline with OVA as a control. Throughout the in vivo experiment, groups of mice that 
received different treatments were housed separately. After 72 h, mice were sacrificed, nose-
draining superficial and deep cervical lymph nodes (CLNs) and spleens were collected and 
single cell suspensions were analyzed by flow cytometry for cell division and stained for 
surface or intracellular protein detection or used for ex vivo T-cells restimulation. 
 
Ex vivo DO11.10 T-cell restimulation 
For ex vivo DO11.10 T-cell restimulation, single cells from CLNs (seeded at a density of 3x106 
cell/well in 48-wells plates) and from spleens (at a density of 107 cells/well in 24-wells plates) 
of BALB/c acceptor mice were restimulated in vitro with 0.2 µg/ml of OVA peptide (OVA 323-
339, synthesized and purified by HPLC at the Netherlands Cancer Institute, Amsterdam, the 
Netherlands). Intracellular transport of protein was blocked adding monensin (GolgiStop, BD) 
for the last 4.5 h of stimulation. After 24 h, the supernatant was collected for cytokine 
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measure and cells were analyzed by flow cytometry for cell division and stained for surface 
and intracellular protein detection. 
 
Cytokine analysis 
Cytokines concentrations in the supernatants were determined using Cytokine bead arrays 
(BD) and a flow cytometer (FACS Canto II, BD). The limits of detection were the following: for 
IL-6 5 pg/ml, for IL-10 17.5 pg/ml, for IFN-γ 2.5 pg/ml, for TNF 7.3 pg/ml and for IL-12p70 10.7 
pg/ml.  
 
Flow cytometry 
BMDCs were stained after stimulation with rat anti-mouse CD40 (clone 3/23, BD) followed by 
donkey anti-rat PE (Jackson), and rat anti-mouse CD86 (BD) and analysed by flow cytometry 
(FACS Calibur, BD Bioscience). DO11.10 T cells used in vitro and single cells isolated from CLNs 
and spleens of mice were analysed by flow cytometry to determine their phenotype and 
division. Cell division was determined based on the decrease of fluorescence intensity of 
single CFSE peaks. Single cells were stained for surface expression with KJ1-26 (Caltag), anti-
CD4 (GK1.5, BD) and for intracellular expression of IL-10 (JES5-16E3), Foxp3 (FJK-16s) IFN-γ 
(XMG1.2, eBioscience) and IL-17A (TC11-18H10, BD) and their isotype matched control. For 
flow cytometry analysis, at least 2x104 KJ1-26+/CD4+ cells were used.  
 
Statistics  
Differences in cytokine secretion, surface marker expression and percentage of dividing or 
positive cells were analysed comparing samples treated with the bacteria or LPS with the 
untreated control. Data were analysed by one way Anova followed by Dunnett’s multiple 
comparison test for the in vitro assays or Newman-Keuls multiple comparison test for the in 
vivo assays using the GraphPad PRISM (GraphPad Software).  
 
 
 
Modulation of DC-T cell interactions by F. prausnitzii 
 
119 
 
Supplementary material 
 
 
Supplementary figure 1: Percentage of dividing OVA-specific T cells in vivo. CFSE labelled naive OVA-specific T 
cells (KJ1-26
+
/CD4
+
) were adoptively transferred in BALB/c mice, after 24 h, mice were administered intranasally 
with bacteria plus OVA and after additional 72 h, OVA-specific T cells were isolated from nose-draining CLNs and 
spleens and analysed. * indicates p<0.05, ** indicates p<0.01 compared to the control administered OVA alone. 
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Abstract 
 
A decrease in the abundance and biodiversity of intestinal bacteria within the Firmicutes 
phylum has been associated with inflammatory bowel disease (IBD). In particular, the anti-
inflammatory bacterium Faecalibacterium prausnitzii, member of the Firmicutes phylum and 
one of the most abundant species in healthy human colon, is underrepresented in the 
microbiota of IBD patients. In this study we investigated the capacity of F. prausnitzii strain 
A2-165, the biofilm forming strain HTF-F and the extracellular polymeric matrix (EPM) isolated 
from strain HTF-F, to suppress inflammation in the mouse dextran sodium sulphate (DSS) 
colitis model. The two F. prausnitzii strains have anti-inflammatory effects in the DSS colitis 
model. F. prausnitzii HTF-F is more effective than A2-165 partly because of the immune-
regulating properties of the EPM. The immunomodulatory effects of the EPM are mediated 
through the TLR2-dependent modulation of IL-12 and IL-10 cytokine production in antigen 
presenting cells. However, the precise anti-inflammatory mechanism of EPM awaits 
identification of the active component. Both F. prausnitzii HTF-F and the EPM may have a 
therapeutic use in IBD.  
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Introduction 
 
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease 
(CD), is a chronic inflammatory disorder of the gastrointestinal tract characterized by 
diarrhoea, bloody stools, abdominal pain and weight loss. UC and CD are driven by an 
aberrant inflammatory T cell response to intestinal microbiota in a genetically susceptible 
host. Profound changes in the diversity and composition of the microbiota are associated with 
UC and CD (Seksik, Rigottier-Gois et al. 2003; Macfarlane, Blackett et al. 2009). A decrease in 
the frequency of the phyla Bacteroidetes and Firmicutes and an increase of Proteobacteria 
and Actinobacteria has been observed in the faecal microbiota of IBD patients (Frank, St 
Amand et al. 2007). In particular, Faecalibacterium prausnitzii, a member of the Firmicutes 
phylum and one of the most abundant species in the healthy human colon (Flint, Scott et al. 
2012), is underrepresented in the microbiota of IBD patients (Sokol, Seksik et al. 2009). 
Mucosal-associated counts of F. prauznitzii from ileal biopsies are also lower in CD patients 
with active disease than in patients in remission (Sokol, Pigneur et al. 2008).  
F. prausnitzii was reported to be an anti-inflammatory bacterium on account of its capacity to 
induce high amounts of IL-10 in human peripheral blood mononuclear cells (PBMCs, (Sokol, 
Pigneur et al. 2008)), and dendritic cells (DCs, Chapter 4). Furthermore, treatment of Caco2 
cells with F. prausnitzii culture supernatant was reported to reduce IL-1-induced NF-κB 
activation and secretion of IL-8. This was attributed to an as yet unidentified factor secreted in 
the medium (Sokol, Pigneur et al. 2008). Additionally, administration of F. prausnitzii strain 
A2-165 and its culture supernatant have been shown to protect against 2,4,6-
trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice (Sokol, Pigneur et al. 2008). This 
model is thought to resemble CD because the resulting mucosal inflammation is mediated by 
a T helper 1 (Th1) response with excessive production of IFN-γ, TNF-α and IL-12. 
The aim of this study was to test the capacity of F. prausnitzii strains A2-165 and HTF-F to 
suppress inflammation in the mouse dextran sodium sulphate (DSS) colitis model. Strain F. 
prausnitzii HTF-F undergoes intercellular aggregation and forms a dense biofilm in liquid 
culture, while strain A2-165 does not. The biofilm might provide some advantage to bacterial 
colonization in vivo. As bacterial exopolysaccharides are common components of biofilm 
matrices and have been previously shown to have immunomodulatory effects (Mazmanian, 
Round et al. 2008; Round and Mazmanian 2010; Fanning, Hall et al. 2011), the purified 
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extracellular polymeric matrix (EPM) of strain HTF-F was also tested for its potential anti-
inflammatory effects in the DSS model of colitis.  
 
  
F. prausnitzii HTF-F and its EPM attenuate clinical parameter in DSS-induced colitis 
 
125 
 
Results 
 
Phenotypic characteristics of F. prausnitzii strain HTF-F and purification of the extracellular 
polymeric matrix 
Although both F. prausnitzii strains HTF-F and A2-165 form colonies with mucoid appearance 
on solid agar, only strain HTF-F forms mucoid biofilm in liquid culture (Figure 1a). This 
phenotype is commonly associated with the production of extracellular polysaccharides and 
intercellular aggregating proteins (Flemming and Wingender 2010). The EPM of strain HTF-F is 
revealed by Gram staining (Figure 1b) and is observed in transmission electron micrographs as 
a diffuse and irregular surface layer (Figure 2a, arrow) resembling the capsule polysaccharide 
(CPS) of Streptococcus suis (Figure 2b, (Meijerink, Ferrando et al. 2012)).  
The cell bound the EPM produced by strain HTF-F was isolated, concentrated and filtered to 
remove possible bacterial contaminants. The EPM yield was 1.2 mg/ml from approximately 
2.5 x 1011 bacteria. Luciferase-based TLR signalling assays for human TLR2, TLR2/6, TLR4 and 
TLR5 indicated that microbe-associated molecular patterns (MAMPs) were not present in 
amounts that would influence activation of immune cells in vitro (Figure 3). This was 
confirmed by the fact that the EPM did not induce activation or cytokine secretion after 
incubation with hDCs (Figure 4 b).  
 
Figure 1: a) Growth and biofilm formation of F. prausnitzii strains HTF-F and A2-165 in YCFAG medium under 
anaerobic conditions. i and ii) F. prausnitzii A2-165 before and after shaking respectively; iii and iv) F. prausnitzii 
HTF-F before and after shaking respectively. b) Gram staining of F. prausnitzii A2-165 (left panel) and HTF-F (right 
panel). 
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Figure 2: Detection of F. prausnitzii HTF-F EPM by transmission electron microscopy. F. prausnitzii HTF-F (a) 
possess a diffuse and irregular surface layer (arrow) which is thinner but similar to the capsule polysaccharide 
(CPS) of S. suis wild type strain (arrow, S. suis wt, left panel b) and absent in S. suis CPS deletion mutant (S. suis 
Δcps, right panel b). 
  
Figure 3: TLR signalling properties of F. prausnitzii HTF-F EPM. NF-κB activation was measured using a 
luminescence reporter in HEK293 cell lines expressing TLR2/1, TLR2/6, TLR5 and TLR4, relative values were 
calculated deducting the medium control values to the measured values. Error bars represent SEM, n=6. 
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The EPM of F. prausnitzii HTF-F decreases transcription and production of pro-inflammatory IL-
12p70 in L. plantarum-activated hDCs 
The immunomodulatory properties of F. prausnitzii A2-165, HTF-F and the EPM were tested in 
vitro using human monocyte-derived DCs (hDCs). DCs were chosen because they are one of 
the most important antigen presenting cells with the capacity to prime naive T cells at 
mucosal sites and to drive the immune response.  
Incubation of hDCs with F. prausnitzii strains A2-165 and HTF-F induced large amounts of IL-10 
and small amounts of IL-12p70 compared with L. plantarum (Figure 4a) or other lactobacilli 
(not shown). The amount of IL-10 produced after incubation of hDCs with strain HTF-F was 
lower than with strain A2-165 (Figure 4a). This was in agreement with an earlier comparative 
study of hDC immune responses to different F. prausnitzii strains and other commensals 
(Chapter 4). 
The EPM alone had no effect on the expression of activation or maturation markers and 
cytokine expression compared to untreated hDCs (Figure 4b) confirming the lack of TLR 
signalling activity (Figure 3). Therefore, the EPM was combined with L. plantarum in hDC 
cultures to investigate whether it would modulate cytokine production. In combination with L. 
plantarum, the EPM reduced the secretion of pro-inflammatory IL-12p70 but had no effect on 
the IL-10, IL-1β or TNF-α elicited by L. plantarum (Figure 4a, IL-1β and TNF-α not shown). This 
was not due to an effect of the EPM on hDCs maturation and activation as evidenced by the 
measurement of the co-stimulatory molecules CD83 and CD86 (Figure 4b).  
In order to investigate whether the reduced secretion of IL-12p70 was due to transcriptional 
regulation, quantitative RT-PCR was performed on IL-10, IL-12, IL-1β and TNF-α mRNA 
extracted from hDCs at 6 and 20 h after incubation with L. plantarum, L. plantarum combined 
with the EPM, EPM alone or unstimulated hDCs. The addition of the EPM had no significant 
effect on transcription of IL-1β, TNF-α or IL-10 in hDCs stimulated with L. plantarum (not 
shown) but significantly decreased the transcript levels of IL-12 at 20h by about 2 fold (Figure 
5).  
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Figure 4: Cytokine secretion and surface marker expression in hDCs after 48 h of incubation with F. prausnitzii 
A2-165 (3 donors), F. prausnitzii HTF-F (3 donors), L. plantarum (5 donors), L. plantarum + EPM (5 donors), EPM 
(3 donors) or left unstimulated (5 donors). a) IL-10 and IL-12p70 were measured in the supernatant of hDCs. 
Error bars represent SEM, * indicates p<0.05 compared with L. plantarum treated samples.  
b) Percentage of CD83
+
 (left panel) and CD86
+
 (right panel) hDCs. Error bars represent SEM, ** indicates p<0.01, 
n.s. indicates non significant compared with the control.  
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Figure 5: Relative gene expression levels in hDCs determined by quantitative RT-PCR. RNA was extracted from 
hDCs after 6 and 20 h of incubation with L. plantarum (in black), L. plantarum + EPM (in dark grey), EPM (in clear 
grey) or from unstimulated cells (in white) and the expression levels of IL-12p70 gene was calculated relative to 
the expression levels of the housekeeping gene GAPDH. Error bars represent SEM, n=3, *** indicates p<0.001 
compared with L. plantarum treated samples.  
 
F. prausnitzii and the EPM of strain HTF-F attenuate clinical symptoms in DSS-colitis 
The potential protective effects of F. prausnitzii strains A2-165, HTF-F and the EPM were 
assessed in mice using the DSS-induced colitis model. The bacteria or the EPM were 
administered to mice intrarectally ten days prior to DSS exposure and continuously 
administered daily over a period of eight days in which DSS was given in the drinking water to 
induce colitis. The severity of colitis was evaluated for individual mice in each group by 
measuring disease activity index (DAI), histological damage score of the colon, body weight 
and colon length. The DAI and the histological colon damage score after DSS treatment were 
assessed according to the scale (0–4) of Cooper et al. (Cooper, Murthy et al. 1993).  
F. prausnitzii A2-165, HTF-F and EPM administration significantly decreased the DAI compared 
to colitis control mice which received PBS intrarectally and DSS in the drinking water, although 
the score was higher than in untreated mice (Figure 6a).  
The histological colon damage score was grade 0 in untreated mice (Figure 6b and 7a). F. 
prausnitzii HTF-F administration significantly decreased colon damage score compared to the 
colitis control mice (grade 1.65 and 3.2 respectively, Figure 6b, 7c and 7b), while F. prausnitzii 
A2-165 and EPM administration did not significantly affect the colon damage score compared 
to colitis control mice (grade 2.8 and 3.3 respectively, Figure 6b, 7d and 7e).  
The colon length was reduced in all DSS treated groups compared to untreated mice but the F. 
prausnitzii HTF-F treated group had significantly longer colons compared with colitis control 
mice (Figure 6c) indicating reduced severity of colitis.  
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Figure 6: Disease activity index (DAI), colon histological damage score and clinical evaluation of DSS treated mice. 
Mice were left untreated (in white) or treated with DSS during 8 days and administered intrarectally with PBS (in 
black), EPM (in blue) or F. prausnitzii strains HTF-F (in red) or strain A2-165 (in green). DAI, histological score and 
colon length (a, b and c respectively) were evaluated at the end of the experiment. Mice body weight (d) was 
measured throughout the experiment, body weight values are expressed as percentage of the initial value 
measured at day 0 before DSS administration. Error bars represent SEM, n=10, * indicates p<0.05, ** p<0.01, *** 
p<0.001 compared with the control colitis mice that received DSS + PBS. 
 
 
The body weight of mice was measured throughout the period of DSS treatment and 
compared to the weight before treatment. In untreated mice, the body weight increased by 
approximately 5 % from day 5 to day 8 (Figure 6d). However, in colitis control mice, the body 
weight decreased by approximately 5 % from day 5 to day 8. In mice administered F. 
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prausnitzii HTF-F, A2-165 or the EPM, the decrease in body weight was delayed by one day 
compared to the colitis control mice. In mice administered F. prausnitzii HTF-F, A2-165 and 
the EPM, the decrease in body weight from day 6 to day 8 was between 2 and 4 % and for F. 
prausnitzii HTF-F and the EPM, it was lower than for the colitis control group (Figure 6d).  
Taken together these results indicate that F. prausnitzii strains A2-165, HTF-F as well as the 
EPM from strain HTF-F can attenuate the clinical symptoms of DSS-induced colitis. 
 
 
 
Figure 7: Histological cross-sectional views of colon descendens of untreated or DSS-treated mice: a) colitis 
control, PBS-DSS-treated mice (damage grade 3-3.5) b) HTF-F-DSS-treated mice (damage grade 1-2.4); c) A2-165-
DSS-treated mice, (damage grade 2-3.7); d) EPM-DSS-treated mice (damage grade 2.8-3.8); e) untreated mice 
(damage grade 0). 
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Effects of F. prausnitzii and F. prausnitzii EPM on Foxp3 expression in mesenteric lymph nodes 
and spleen of DSS treated mice 
To investigate the potential role of Foxp3+ Tregs in the attenuation of DSS-induced colitis, we 
measured the number of CD4+ T cells isolated from mesenteric lymph nodes (MLNs) and 
spleens that express intracellular Foxp3 by fluorescence-activated cell sorting (FACS). DSS 
treatment did not significantly affect the levels of Foxp3+ CD4+ T cells in the MLNs or spleen 
compared to untreated mice. Administration of F. prausnitzii also had no effect on Foxp3+ 
CD4+ T cells compared to untreated mice. However, administration of the EPM induced a 
small but significant increase in Foxp3+ CD4+ T cells in the MLNs but not in the spleen (Figure 
8). 
 
 
Figure 8: Percentage of Foxp3
+
 CD4
+
 T cells isolated from mesenteric lymph nodes (MLNs, left panel) and spleens 
(right panel) of mice untreated (in white) or treated with DSS during 8 days and administered intrarectally with 
PBS (in black), EPM (in blue) or F. prausnitzii strains HTF-F or strain A2-165 (HTF-F in red and A2-165 in green, 
respectively).  
 
The immunomodulatory effects of the EPM are TLR2 dependent 
To investigate whether the anti-inflammatory effects of the EPM on IL-12p70 production by 
DCs contribute to the protective effects observed in DSS-induced colitis, we performed an in 
vitro experiment using mouse bone marrow-derived DCs (BMDCs) stimulated with L. 
plantarum with and without EPM. As found using hDCs, the presence of EPM reduced the 
secretion of pro-inflammatory IL-12p70 by mouse BMDC stimulated with L. plantarum. 
Strikingly, the EPM also increased the production of IL-10 in BMDC stimulated with L. 
plantarum which was already induced at much higher levels than in hDCs stimulated with L. 
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plantarum. These effects were not due to the induction of cytokine secretion by EPM alone 
(Figure 9a). Additionally, we tested whether the immunomodulatory effects of the EPM were 
dependent on TLR2 signalling by including a TLR2 blocking antibody or an irrelevant antibody 
of the same isotype in the assays. The effects of the EPM on IL-12p70 and IL-10 production by 
L. plantarum stimulated BMDCs were inhibited in the presence of TLR2 blocking antibody but 
not in the presence of the isotype antibody. As EPM itself did not induce TLR2 signalling 
(Figure 3) the mechanism leading to reduced transcription of IL-12p70 and increased 
production of IL-10 was dependent on the TLR2 signalling by L. plantarum (Figure 9b).  
 
Figure 9: Cytokine secretion in mouse BMDCs. a) IL-10 and IL-12p70 were measured in BMDC supernatants after 
incubation with L. plantarum, L. plantarum + EPM, EPM and unstimulated DCs. b) IL-10 and IL-12p70 were 
measured after incubation of BMDCs with the same samples as in panel (a) except that anti-TLR2 blocking 
antibody (anti-TLR2 Ab, dark grey bars) or an isotype control (isotype Ab, clear grey bars) were included during 
the incubation period. Error bars represent SEM (n=3), *** indicates p<0.001, * indicates p<0.01, n.s. non 
significant compared to L. plantarum treated samples.  
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Discussion 
 
In this study, we demonstrated that F. prausnitzii strain A2-165, the biofilm forming strain 
HTF-F as well as the EPM isolated from strain HTF-F can attenuate the clinical symptoms of 
DSS-induced colitis. Strain HTF-F had a stronger effect than strain A2-165 or the EPM alone in 
suppressing inflammation as evidenced by the colon damage score and colon length (Figure 
6). The administration of purified EPM alone decreased the DAI indicating that it contributes 
to the protective effect of strain HTF-F and may be responsible for the stronger protection 
seen with strain HTF-F compared to A2-165. However, we cannot rule out other possible 
strain differences, for example in colonization potential, stress resistance or fitness in vivo 
which might contribute to the efficacy of immune suppression.  
Previously, F. prausnitzii A2-165 and its supernatant were shown to attenuate 2,4,6-
trinitrobenzenesulfonic acid (TNBS) colitis in mice by daily intragastric administration prior to 
and during the induction of colitis (Sokol, Pigneur et al. 2008). In the study of Sokol et al., the 
colons of mice treated with either F. prausnitzii A2-165 or its supernatant had a reduced 
amount of IL-12p70 and an elevated amount of IL-10 compared with the colitis control group. 
This is compatible with the relatively high amount of IL-10 induced by in vitro culture of F. 
prausnitzii A2-165 with mouse BMDCs, hDCs (Figure 4) and human PBMCs (Sokol, Pigneur et 
al. 2008). IL-10 is fundamental for the maintenance of homeostasis in the intestine (Geuking, 
Cahenzli et al. 2011; Veenbergen and Samsom 2012). It is secreted by DCs as well as Foxp3+ 
and Foxp3- T cells in the lamina propria. Secretion of IL-10 by DCs is important for the 
maintenance of functional Foxp3+ Tregs during intestinal inflammation (Murai, Turovskaya et 
al. 2009). IL-10 also inhibits the production of pro-inflammatory cytokines such as IFN-γ, TNF-
α, IL-6 and IL-12. Moreover, IL-10 was shown to play a role in controlling pro-inflammatory 
responses to translocated microbes by abrogating IL-23 production (Manuzak, Dillon et al. 
2012). Nevertheless, differences in IL-10 produced in vitro by DCs cultured with F. prausnitzii 
A2-165 and strain HTF-F cannot explain the better protection seen with HTF-F as it induced 
less IL-10 than A2-165. 
Butyrate produced in the colon by F. prausnitzii may also contribute to the anti-inflammatory 
effects observed in experimental colitis model as oral administration of sodium butyrate has 
been recently shown to attenuate inflammation in experimental UC (Vieira, Leonel et al. 
2012). Microbially-produced butyrate is considered important for colonic health, and in the 
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prevention of colorectal cancer owing to its use as an energy source for epithelial cells and as 
a modulator of oxidative stress and inflammation (Hamer, Jonkers et al. 2008). Moreover, 
butyrate enemas have been reported to be effective in the therapy of UC (Hamer, Jonkers et 
al. 2010). 
In vitro assays indicated that the anti-inflammatory mechanism of the EPM was not due to 
contamination with MAMPs or activation of DCs. However, when the EPM was added 
together with L. plantarum as an inflammatory stimulus to hDCs it decreased the production 
of IL-12p70 compared to L. plantarum alone and had no effect on IL-10, IL-1β and TNF-α 
production (Figure 4). A similar effect of the EPM was seen on IL-12p70 production by mouse 
BMDCs (Figure 9) but, in contrast to hDCs, IL-10 was significantly increased. The effect of EPM 
on IL-12p70 production occurred at the transcriptional level (Figure 5) suggesting the 
involvement of the EPM in cell signalling. This mechanism was dependent on TLR2 signalling 
although the EPM itself did not induce TLR2 signalling in reporter assays, or activate hDCs or 
mouse BMDCs as in the case of synthetic TLR2 agonists (Figure 9). The mechanism may 
involve interaction of carbohydrate structures in the EPM with C-type lectin receptors, some 
of which are known to modulate cytokine production in response to TLR agonists. In the DSS 
colitis model, administration of EPM but not F. prausnitzii increased the number of Foxp3+ T 
cells in the MLNs. Similarly, the extracellular polysaccharide A of Bacteroides fragilis (Round 
and Mazmanian 2010), has also been shown to expand the number of mucosal Foxp3+ T cells 
and confers a TLR2-dependent protection in mouse colitis models (Mazmanian, Round et al. 
2008; Round and Mazmanian 2010). 
In summary, we demonstrated the anti-inflammatory effect of two different F. prausnitzii 
strains in the mouse DSS colitis model. Furthermore, we showed that F. prausnitzii HTF-F 
which produces a thick biofilm is more anti-inflammatory and this may in part be due to the 
immune-regulating properties of the EPM. In vitro immune assays suggest that the 
immunomodulatory effects of the EPM are mediated through the TLR2-dependent 
modulation of IL-12 and IL-10 cytokine production in antigen presenting cells. However, the 
precise anti-inflammatory mechanism of EPM awaits identification of the active component. 
Both F. prausnitzii HTF-F and the EPM may have a therapeutic use in IBD.  
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Materials and methods  
 
Animals  
BALB/c mice were reared in conventional conditions. Two-month-old females were used for 
these studies and their body weights were measured before and after each experiment. 
Animal experiments were approved by the Ethical Committee of the Institute of Microbiology, 
Academy of Sciences of the Czech Republic. 
 
Bacterial strains and culturing conditions 
F. prausnitzii strain HTF-F and A2-165 have been described elsewhere (Barcenilla, Pryde et al. 
2000; Duncan 2002; Lopez-Siles, Khan et al. 2012) and were maintained at 37°C on yeast 
extract, casitone, fatty acid and glucose medium (YCFAG, described in (Lopez-Siles, Khan et al. 
2012)) under anaerobic conditions. For EPM production, F. prausnitzii strains were cultured in 
YCAG broth, which have the same composition as YCFAG medium but, except acetate, all 
short chain fatty acids were omitted. L. plantarum WCFS1 was cultured overnight until 
stationary phase in deMan, Rogosa Sharpe broth (MRS, Merck, Darmstadt, Germany) at 37°C. 
Bacteria were harvested by centrifugation at 4oC, 3300 g for 15 min, washed in phosphate 
buffer saline (PBS), resuspended in PBS containing 20% glycerol and stored at -80°C prior to 
use. For the BMDCs assays, L. plantarum WCFS1 grown in MRS at 37°C overnight were 
inactivated with 1% formaldehyde-PBS as described prevoiusly (Schabussova, Hufnagl et al. 
2012).  
Bacteria were quantified by fluorescent in situ hybridization (FISH) or phase contrast 
microscopy. All buffers and media used for the anaerobic bacteria were deoxygenated by 
flushing with oxygen free nitrogen for 30 minutes. 
  
Isolation and staining of the F. prausnitzii extracellular polymeric matrix  
The cell bound EPM was extracted as previously described (Ricciardi, Parente et al. 1998). 
Briefly, 250 ml of 24 h cultures of F. prausnitzii strains HTF-F or A2-165 were recovered by 
centrifugation at 18400 g for 10 min (4°C). The pre-washed cell pellet was suspended in 8 ml 
of PBS by vortexing for 5 min allowing the cell bound EPM to dissolve. Planktonic cells were 
subsequently pelleted by centrifugation at 18400 g for 10 min (4oC). The supernatant was 
then carefully removed and added to 4 volumes of ice cold absolute ethanol to precipitate the 
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EPM. After centrifugation at 3300 g for 30 min, the EPM precipitated pellet was washed with 
70% ethanol, then lyophilized and stored at -20oC. For further experiments, lyophilized EPM 
fractions were dissolved in PBS at the desired concentrations. The EPM was shown to be free 
of bacterial contamination by visual inspection after Gram staining. TLR assays (described in 
the following section) showed that the EPM was free of contaminating MAMPs. 
 
TLR signalling assays 
TLR assays were performed using human embryonic kidney cells (HEK293) stably expressing 
human TLR2/6, TLR2/1, TLR4 or TLR5 (Invivogen, Toulouse, France) and transfected with a 
reporter plasmid (pNiFTY, Invivogen) containing the luciferase gene under the control of the 
NF-κB promoter. HEK293 cells expressing the different TLRs and pNiFTY were incubated with 
the EPM (1.2 % v/v), the TLR agonists, Pam2CSK4 (Invivogen) for TLR2/6, Pam3CSK4 
(Invivogen) for TLR2/1, flagellin (Invivogen) for TLR5 and LPS for TLR4, or medium alone as a 
control. After 6 hours of incubation, the medium was replaced with Bright glow (Promega), 
and the luminescence was measured using a Spectramax M5 (Molecular Devices). As a 
negative control, HEK293 cells not expressing TLRs but harbouring pNiFTY were tested in the 
same conditions and did not show any luciferase activity. The limits of sensitivity for the TLR 
reporter cell lines were determined in independent experiments using a dose range for each 
purified agonist. The limits of detection for these reporter cell lines were determined as 
follows: 2 ng/ml for Pam2CSK4 (TLR2), 8 ng/ml for flagellin (TLR5) and 50 pg/ml for LPS (TLR4); 
MAMPs present at concentrations lower than this would not activate immune cells in our in 
vitro assays and, as expected, the EPM did not activate hDCs or mouse BMDCs (Figure 4 and 
9). 
 
Human DCs assays 
This study was approved by Wageningen University Ethical Committee and was performed 
according to the principles of the Declaration of Helsinki. Buffy coats from blood donors were 
obtained from the Sanquin Blood bank in Nijmegen (The Netherlands). A written informed 
consent was obtained before sample collection. 
The immunomodulatory properties of the EPM was investigated by measuring the expression 
of surface markers and the cytokines secreted in the supernatant after incubation of human 
monocyte-derived DCs (hDCs) with F. prausnitzii A2-165 (hDCs from 3 donors), F. prausnitzii 
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HTF-F (hDCs from 3 donors), L. plantarum (hDCs from 5 donors), EPM (hDCs from 3 donors) or 
L. plantarum together with EPM (hDCs from 5 donors). Bacteria were used at a bacterium: DC 
ratio of 10:1, EPM at 1.2% v/v.  Mononuclear cells were isolated from buffy coats of healthy 
donors using Ficoll Paque Plus density gradient (GE Healthcare, Diegem Belgium) according to 
the manufacturer’s protocol. After centrifugation, mononuclear cells were collected and 
monocytes were isolated by positive selection of CD14+ cells using CD14-specific antibody 
coated magnetic microbeads (Miltentyi Biotec, Leiden, The Netherlands). CD14+ cells were 
cultured for 6 days in complete medium in the presence of IL-4 and granulocyte-macrophage 
colony-stimulating factor (GMCFS, R&D Systems, Minneapolis, MN) to differentiate into 
immature monocyte-derived DCs. At day 6, cells were seeded at 106 cells/ well in 24-well 
plates and were treated with L. plantarum (bacterium: DC, 10:1) in the presence or absence of 
the EPM isolated from F. prausnitzii (1,2% v/v) or left untreated. After 48 hours of co-
incubation, the supernatant was collected for cytokine measurements.  
During the culture period and the stimulation, DCs were cultured in Rosewell Park Memorial 
Institute (RPMI) 1640 culture medium (Invitrogen) supplemented with 10 % FCS, 100 U/ml 
penicillin and 100 µg/ml streptomycin (Sigma, St. Louis, MO) and no bacterial growth was 
observed. On day 6 and 8, the activation and maturation status of the CD14+ cells were 
assessed by measuring CD83 and CD86 surface expression and the cell viability was measured 
using Annexin V and propidium iodide (PI). Cells were stained with fluorescence conjugated 
monoclonal antibodies specific for CD83, CD86, their isotype-matched controls and with 
annexin V and PI (BD Biosciences, Breda, The Netherlands) and analysed on a flow cytometer 
(FACS Canto II, BD). CD86 and CD83 were expressed at low levels on immature or untreated 
DCs and were highly expressed after stimulation. On days 6 and 8 the viability of the cells was 
between 60–80% (not shown). 
 
RNA isolation and real-time qPCR 
Total RNA was isolated from hDCs using the RNAeasy Mini Kit (Qiagen, Venlo, The 
Netherlands) following the manufacturer instructions. cDNA synthesis was performed using 
500 ng of isolated total RNA and Q-script (Quanta bioscience, Gaithersburg, MD) according to 
the manufacturer instructions. cDNA was diluted in nuclease-free water to a final volume of 
100 µl and stored at -20°C until further use. Primers for IL-10 (forward 5’-
GTGATGCCCCAAGCTGAGA-3’, reverse 5’-CACGGCCTTGCTCTTGTTTT-3’), IL-12p40 (forward 5’-
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CTCTGGCAAAACCCTGACC-3’, reverse 5’-GCTTAGAACCTCGCCTCCTT-3’), IL-1β (forward 5’-
GTGGCAATGAGGATGACTTGTTC-3’, reverse 5’-TAGTGGTGGTCGGAGATTCGTA-3’), TNF-α 
(forward 5’- CTGCTGCACTTTGGAGTGAT-3’, reverse 5’-AGATGATCTGACTGCCTGGG-3’), and the 
reference genes GAPDH (forward 5’-CTGCACCACCAACTGCTTAG-3’, reverse 5’-
GTCTTCTGGGTGGCAGTGAT-3’) and β-actin (forward 5’-TTGCGTTACACCCTTTCTTG-3’, reverse 
5’-CACCTTCACCGTTCCAGTTT-3’) were designed using PRIMER3 software (Rozen and 
Skaletsky, 2000). Quantitative RT-PCR (qPCR) was performed using the GoTaq qPCR mastermix 
(Promega), briefly, 5 µl cDNA (20x dilution), forward and reverse primers (300 nM each) were 
added to 7 µl qPCR mastermix and demineralised water was added to a final volume of 14 µl. 
The qPCR reaction (2 min 95°C, 40 cycles of 15 s at 95°C, 60 s at 60°C) was carried out on a 
Rotorgene 6000 real-time cycler (Qiagen). Raw data were analysed using the comparative 
quantitation method of the Rotor-gene Analysis Software V5.0 and relative gene expression 
levels were determined as ratio of target gene vs. reference gene and were calculated 
according to the ΔCt method described by Pfaffl (Pfaffl 2001) using the following equation: 
Ratio = (Etarget) Cttarget (control-sample)/(Ereference) Ctreference (control-sample). Where E is the 
amplification efficiency and Ct is the number of PCR cycles needed for the signal to exceed a 
predetermined threshold value. Dual internal reference genes (GAPDH and β-actin) were 
incorporated in all qPCR experiments and results were similar following standardization to 
either gene. For each sample a controls that was not treated with reverse transcriptase was 
included and no amplification above background levels was observed. Non-template controls 
were included for each gene in each run and no amplification above background levels was 
observed. Specificity of the amplification was ensured by checking the melting temperature 
and profile of each melting curve. The product of each template was checked at least once by 
sequencing. 
 
Mouse BMDCs assays 
Mouse BMDCs from BALB/c mice were prepared as previously described (Lutz, Kukutsch et al. 
1999). Briefly, bone marrow cells isolated from femurs and tibias were seeded at 2 x 105 
cells/ml in bacteriological Petri dishes in RPMI 1640 medium containing 10% fetal bovine 
serum (FBS), 150 µg/ml gentamycin and 20 ng/ml mouse rGM-CSF (Sigma-Aldrich, USA). Fresh 
medium was added at day 3 and 6 and BMDC were used on day 8 of culture. Where indicated 
BMDCs (106 cells/ml) were incubated with anti-TLR2 antibody (InvivoGen, USA) or control 
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isotype antibody IgG2a (eBioscience, USA) at concentration 10 µg/ml for 1 hour 37°C prior to 
stimulation with L. plantarum, EPM or L. plantarum together with EPM for 20 h. L. plantarum 
was used at a bacterium: DC ratio of 10:1, EPM at 1.2 % v/v. Culture supernatants of 
stimulated BMDC were stored at -20°C until use. For cell surface marker analysis, BMDCs were 
collected after cultivation and pre-incubated with anti-mouse CD16/CD32 (eBioscience, USA) 
for 5 min on ice prior to staining for 30 min at 4°C with anti-mouse FITC-conjugated CD11c, 
APC-conjugated MHCII and PE-conjugated CD40, CD80 or CD86 monoclonal antibody 
(eBioscience, USA). The sample data were acquired on a FACSCalibur flow cytometer (Becton-
Dickinson, USA) and analyzed with FlowJo software 7.6.2 (TreeStar, USA). 
 
Cytokine analysis 
Cytokines concentrations in the hDC culture supernatants were determined using Cytokine 
bead arrays (BD) and a flow cytometer (FACS Canto II, BD). In hDCs studies, the limits of 
detection were the following: for IL-1β 7.2 pg/ml, for IL-10 3.3 pg/ml, for TNF 3.7 pg/ml and 
for IL-12p70 1.9 pg/ml. Mouse IL-10 was assayed in culture supernatants by enzyme-linked 
immunosorbent assay (ELISA) using Ready-Set-Go! kit (eBioscience, USA) according to 
manufacturer’s instructions. Levels of IL-12p70 were measured with matched antibody pairs 
(BD Pharmingen, USA). 
 
Intrarectal administration of bacteria or the EPM and induction of acute ulcerative colitis  
The experimental groups of 10 mice and their respective treatments are shown in Table 1. 
Mice from groups 2, 3, 4 and 5 received 2.5 % DSS (molecular weight 40 kDa; ICN Biomedicals, 
Ohio, USA) in the drinking water ad libitum for one week. Mice from the untreated control 
group 1 received only drinking water. Mice from groups 3 and 4 received intrarectally (via 
tubing) daily doses of 2 to 3 x 109 CFU of F. prausnitzii HTF-F and A2-165, respectively in 100 µl 
PBS for ten days prior the DSS exposure and during the eight days of DSS treatment. Mice 
from group 5 received intrarectally daily doses of 50 µg the EPM in 100 µl PBS for ten days 
prior the DSS exposure and during the eight days of DSS treatment. Mice from the colitis 
control group received intrarectally 100 µl PBS. The following clinical symptoms were 
measured or assessed: firmness of faeces, rectal prolapses, rectal bleeding and colon length 
after the sacrifice. The colon descendens was taken for myeloperoxidase assay, isolation of 
mRNA, histological assessment and for intestinal fragment cultivation.  
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Table 1: DSS induced colitis experimental groups 
Group Intrarectal treatment DSS 
1 PBS - 
2 PBS + 
3 F. prausnitzii HTF-F + 
4 F. prausnitzii A2-165 + 
5 the EPM  + 
 
Disease activity index  
Disease activity index (DAI), measured according to Cooper et al. (Cooper, Murthy et al. 1993), 
is a combined score of weight loss, stool consistency and bleeding divided by 3. Acute clinical 
symptoms are diarrhoea and/or grossly bloody stools. The scores are explained in Table 2.  
 
Table 2: Scoring of DAI (modified according to Cooper et al. 1993)  
Score  Weight loss Stool consistency* Occult/gross bleeding 
0 None Normal  Normal 
1 1 - 5% Normal  Normal 
2 5 - 10 % Loose  Hemacult +  
3 1 – 20 % Loose  Blood in colon 
Starting bleeding from anus 
4 > 20 % Diarrhoea Gross bleeding 
* Normal stools, well formed pellets; loose stools, pasty and semiformed stools which do not stick to the anus; 
diarrhoea, liquid stools that stick to the anus.  
 
Histological evaluation of colon damage  
Colon tissue was fixed in Carnoy’s fluid for 30 min, transferred into 96% ethanol and 
embedded in paraffin. Paraffin-embedded tissue (5 mm) were sectioned and stained with 
haematoxylin and eosin (H&E) and Alcian Blue and poststained with NuclearFastRed (Vector, 
Burlingame, CA) for mucin production. Samples were examined using an Olympus BX 40 
microscope equipped with an Olympus Camedia DP 70 digital camera, and the images were 
analysed using Olympus DP-Soft. The degree of damage to the surface epithelium, crypt 
distortion and mucin production in individual colon segments were evaluated according to 
Cooper et al. (Cooper, Murthy et al. 1993).  
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The human gastrointestinal tract (GI-tract) is colonized by a multitude of microorganisms 
collectively known as the microbiota. The microbiota includes archaea, fungi, viruses and 
protozoa but is largely dominated by bacteria. The composition and density of the microbiota 
vary along the GI-tract and can reach densities of 1012 bacteria per gram of luminal content in 
the colon (Whitman, Coleman et al. 1998) with an estimated total of 1014 bacteria in a healthy 
adult amounting to 1 kg in weight. The intestinal microbiota of healthy adults is dominated by 
bacteria belonging to the Bacteroidetes, Firmicutes and Actinobacteria phyla (Backhed, Ley et 
al. 2005; Eckburg, Bik et al. 2005; Ley, Hamady et al. 2008). The relationship between 
mammals and the microbiota has evolved to be mutualistic and largely symbiotic in nature. In 
the colon, the microbiota obtains energy from the degradation of plant polysaccharides and 
other non-digestible carbohydrates increasing the energy harvest for the host. Moreover, the 
microbiota contributes to homeostasis of tolerance and immunity through interactions of 
microbial metabolites and other components with the host innate and adaptive immune 
systems. The coevolution of a mutualistic relationship between the host and the microbiota 
required the mucosal immune system to develop the ability to defend the body against 
infections of pathogenic microorganisms while avoiding excessive inflammatory responses to 
harmless antigens and commensal bacteria. This is achieved by the presence of an effective 
gut barrier to prevent bacterial contact with the epithelium and a finely tuned network of 
mechanisms for microbial recognition and tolerance to the microbiota. These mechanisms are 
described in detail in Chapter 1, where it is shown how the host immune system actively 
controls the microbiota and the microbiota, in turn, actively shapes the host immune 
response. The contribution of different components of the microbiota to the homeostasis of 
this mutualistic relationship is still being unravelled. The research described in this thesis 
aimed at enhancing our understanding of this mutualism between the microbiota, its 
components and the host. The two broad aims of this thesis were, firstly, to investigate the 
physical interaction of bacteria with the mucosa and mucosal lymphoid tissue in vivo and the 
microbe-epithelial Toll-like receptor (TLR) signalling in vitro and  secondly, to investigate the 
interactions of an abundant colonic commensal, Faecalibacterium prausnitzii, with the 
immune system in vitro and in vivo.  
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Host-microbe interactions at the mucosal interface 
In Chapter 3, using histology techniques we showed that the secreted mucus presents a 
formidable physical barrier to the direct interaction of bacteria with the epithelial surface. 
Nevertheless, intact and viable intestinal bacteria were found intracellularly in the Peyer’s 
patches (PPs) and the mesenteric lymph nodes (MLNs, most likely within dendritic cells (DCs)). 
Intestinal DCs were previously shown to be restricted to the mucosal tissues, PP, and MLNs 
(Macpherson 2004). Retinoic acid, synthesized by the intestinal epithelium and gut-associated 
DCs, induces the expression of the specific mucosal homing receptors integrin α4β7 and 
chemokine receptor CCR9 in T cells residing in the mucosal lymphoid tissue, ensuring their 
homing to the mucosa. This ensures that immune responses to commensal bacteria are 
induced locally, without potentially damaging systemic immune responses (Iwata, Hirakiyama 
et al. 2004). The compartmentalisation of mucosal immunity is one of the mechanisms by 
which pathological immune responses to the intestinal microbiota are avoided. The 
preliminary study described in Chapter 3 focused on PPs and antigen sampling. It is now 
appreciated that the colon also contains an additional type of lymphoid tissue, the solitary 
intestinal lymphoid tissues (SILT) which change in response to the luminal microbiota and 
develop in mature isolated lymphoid follicles (ILFs) (Hamada, Hiroi et al. 2002; Lorenz, Chaplin 
et al. 2003; Pabst, Herbrand et al. 2006). ILFs can also function as inductive sites for mucosal 
immune responses and possess a follicle associated epithelium containing M cells as well as B 
cell follicles, with germinal centers and interfollicular T cells (Lorenz, Chaplin et al. 2003).  
The conclusion of the preliminary work discussed in Chapter 3 was that the uptake of bacteria 
occurs mainly in organized lymphoid structures such as PPs or ILFs because, with the 
exception of segmented filamentous bacteria (SFB), bacteria were not seen below the mucus 
and in contact with the intestinal epithelium. However, these observations are based on 
inspection of microscopy images and do not exclude the possibility that at low frequency, 
commensal bacteria breach the mucus barrier and contact the epithelium. Furthermore, 
microbial associated molecular patterns (MAMPs) of commensal organisms could diffuse 
through the mucus and trigger pattern recognition receptor signalling in epithelial cells.   
The recognition of bacterial components by innate TLRs on intestinal epithelial cells (IECs) was 
studied using Caco-2 and HT-29 cell lines in Chapter 2. In the intestinal mucosa, several 
adaptations of TLR signalling have evolved to avoid chronic inflammatory responses to the 
presence of commensal microbes. In this chapter, we investigated whether polarized IECs 
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might regulate inflammatory responses by secreting interleukin 8 (IL-8) in a vectorial fashion 
(i.e. apical versus basolateral) depending on the location of the TLR stimulus. In addition, we 
hypothesized that CXCR1, the G-protein coupled receptor (GPCR) for IL-8, might control 
specific functions in polarized IECs depending on its location. The vectorial secretion of IL-8 
was studied stimulating the polarized IEC lines Caco-2 and HT-29 with TLR agonists applied 
from the apical or basolateral side and IL-8 was measured in the two compartments. Both 
Caco-2 and HT-29 stimulation with TLR agonists induced apical secretion of IL-8 suggesting 
that, depending on the TLR stimulus, the chemokine could be secreted either from the apical 
or the basolateral side of the epithelial monolayer. CXCR1 was located on the apical side of 
Caco-2 cells and of differentiated epithelial cells in human duodenum and colon but not in 
crypt epithelial cells. Moreover, transcriptome analyses suggested that IL-8 induced GPCR 
signalling in Caco-2 cells and was involved in the regulation of cell differentiation but not 
proliferation. Previous studies have reported that IL-8 promotes wound repair in epithelial 
cells by stimulating cell migration. Luminal IL-8 has been measured in the colon milieu of 
healthy volunteers (Keshavarzian, Fusunyan et al. 1999). This result, together with the apical 
location of CXCR1 in human intestinal tissues and the microarray analysis of Caco-2 cells 
treated with IL-8, support the hypothesis that this chemokine has an autocrine function in 
vivo. Apical IL-8 could be induced in vivo by steady-state activation of TLRs by MAMPs of 
commensal bacteria and have an autocrine role on IECs. The polarized secretion of IL-8, IL-1 
and IL-6 has been reported in epithelial cell lines of different tissue origin (Cudicini, Kercret et 
al. 1997; Holtkamp, Van Rossem et al. 1998; Sonnier, Bailey et al. 2010). A similar autocrine 
role has been proposed for CCL20, which is also induced by inflammatory pathways in 
epithelial cells. CCL20 binds to the CCR6 receptor on the apical pole of differentiated epithelial 
cells (Yang, Ogawa et al. 2005) and induces epithelial cell migration in vitro (Vongsa, 
Zimmerman et al. 2009).  
In summary, the findings of Chapter 2 suggest that IL-8 is secreted apically in vivo and that it 
has a role in epithelial repair. However, this hypothesis remains to be confirmed by in vivo 
studies. 
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Effects of the commensal F. prausnitzii on mucosal dendritic cells and T cells  
Faecalibacterium prausnitzii was selected as a commensal to study in more detail due to its 
reduced abundance in inflammatory bowel disease (IBD) patients and reported anti-
inflammatory effects (Sokol, Pigneur et al. 2008; Sokol, Seksik et al. 2009). The demonstration 
that F. prausnitzii can attenuate TNBS-induced colitis in mice highlights its potential to be 
exploited as a therapeutic for IBD (Sokol, Pigneur et al. 2008). However, it is necessary to 
understand the mechanisms involved in the suppression of inflammation and whether all 
strains of F. prausnitzii have similar immunomodulatory effects on the immune system. The 
latter is especially important considering the fact that the beneficial effects of probiotics in 
animal models and clinical trials has been shown to be strain-dependent (Rijkers, Bengmark et 
al. 2010). F. prausnitzii is one of the most abundant commensal bacteria in humans and is a 
strict anaerobe; this bacterium is most abundant in the colon where it metabolizes butyrate as 
the main end product of fermentation. Being a highly abundant member of the colonic 
microbiota, F. prausnitzii could be sampled by M cells in the follicular epithelium of ILFs and 
influences primary T cell responses. Additionally, anti-inflammatory components of F. 
prausnitzii could diffuse through the mucus layer and interact with epithelial cells. In this 
respect, Sokol et al., showed that an unidentified component of F. prausnitzii supernatant 
inhibits IL-8 secretion induced by IL-1β in Caco-2 cells (Figure 1) (Sokol, Pigneur et al. 2008). 
Furthermore, colitis results in translocation of intestinal bacteria into the mucosal tissues 
(Waeytens, Ferdinande et al. 2008) highlighting the relevance of also studying the direct 
interactions of F. prausnitzii with antigen presenting cells and T cells in the lamina propria and 
the immune response in mouse colitis models.  
Chapter 4, 5 and 6 focused on the effects of F. prausnitzii on the host immune system, in 
particular, on DCs and T cells in vitro and on mucosal T cells in vivo.  
In Chapter 4, thirteen human commensal bacteria, including five F. prausnitzii strains, were 
tested for their immunomodulatory properties in vitro on human monocyte-derived DCs 
(hDCs). All commensal strains induced increased surface expression of the co-stimulatory 
molecules CD83 and CD86 but among these, F. prausnitzii A2-165, Megamonas rupellensis 
Mag1B and Eubacterium hallii L2-7 elicited distinct patterns of cytokine response in hDCs. 
These differential immunomodulatory effects were due to the high levels of IL-10 and low 
levels of IL-12 secretion induced by F. prausnitzii A2-165, the high levels of IL-12 and TNF-α 
induced by M. rupellensis Mag1B and the high levels of IL-10 and IL-12 induced by E. hallii L2-
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7. Clostridium hathewayi 82-B and C. xylanovorans Lac1D induced low or no NF-κB activation 
in the TLR assays and low or undetectable cytokines in hDCs despite the fact that they induced 
their activation and maturation; suggesting that these strains might express MAMPs that are 
shielded or not recognized by the TLRs tested or that they possess immunomodulatory 
components that inhibit activation of the NF-κB pathway. This appears to be a unique 
property and may be an evolutionary adaptation to avoid immune recognition by the host as 
proposed for Bacteroides fragilis (Weintraub, Zahringer et al. 1989). Interestingly, F. 
prausnitzii A2-165 had a different immune profile compared to the other F. prausnitzii strains 
tested. The high IL-10 to IL-12 ratio induced by F. prausnitzii A2-165 in hDCs, was previously 
observed in human peripheral blood mononuclear cells (hPBMCs) and was suggested to be 
linked to  the protective effects  in vivo against 2,4,6-trinitrobenzene sulfonic acid (TNBS)-
induced colitis (Sokol, Pigneur et al. 2008). In Chapter 5, we showed that F. prausnitzii A2-165 
stimulation of mouse bone marrow-derived DCs (BMDCs) enhanced CD86 and CD40 
expression and induced IL-10 and TNF secretion but, in contrast with what observed in hDCs, 
it also induced IL-12 secretion. The induction of IL-10 secretion by hDCs in response to F. 
prausnitzii may be linked to its anti-inflammatory properties (Figure 1) because IL-10 is 
important for the maintenance of functional Foxp3+ Tregs during intestinal inflammation 
(Murai, Turovskaya et al. 2009). IL-10 also inhibits the production of pro-inflammatory 
cytokines such as IFN-γ, TNF-α, IL-6 and IL-12 and it was shown to enhance the suppressive 
activity of Foxp3+ Tregs in the mucosa (Murai, Turovskaya et al. 2009).  
The effects of BMDCs stimulated with F. prausnitzii A2-165 on antigen-specific CD4+ T cell 
proliferation as well the direct effect on T cells were studied in vitro. BMDCs stimulated with 
F. prausnitzii A2-165 induced increased proliferation of antigen-specific CD4+ T cells. When 
added directly to CD4+ T cells, F. prausnitzii A2-165 stimulated differentiation of IL-10 or IFN-γ 
producing T cells without affecting the number of proliferating cells. In these experiments, C. 
hathewayi 82-B was used for comparison. Despite inducing little or no cytokine secretion in 
hDCs or mouse BMDCs, BMDCs pre-stimulated with C. hathewayi 82-B appeared to be highly 
effective in stimulating T cells in vitro.  Indeed, the percentage of T cells staining positive for 
intracellular markers of different T cell subsets (i.e. IFN-γ, IL-17 and Foxp3) were significantly 
higher for T cells incubated with BMDCs pre-stimulated with C. hathewayi 82-B than with 
BMDCs pre-stimulated with F. prausnitzii A2-165.  
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Commensal bacteria play an essential role in shaping T cells responses, in particular in the 
induction of Tregs in the colon (Kiyono, McGhee et al. 1982; Tanaka and Ishikawa 2004). 
Accumulation of colonic IL-10-secreting Foxp3+ Tregs is also induced by colonization of germ-
free mice with B. fragilis (Round and Mazmanian 2010). Additionally, in conventional mice, 
administration of Bifidobacterium species has been shown to induce IL-10 producing Tregs in 
the colon (Jeon, Kayama et al. 2012). Thus, commensals can act on mucosal T cells at different 
stages during their activation, differentiation, accumulation in the LP and maintenance in the 
LP.   
In order to gain insight into how the in vitro immune properties of F. prausnitzii A2-165 and C. 
hathewayi 82-B would translate to effects on T cell priming in vivo, in Chapter 5 we 
investigated their effects in a model for nasal tolerance induction to the antigen ovalbumin 
(OVA). Nasal tolerance is known to have many similarities to oral tolerance induction (Unger, 
Hauet-Broere et al. 2003; Samsom 2004) and application of bacteria via the nasal route 
effectively targets responses in the nose-draining cervical lymph nodes (CLNs). The in vitro 
immunoregulatory effects of F. prausnitzii A2-165, translated in vivo into enhanced OVA-
specific T cell proliferation in the nose-draining CLNs after intranasal administration of F. 
prausnitzii A2-165 with OVA. Interestingly, this was associated with a reduction of IFN-γ+ T 
cells in the CLNs. In contrast to F. prausnitzii A2-165, C. hathewayi 82-B significantly decreased 
the percentage of dividing T cells in the CLNs and spleen in vivo. These data show that the in 
vitro and in vivo outcomes can differ. In vivo the epithelium and other stromal cells can 
influence the crosstalk between signals in the lumen and the underlying immune cells. In vivo 
factors produced by enterocytes and other stromal cells such as TGF- and retinoic acid and 
thymic stromal lymphopoietin (TSLP) induce tolerogenic DCs expressing CD103 and CCR7 that 
migrate to the draining lymph nodes and induce Foxp3+ Tregs (Iliev, Spadoni et al. 2009). 
These observations do not explain why intranasal administration of C. hathewayi 82-B with 
OVA inhibits OVA-specific T cell proliferation in the nose-draining CLNs. This might be related 
to effects of the bacterium on epithelium signalling or C. hathewayi 82-B might inhibit the 
migration of DCs from the mucosa to the draining lymph nodes, blocking the activation and 
expansion of T cells within the CLNs. Alternatively, the suppression of DC cytokine production 
induced by C. hathewayi 82-B may have a negative influence on their capacity to induce T cell 
priming in the CLNs. Future experiments are in progress to investigate these hypotheses in 
vivo. 
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In summary, our data demonstrate that F. prausnitzii A2-165 has immunoregulatory 
properties and indicate that the bacterium has a strong capacity to induce IL-10 by both DCs 
and T cells. Moreover, F. prausnitzii A2-165 administration in vivo induced an increase in 
proliferating T cells and a decrease of IFN-γ producing T cells without modifying the other T 
cell subsets analyzed (IL-10+, IL-17+, Foxp3+) suggesting that another T cell population might 
be affected (Figure 1). 
 
Effects of F. prausnitzii on colitis 
The protective effects of F. prausnitzii strain A2-165, HTF-F and the extracellular polymeric 
matrix (EPM) produced by strain HTF-F were explored using the dextran sodium sulphate 
(DSS)-induced colitis model in Chapter 6. F. prausnitzii HTF-F was selected on the basis of its 
distinct capacity to undergo intercellular aggregation and form a dense biofilm in liquid 
culture. Bacterial exopolysaccharides are common components of biofilm matrices and have 
been previously shown to have immunomodulatory effects (Mazmanian, Round et al. 2008; 
Round and Mazmanian 2010; Fanning, Hall et al. 2011). For this reason, we also characterised 
the immune properties of the cell-free EPM from strain HTF-F in vitro and compared its 
protective effects to F. prausnitzii strains A2-165 and HTF-F in DSS-induced colitis. Both strains 
of F. prausnitzii attenuated the clinical symptoms of DSS-induced colitis, decreased the 
disease activity index (DAI) and reduced the loss of body weight. F. prausnitzii HTF-F appeared 
to have a stronger anti-inflammatory effect than strain A2-165 because it also significantly 
reduced the colon histological damage score and increased colon length.  
A decrease in the frequency of Bacteroidetes and Firmicutes and an increase of 
Proteobacteria and Actinobacteria has been observed in the faecal microbiota of 
inflammatory bowel disease patients (Frank, St Amand et al. 2007). Patients with active 
Crohn’s disease and ulcerative colitis have lower faecal counts of Firmicutes, in particular 
lower counts of F. prausnitzii, compared with healthy subjects (Sokol, Seksik et al. 2009). 
Moreover, F. prausnitzii A2-165 and its culture supernatant were shown to attenuate TNBS-
induced colitis in mice by daily intragastric administration prior to and during the induction of 
colitis (Sokol, Pigneur et al. 2008). Intraperitoneal injection of F. prausnitzii A2-165 also 
significantly improved survival of mice with TNBS-induced colitis (Sokol, Pigneur et al. 2008).  
In the study of Sokol et al., the colons of mice treated with either F. prausnitzii or its 
supernatant had a reduced amount of IL-12 and an elevated amount of IL-10 compared with 
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the colitis control group which is compatible with the high amount of IL-10 induced by F. 
prausnitzii A2-165 in vitro in hPBMCs (Sokol, Pigneur et al. 2008) and our results in human and 
murine DCs. The TNBS colitis model is thought to resemble Crohn’s disease because the 
resulting mucosal inflammation is mediated by a Th1 response with excessive production of 
IFN-γ, TNF-α and IL-12. The DSS model mimics the clinical and histological characteristics of UC 
(Yan, Kolachala et al. 2009); this could explain the differences between our results and that 
previously reported. 
 
 
 
Figure 1: Proposed anti-inflammatory mechanism of F. prausnitzii. 
The supernatant of F. prausnitzii blocks NF-κB activation induced by a pro-inflammatory stimulus (Sokol, Pigneur 
et al. 2008). F. prausnitzii components might interact with CD103
+
 dendritic cells (DCs) in the lamina propria and 
stimulate their migration to mesenteric lymph nodes (MLN) or gut associated lymphoid tissue (GALT) and the 
induction of Tregs. In vivo, F. prausnitzii stimulates mucosal T cell priming to a model antigen but decreased the 
IFN-γ
+
 (Th1) response through an unknown mechanism. This may occur through M cell transcytosis of F. 
prausnitzii in organized lymphoid structures (GALT or MLN) or via the migrating population of CD103
+
 DCs. The 
capacity of F. prausnitzii to induce high amounts of IL-10 in antigen presenting cells, such as DCs, may enhance 
the suppressive activity of Foxp3
+
 Tregs and block Th17 cells induced by pro-inflammatory stimuli. 
 
The purified cell-bound EPM isolated from F. prausnitzii HTF-F contains carbohydrate and 
protein which are commonly involved in intercellular aggregation of biofilms (Flemming and 
Wingender 2010). To investigate the contribution of the EPM to the protective effects of F. 
prausnitzii HTF-F, the immunomodulatory properties of the EPM were investigated in vitro 
and in vivo. If added together with L. plantarum as an inflammatory stimulus to hDCs, the EPM 
decreased the production of IL-12 compared to L. plantarum and had no effect on IL-10, IL-1β 
and TNF-α. A similar effect was seen on IL-12 production by mouse BMDCs but, in contrast to 
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hDCs, the EPM induced an increase in IL-10. Furthermore, the EPM had an anti-inflammatory 
effect in the DSS-induced colitis model and induced an increase in Foxp3+ T cells in MLNs 
suggesting that it contributes to the protective effects of F. prausnitzii HFT-F. Although the 
EPM itself did not activate DCs or induce TLR2 signalling in reporter cell lines, its effect on 
cytokine production in vitro was dependent on TLR2, suggesting an interaction with this 
signalling pathway. This might involve interactions via carbohydrate receptors such as C-type 
lectins some of which are known to modulate cytokine production in response to TLR 
agonists. Similarly to the EPM, polysaccharide A (PSA) from B. fragilis can activate T cell-
dependent immune responses and confer protection against TNBS-induced colitis through a 
TLR2-dependent mechanism (Round and Mazmanian 2010) but in this case a direct interaction 
of PSA with TLR2 has been proposed. 
 
Major conclusions and future perspectives  
In conclusion, this work increased our knowledge on the role of the microbiota and its 
components on host immunity.  
Chapter 2 demonstrated that the chemokine IL-8 can be secreted from the apical side of IECs 
and have an autocrine role on IECs. Moreover, we hypothesise that IL-8 might be involved in 
epithelial repair but this hypothesis remains to be confirmed by in vivo studies. In Chapter 3 
we showed that the uptake of bacteria occurs mainly in the organized lymphoid structures 
such as the PPs or ILFs and their presence in the MLN cells suggests an influence on mucosal T 
cell priming. The results presented in this chapter, are preliminary and one of our future aims 
will be to confirm the reported lack of mucus over the follicular epithelium of the PPs and to 
stain for both L. plantarum and DCs in tissue section of the ileum, colon and PPs.  
In the studies presented in Chapter 4 to 6, we demonstrate that the commensal bacterium F. 
prausnitzii has immunomodulatory effects on DCs and on T cells both in vitro and in vivo. F. 
prausnitzii strain A2-165, which was previously described for its anti-inflammatory properties 
and for its protective effects (Sokol, Pigneur et al. 2008), induces a unique cytokine profile 
compared to other commensal bacteria in hDCs. This strain induced large amounts of secreted 
IL-10 in hDCs and mouse BMDCs and in vivo, it reduced the numbers of IFN-γ producing T cells 
but had no effects on IL-10, IL-17 or Foxp3 expression. The cytokine profiles induced by F. 
prausnitzii were strain dependent and among 5 strains tested; strain A2-165 induced the 
largest amount of IL-10 and the smallest amount of IL-12. Strain dependent differences in 
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cytokine profiles have been described previously for L. plantarum and linked to genetic factors 
such as bacteriocin production and altered TLR recognition due to enzymes modifying 
structures of MAMPs (Meijerink, van Hemert et al. 2010). Gene-trait matching could be used 
to identify genetic loci correlated with the immune response. At the moment only the 
genome of two F. prausnitzii strains is complete and only one has been annotated. Therefore, 
microarray-based genome composition studies are already feasible using labelled genomic 
DNA from different strains. Furthermore, F. prausnitzii strain HTF-F which produces a thick 
biofilm in liquid culture is protective against DSS-induced colitis and this may in part be due to 
the immune-regulating properties of the EPM. F. prausnitzii HTF-F and the EPM are interesting 
candidates for the treatment of IBD because they were more effective at suppressing 
inflammation in DSS colitis than the previously described F. prausnitzii strain A2-165. Although 
we could prove that the EPM was not contaminated with MAMPs, its composition and its level 
of purity are still unknown. We hypothesise that the major component of the EPM is an 
exopolysaccharide (EPS). EPS production is common among different bacteria and has roles in 
colonization, protection from bile conditions and low pH. Examples of beneficial surface-
polysaccharide from commensal bacteria are the cell surface-associated EPS from 
Bifidobacteium breve which promotes the in vivo persistence of the bacterium (Fanning, Hall 
et al. 2011) and the PSA from B. fragilis which increases the numbers of Foxp3+ Tregs in MLNs 
and confers protection from TNBS-induced colitis in mice (Mazmanian, Round et al. 2008; 
Round and Mazmanian 2010). Efforts are underway to purify the EPS and determine and its 
composition and structure so that future experiments can be performed with purified 
components. Once the EPS is purified it might be interesting to identify the EPS-encoding 
genetic loci and to create EPS deletion mutants. Presently, no methods have been described 
for the genetic manipulation of F. prausnitzii but this would open up possibilities for using 
genetic approaches to confirm the anti-inflammatory and protective role of the EPS.  
Apart from the study on F. prausnitzii, our work identified other commensal bacterial strains 
with interesting effects on immune cells in vitro and in vivo. C. hathewayi 82-B for example, 
induced very low cytokine production in DCs despite inducing their activation in vitro. 
Furthermore, this strain significantly reduced the number of dividing antigen-specific T cells in 
vivo. C. hathewayi 82-B might prevent DCs migration from the periphery to the CLNs or it 
might affect the capacity of DCs to prime naive T cells and will be the subject of future studies.  
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Summary 
 
The intestinal microbiota plays role in intestinal homeostasis via interactions with the 
epithelium and innate and adaptive immune mechanisms of the gut thereby profoundly 
shaping mammalian mucosal immunity and tolerance. However, in some diseases, such as 
inflammatory bowel disease (IBD), the microbiota may assume a pathologic character 
accentuating the damage to the host. Despite the recent advances in our understanding of the 
microbiota structure at different stages of life and the perturbations associated with disease, 
our understanding of its functional impact and the contribution of individual microbial 
components on health is still in its infancy. The aim of this thesis was to contribute to our 
knowledge and understanding of several aspects of the interactions between gut commensal 
bacteria and host, focusing on one of the most abundant colonic microbes, F. prausnitzii, for 
the detailed mechanistic studies.  
In Chapter 2, we investigated whether polarized intestinal epithelial cells regulate 
inflammatory responses to microbes by secreting the chemokine IL-8 in a vectorial fashion 
depending on the location of the Toll-like receptor (TLR) stimulus. In the Caco-2 model of 
polarized epithelium, apical stimulation with TLR2 and TLR5 ligands resulted in the apical 
secretion of IL-8. The CXCR1 receptor for IL-8 was expressed only on the apical membrane of 
Caco-2 cells and differentiated epithelial cells in the human small intestine and colon 
suggesting that IL-8 has an autocrine function. Transcriptome analyses revealed that Caco-2 
cells respond to stimulation with IL-8, supporting the hypothesis of autocrine signalling via 
CXCR1. We speculated that this mechanism might be an evolutionary adaptation to the 
coexistence with microbiota whereby bacterial microbe-associated molecular patterns are 
utilized to trigger repair mechanisms in epithelial cells.  
In Chapter 3, mono-associated and conventional mice were used to gain new insights into the 
interaction of bacteria with the host mucosa and mucosal-associated lymphoid tissue. The 
vast majority of the bacteria are kept at a distance by the host physical and chemical barriers 
except for segmented filamentous bacteria which appear to have unique and specialized 
physical interactions with the epithelium.  
Chapter 4, 5 and 6 focused on the immunoregulatory mechanisms of the human commensal 
F. prausnitzii, which has been proposed to have anti-inflammatory properties and is 
underrepresented in IBD patients with active disease.  
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In Chapter 4, we compared the effects of F. prausnitzii and other commensal bacterial strains 
on human monocyte derived dendritic cells (hDCs). F. prausnitzii strain A2-165 induced a very 
different cytokine profile in hDCs compared with four other F. prausnitzii strains and eight 
other commensal strains, this was due to the high levels of secreted IL-10 and low levels of IL-
12. 
The effects of F. prausnitzii A2-165 and another commensal strain on the induction of mucosal 
T cell responses to the model antigen ovalbumin (OVA) in vitro and in vivo were studied in 
Chapter 5. Here we demonstrated that F. prausnitzii A2-165 had immunoregulatory 
properties in vitro which may be related to its strong capacity to induce IL-10 by both DCs and 
T cells. These effects translated in vivo into enhanced OVA-specific T cell proliferation in the 
nose-draining cervical lymph nodes (CLNs) after combined nasal application of F. prausnitzii 
A2-165 and OVA. Strikingly, this was associated with a reduction in the differentiation of IFN-γ 
secreting T cells in the CLNs. In contrast, a different commensal, Clostridium hathewayi 82-B, 
significantly decreased the percentage of dividing OVA-specific T cells in the CLNs and spleen.  
In Chapter 6, we investigated the immunomodulatory effects of F. prausnitzii strain A2-615, 
strain HTF-F which forms a biofilm in liquid culture and the extracellular polymeric matrix 
(EPM) purified from strain HTF-F. The protective capacity of the two strains and the EPM were 
investigated in the DSS-induced colitis model. Both F. prausnitzii strains attenuated the 
disease activity index, but the biofilm producing strain HTF-F conferred increased protection 
compared to strain A2-165 and this was partly due to the immunomodulatory properties of 
the EPM.  
Chapter 7 summarizes and discusses the results of the thesis in the context of wider literature 
on host-microbe interactions and mucosal immunology. Furthermore, the implications of this 
work on intestinal health and the possible directions for future research are discussed. 
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De darm microbiota speelt een rol in het bewaren van evenwicht in de darm via interacties 
met epitheel en aangeboren en adaptieve immuunsystemen in de darm, tegelijkertijd een 
aanzienlijke bijdrage leverend aan het tot stand komen van mucosale immuniteit en immuun-
tolerantie in zoogdieren. Echter, in een aantal ziektes waaronder ontstekingsziekten van de 
darm (IBD) kan de microbiota een ziekteverwekkend karakter aannemen, onder die 
omstandigheden bijdragend aan schade aan de gastheer. Ondanks de recente doorbraken in 
ons begrip van de microbiota samenstelling gedurende verschillende levens-stadia en de 
verstoringen welke gepaard gaan met ziekte staat ons begrip van het functionele belang en de 
bijdrage van individuele microbiële componenten op gezondheid nog steeds in de 
kinderschoenen. Het doel van dit proefschrift was: bijdragen aan onze kennis en begrip van 
een aantal aspecten van de interacties tussen symbiotische bacteriën in de darm en hun 
gastheer, met speciale aandacht voor één van de meest voorkomende bacteriën van de dikke 
darm: Faecalibacterium prausnitzii, in gedetailleerde mechanistische studies.  
In Hoofdstuk 2 hebben we onderzocht of gepolariseerde darmepitheel cellen een ontstekings-
respons op microbes induceren door het gericht uitscheiden van de chemokine IL-8, 
afhankelijk van de locatie van een Toll-like receptor (TLR) prikkel. In het Caco-2 model van 
gepolariseerd epitheel leidde prikkelen vanaf de apicale zijde met TLR2 en TLR5 liganden tot 
de apicale uitscheiding van IL-8. De IL-8 receptor CXCR1 kwam alleen op het apicale 
membraan van Caco-2 cellen en gedifferentiëerde epitheelcellen in de menselijke dunne en 
dikke darm tot expressie, suggererend dat IL-8 een autocriene functie zou kunnen hebben. 
Transcriptoom analyses lieten zien dat Caco-2 cellen reageren op prikkeling met IL-8, wat de 
hypothese van het bestaan van autocriene signalen via CXCR1 ondersteunde. We 
speculeerden dat dit mechanisme een evolutionaire aanpassing aan het samenleven met de 
microbiota zou kunnen zijn, waarbij bacteriële microbe-geassociëerde moleculaire patronen 
worden benut om weefsel-herstelmechanismen in epitheelcellen te stimuleren.  
In Hoofdstuk 3 werden muizen gekoloniseerd met 1 bacterie-stam samen met standaard 
gekweekte muizen gebruikt om nieuwe inzichten in het samenspel van bacteriën met de 
mucosa en het mucosaal-geassociëerde lymphoïde weefsel van hun gastheer te verwerven. 
De overgrote meerderheid van de bacteriën worden op afstand van hun gastheer gehouden 
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door fysieke en chemische barrières; dit gold niet voor gesegmenteerde filamenteuze 
bacteriën die unieke en gespecialiseerde interacties met het epitheel lijken te hebben.  
Hoofdstuk 4, 5 en 6 richtten zich op immuun-regulerende processen van de humane 
commensale bacterie Faecalibacterium prausnitzii, welke verondersteld wordt 
ontstekingsremmende eigenschappen te hebben, en welke in lagere aantallen voorkomt in 
IBD patiënten met actieve ziekte.  
In Hoofdstuk 4 vergeleken we de effecten van F. prausnitzii en andere commensale 
bacteriestammen op uit monocyten verkregen dendritische cellen (hDCs) van de mens. F. 
prausnitzii stam A2-165 induceerde, als gevolg van hoge niveau's van uitgescheiden IL-10 en 
lage niveau's van IL-12, een sterk afwijkend cytokine profiel in hDCs in vergelijking met vier 
andere F. prausnitzii stammen en acht andere commensale stammen. 
De effecten van F. prausnitzii A2-165 en een tweede commensale stam op de inductie van 
mucosale T cel responsen op het model antigen ovalbumin (OVA) in vitro en in vivo werden in 
Hoofdstuk 5 bestudeerd. We tonen hier aan dat F. prausnitzii A2-165 in vitro een aantal 
immuun-regulerende eigenschappen had welke gerelateerd zouden kunnen zijn aan de sterke 
capaciteit van deze stam om IL-10 productie door DCs en T cellen te induceren. Deze effecten 
vertaalden zich in vivo in een toegenomen OVA-specifieke T cel vermenigvuldiging in de 
lymfeknopen uit de nek (CLNs) die de neus draineren, na een gecombineerde toediening van 
F. prausnitzii A2-165 en OVA via de neus. Het was opmerkelijk dat dit gepaard ging met een 
afname van de differentiatie van gamma-interferon (IFN-γ) uitscheidende T cellen in de CLNs. 
In contrast hiertoe stond een andere commensale stam, Clostridium hathewayi 82-B, welke 
een significante afname van het percentage delende OVA-specifieke T cellen in de CLNs en 
milt bewerkstelligde.  
In Hoofdstuk 6 onderzochten we immuun-modulerende effecten van F. prausnitzii stam A2-
615, van stam HTF-F welke een biofilm vormt in vloeibaar medium, en van de extracellulaire 
polymeer matrix (EPM) gezuiverd uit stam HTF-F. De beschermende capaciteit van de twee 
stammen en de EPM werden onderzocht in het DSS-colitis muis model. Beide F. prausnitzii 
stammen beperkten de ziekte-activiteits score, maar de biofilm-producerende stam HTF-F 
bewerkstelligde een verhoogde bescherming in vergelijking tot stam A2-165 en dit was 
gedeeltelijk het gevolg van de immuun-modulerende eigenschappen van het EPM.  
Hoofdstuk 7 vat de resultaten uit dit proefschrift samen en bediscussiëert ze in een brede 
literatuur context in het licht van gastheer- microbe interacties en mucosale immunologie. 
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Voorts worden de voortvloeisels van dit onderzoek op gezondheid van de darm, en de 
mogelijkheden voor verder onderzoek bediscussiëerd.                                 
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